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ABSTRACT 
 
Mechanistic Studies and Function Discovery of Mononuclear Amidohydrolase Enzymes. 
(December 2009) 
Richard Stuart Hall, B.S., The University of Arizona 
Chair of Advisory Committee: Dr. Frank M. Raushel 
 
The amidohydrolase superfamily is a functionally diverse group of evolutionarily 
related proteins which utilize metal cofactors in the activation of a hydrolytic water 
molecule and in the stabilization of the resulting tetrahedral intermediate. Members of 
this superfamily have been described which use one or two divalent transition metals. 
These metal cofactors are located in either or both of two active-site metal binding 
centers which are labeled as the Mα and Mβ sites. The goal of this research was to 
elucidate the nature of the reactions catalyzed by Mα and Mβ mononuclear members of 
the amidohydrolase superfamily. This was approached through comprehensive 
mechanistic evaluations of two enzymes which utilized the different metal sites. N-
acetyl-D-glucosamine-6-phosphate deacetylase from E. coli (NagA) and cytosine 
deaminase from E. coli (CDA) served as models for mononuclear amidohydrolase 
superfamily enzymes which have evolved to utilize a single β-metal and a single α-metal 
for hydrolysis, respectively. This research elucidated the different properties imparted by 
the distinct α and β active sites and the specific interactions utilized by the enzymes for 
substrate binding and catalysis. These studies led to the eventual proposal of detailed 
 iv
chemical mechanisms and the identification of rate determining steps. Knowledge of 
sequence-function relationships was applied toward the discovery of function for 
enzymes related to cytosine deaminase and guanine deaminase. The first group of 
enzymes investigated was proposed to catalyze the fourth step in riboflavin and 
coenzyme F420 biosynthesis in Achaea. Three putative deaminases; Mm0823 from 
Methanosarcina mazei, MmarC7_0625 from Methanococcus maripaludis C7 and 
Sso0398 from Sulfolobus solfataricus were cloned and expressed. These proteins proved 
to be intractably insoluble. A second set of enzymes, Pa0142 from Pseudomonas 
aeruginosa PA01 and SGX-9236e (with crystal structure PDB: 3HPA) were found to 
catalyze the novel deamination of 8-oxoguanine, a mutagenic product of DNA oxidation. 
9236e was cloned from an unidentified environmental sample of the Sargasso Sea. The 
closest homolog (98% identical) is Bcep18194_A5267 from Burkholderia sp. 383. 
Additionally, it was discovered that the proteins SGX-9339a (with crystal structure PDB: 
2PAJ) and SGX-9236b catalyzed the deamination of isoxanthopterin and pterin-6-
carboxylate in a poorly characterized folate degradation pathway. These enzymes were 
also from unknown environmental samples of the Sargasso Sea. The closest homolog of 
9339a (88% identical) is Bxe_A2016 from Burkholderia xenovorans LB400. The closest 
homolog of 9236b (95% identical) is Bphyt_7136 from Burkholderia phytofirmans 
PsJN. 
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CHAPTER I 
INTRODUCTION: ENZYMES AND THE AMIDOHYDROLASE SUPERFAMILY 
  Enzymes play an essential role in nature by catalyzing the transformation of 
energy and materials into a variety of useful forms. At first glance, enzymes can be 
viewed as mere protein.  Fundamentally, enzymes are folded polymers made up of 
twenty different amino acids which may have acidic, basic, hydrophobic, hydrophilic, 
positively charged or negatively charged side chains. The true utility of enzymes is 
evident in the reactions they catalyze, often at rates only limited by diffusion.  For 
example, the Cu, Zn superoxide dismutase has a reported catalytic efficiency of 2 x 109 
M-1s-1 (1, 2). The extraordinary feat of catalytic power that can be exerted by a protein is 
best demonstrated with the decarboxylation of uroporphyrinogen III by human 
urophorphyrinogen decarboxylase (UroD). In this example a rate enhancement of over 
1.2 x 1017  was measured, compared to the extrapolated un-catalyzed reaction that occurs 
in water (3). Astonishingly even greater rate enhancements may be achieved by enzymes 
through the use of bound metal cofactors for the activation of hydrolytic water as seen in 
type I protein phosphatase, fructose bisphosphatase and inositol phosphatase, where rate 
enhancements on the order of 1021 were determined (4). Even with diffusion limited 
reaction rates, enzymes are able to exert exquisite substrate specificity as well as   
stereospecific and stereoselective control over the chemical transformations they  
 
catalyze. These molecular machines make it possible for life to exist, providing a steady 
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stream of the energetic and structural compounds necessary for survival and 
reproduction.  
 Enzymology has been studied since the 19th century, when Louis Pasteur 
discovered that fermentation could be performed outside of living cells. In 1926 James 
Sumner purified and crystallized the first protein,  jack bean urease, establishing for the 
first time that enzymes are well defined chemical compounds (5). Since the discovery of 
enzymes, there has always been a great deal of research and even debate over exactly 
how enzymes are able to perform these feats of chemistry. It was proposed by Linus 
Pauling in 1946 that for catalysis to occur, enzymes must have a higher affinity for the 
transition state of the substrate than for the ground state (6).  If an enzyme was to bind 
either the substrate or the product with any great affinity, then a stable complex would 
result, and catalysis might occur slowly or not at all. 
ENZYME CHARACTERIZATION     
 Database Information. Since the beginning of the human genome project in 
1990, there has been an ever growing amount of gene sequence information filling the 
databases.  According to the National Center for Biotechnology Information (NCBI) as 
of May 2009, there are 2538 bacterial, 108 archaeal, 149 animal, 114 fungal, 55 plant, 
and 52 protist genomes that have either been completely sequenced, or are currently 
being sequenced. Meanwhile, protein chemists are utilizing this information for the 
selection, production and purification of many gene products. According to the RCSB 
Protein Data Bank (PDB), there are 57424 protein structures posted as of May 05, 2009. 
230 of those structures have been solved by electron microscopy, 7836 were solved by 
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NMR and 49232 structures were solved by X-ray diffraction. The result is the 
identification of 1283 distinct folds as defined by Structural Classification of Proteins 
(SCOP). Of the available structures, many proteins still do not have a functional 
assignment. According to the PSI Structural Genomics Knowledgebase, there are 1491 
unique proteins of unknown function with available structures that were published by 
four of the associated research centers. Undoubtedly there are many more proteins with a 
known crystal structure that still have no verified function. Even with all of this 
knowledge, there is an even greater amount of biology still left to be discovered. The 
presence of incorrectly annotated enzymes in the genomic databases creates an 
additional layer of complexity for researchers trying to discover the function of unknown 
enzymes. 
  Function Prediction. Modern technology is unable to reliably predict protein 
structure without a high degree of sequence similarity to enzymes whose structures have 
already been determined.  It is more difficult to assign function to those enzymes with no 
known structure, although the identification of a highly conserved cluster of enzymes 
related to a specific pathway may lead toward the proposal of a function. Of the proteins 
with known structure, it has been recently shown that functions may be proposed 
through the docking of high energy transition state structures to the active site of a high 
resolution crystal structure as was recently reported for the discovery of function for 
Tm0936 as an S-adenosylhomocysteine deaminase (7). Even with the increasingly rapid 
progress in computer technology for structural docking and sequence analysis, 
experimental verification of substrate specificity and mechanistic evaluation of active 
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site residues will remain an essential part of the discovery process for the foreseeable 
future. It is these experimental results which give bioinformatics analyses a basis for the 
evaluation and organization of the ever accumulating genetic information.   
 Superfamilies. Proteins which perform similar reactions may be grouped by 
sequence and structural homologies into families, while more divergent groups of related 
enzymes which still share some aspects of function may be grouped into superfamilies 
(8).  Currently there are a total of 2033 protein superfamilies reported by the PDB. Of 
these, there are currently 33 superfamilies identified by SCOP which share the common 
TIM barrel fold (http://scop.mrc-lmb.cam.ac.uk/). Enzymes which are labeled as 
members of the metallo-dependent hydrolases superfamily (amidohydrolase 
superfamily) share the common TIM barrel fold.  It is typically a (β/α) 8 barrel fold 
comprised of eight parallel β-strands which are connected by eight α-helices. Recent 
discoveries have shown the presence of a (β/α) 7 barrel fold as seen for histidinol 
phosphate phosphatase (9).  Flexible loops connecting the carboxyl ends of the β-strands 
to the α-helices provide an inherent flexibility in the enzyme architecture which is 
capable of providing substrate binding as seen for adenosine deaminase (10). The 
conservation of several metal binding histidine residues and an aspartate provide key 
landmarks for the identification of enzymes within this superfamily. However, the 
absolute dependence of the different mechanisms on divalent transition metal cations 
appears to be the most salient unifying feature. Amidohydrolase enzymes are found in 
every organism sequenced to date and are thought to have evolved through divergent 
evolution from a common ancestral precursor (10). It also has been proposed that the 
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ancestral precursor may have actually evolved from the combination of two separate 
(β/α) 4 half-barrels (11).  
 The amidohydrolase superfamily was originally identified by Holm and Sander 
in 1997 based on the conserved structural fold and several catalytically important 
residues possessed by phosphotriesterase, urease and adenosine deaminase (12). 
Currently, there are 10,045 unique sequences in the NCBI database which are labeled as 
members of the amidohydrolase superfamily. Out of these sequences, 41 distinct 
reactions have been characterized and are shown in Scheme 1.1.  The proteins have been 
grouped into clusters of orthologous groups (COGs) which are based on consistent 
patterns of sequence identities, organizing them into families which are evolutionarily 
related. 4873 different COGs have been identified from the comparisons of conserved 
proteins among prokaryotic genomes and 4852 different KOGs have been identified 
from orthologous eukaryotic groups (13, 14). The COG assignments for 66 genomes are 
available at http://www.ncbi.nlm.nih.gov/COG/.  The annotation of genes in newly 
sequenced genomes may be aided through comparison to the existing COG database by 
using the COGnitor sequence comparison tool available at the same site.  
 Divergent Activity within the AHS. Adenine deaminase (ADE) catalyzes the 
deamination of adenine to hypoxanthine (15) and is a member of COG 1001F (Adenine 
Deaminase). Adenosine deaminase (ADA) (16, 17) and adenosine monophosphate 
deaminase (AMPD) (18) catalyze the formation of inosine and inosine monophosphate 
and belong to COG 1816 F (Adenosine deaminase).  Cytosine deaminase (CDA) 
catalyzes the deamination of cytosine to uracil (19-23), and belongs to COG 0402 FR 
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(Cytosine deaminase and related metal-dependent hydrolases). This COG also contains, 
guanine deaminase (GDA) (24), S-adenosylhomocysteine deaminase (SAHD) (7), N-
formimino-L-glutamate deiminase (HutF) (25), atrazine chlorohydrolase (AtzA) and 
melamine deaminase (TriA) (26), s-triazine hydrolase (TrzA) (27), the broad specificity 
triazine hydrolase (TrzN) (28), hydroxyatrazine ethylaminohydrolase (AtzB) (29) and N-
isopropylammelide isopropylaminohydrolase (AtzC) (30).  
 Dihydroorotase (DHO) is the sole member of COG 0148 F and reversibly 
catalyzes the interconversion of carbamoyl aspartate to dihydroorotate in the pyrimidine 
biosynthesis pathway (31-33).  Dihydropyrimidinase (DHP) and the other members of 
COG 0044F (dihydroorotase and related cyclic amidohydrolases) are related to DHO.  
DHP catalyzes the hydrolysis of dihydropyrimidines to 3-ureido acids in the reductive 
catabolism of pyrimidines (34). Hydantoinase (HYD) catalyzes the hydrolysis of 5’ 
substituted hydantoins to carbamoyl amino acids (35, 36). Allantoinase (ALN) belongs 
in COG 0044 F along with DHP and HYD. ALN is responsible for the conversion of S-
allantoin into allantoate in the ureide pathway (37). Isoaspartyl dipeptidase (IAD) 
catalyzes the hydrolysis of beta-L-isoaspartyl linkages in dipeptides (38-40). IAD is 
unique in that it has an ambiguous COG assignment, aligning with either COG 0044 F or 
COG 1228 Q (imidazolone propionase and related amidohydrolases). Other members of 
COG 1228 Q include enamidase (ENA) (41), hydrophobic carboxypeptidase (Cc0300) 
(42), Lys/Arg carboxypeptidase (Cc3125) (43), and imidazolone propionase (HutI) (44).  
 Human renal dipeptidase (RDP) hydrolyzes dipeptides and is involved in the 
metabolism of penem and carbapenem beta-lactam antibiotics (45). RDP is associated 
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with COG 2335 E (Zn-dependent dipeptidase, microsomal dependent homolog). 
Lactonase (Dr0930) belongs to COG 1735 R (predicted metal-dependent hydrolase with 
the TIM-barrel fold) and catalyzes the hydrolysis of δ- and γ-lactones possessing alkyl 
substitutions on the carbon adjacent to the ring oxygen (46). SsoPox is a promiscuouos 
hyperthermophilic phosphotriesterase of COG 1735R which is found to have very high 
and possibly natural quorum-quenching homoserine lactonase activity (47, 48). 
Phosphotriesterase (PTE) catalyzes the hydrolysis of organophosphorus compounds (49-
51) and also belongs to COG 1735 R. Histidinol phosphate phosphatase (HisJ) of COG 
1387 (histidinol phosphatase and related hydrolases of the PHP family) catalyzes the de-
phosphorylation of L-histidinol phosphate in histidine biosynthesis, forming histidinol 
(9, 52).  
 The enzyme called meta-cleavage compound hydrolase (LigY)  is involved in the 
degradation of the meta-cleavage compound of 2, 2',3-trihydroxy-3'-methoxy-5,5'-
dicarboxybiphenyl (OH-DDVA), forming 5-carboxyvanillic acid (5CVA) (53), and is 
associated with COG 2159 R (predicted metal-dependent hydrolase with the TIM-barrel 
fold).  Several non-oxidative decarboxylases were recently discovered, also belonging to 
COG 2159 R which do not catalyze hydrolysis reactions. Those enzymes are 5-
carboxyvannilate decarboxylase (LigW), which catalyzes the formation of vannilate 
from 5CVA (54); gamma-resorcylate decarboxylase (Rdc), which catalyzes the 
reversible carboxylation of resorcinol 1,3-dihydroxybenzene (55); alpha-amino-beta-
carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD), which produces 2-
aminomuconate semialdehyde (56); and finally uracil-5-carboxylate decarboxylase 
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(IDCase), which catalyzes the formation of uracil from uracil-5-carboxylate (iso-orotate) 
in the thymine salvage pathway (57).  
 Urease (URE) is the sole representative of COG 0804 E (Urea amidohydrolase 
(urease) alpha subunit) and catalyzes the conversion of urea to CO2 and 2 NH3 
molecules (58-61).  Uronate isomerase (URI) catalyzes the isomerization of D-
glucuronate to D-fructuronate and of D-galacturonate to D-tagaturonate (62-64). The 
uronate isomerase family belongs to COG 1904 G (Glucuronate isomerase) and is 
unique in that it is the only family within the amidohydrolase superfamily found to 
catalyze an isomerization reaction.  
 N-acetyl-D-glucosamine-6-phosphate deacetylase (NagA) catalyzes the 
deacetylation of N-acetylglucosamine-6-phosphate and N-acetylgalactosamine-6-
phosphate in the aminosugar metabolism (65-71). Uniquely, NagA is the only member 
of COG 1820 G (N-acetylglucosamine-6-phosphate deacetylase), while all of the other 
identified deacetylases co-occupy COG 3653 Q (N-acyl-D-aspartate/D-glutamate 
deacylase). The corresponding amino acid deacetylases are N-acyl-D-neutral deacetylase 
(D-ANase) (72), N-acyl-D-methionine deacetylase (DAA) (73), N-acyl-D-glutamate 
deacetylase (D-AGase) (72), and N-acyl-D-aspartate deacetylase (D-AAase) (74). 4-
oxalomesaconate hydratase (LigJ) catalyzes the conversion of 4-oxalomesaconate to 4-
carboxy-4-hydroxy-2-oxo adipate (75) and is quite possibly the most unusual member of 
the amidohydrolase superfamily; because according to a sequence comparison with 
COGnitor, there are no COGs of related sequence.   
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Scheme 1.1: Reactions catalyzed by members of the amidohydrolase superfamily. 
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Scheme 1.1: Continued. 
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Scheme 1.1: Continued 
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Scheme 1.1: Continued.  
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Scheme 1.1: Continued.  
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Crystal Structures. An exhaustive search of the PDB has yielded 237 crystal 
structures of enzymes which belong to the AHS and is presented in Table 1.1.  Structural 
analyses of enzymes identified as members of the AHS indicate that there are up to four 
metal binding positions which have been found to contain various divalent transition 
metal cations including Mg, Fe, Mn, Ni, Co and Zn. The four metal binding positions are 
named Mα and Mβ, Mγ and Mδ.  The Mα site is located deepest within the active site 
pocket, while the Mβ, Mγ and Mδ sites become increasingly more solvent exposed. 
Historically, the three major types of enzymes within the AHS that have been 
characterized are the α/β-binuclear enzymes, the α-mononuclear enzymes and the β-
mononuclear enzymes. The recently discovered Mγ and Mδ sites are found in a group of 
enzymes related to histidinol phosphate phosphatase like enzymes.  
Thorough examination of the 237 crystal structures of identified members of the 
AHS have found that there are 17 unique types of AHS enzyme active site metal centers 
and they are summarized in Table 1.2. Identifications of the metal binding residues were 
determined with the criteria of a coordination distance of 2.5 Å or less between metal ion 
and amino acid side chain. Mechanistic characterizations of members of this superfamily 
have shown that the metals which may be utilized for catalysis are the divalent transition 
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metals: Mn2+, Ni2+, Co2+, Fe2+, and Zn2+.  While not found naturally in AHS enzymes, 
Cd2+ may be utilized by DHO (33) and NagA (67) for catalysis. The divalent transition 
metal cations are utilized as Lewis acids by these enzymes, effectively lowering the pKa 
of a bound water molecule enabling the formation of a nucleophilic hydroxide (76).  
These metals may also provide a structural role within the enzymes, providing a nucleus 
around which proper folding of the enzyme can occur.   
Table 1.1:  All Crystal Structures of AHS Members Available in the PDB. 
deposition PDB # annotation organism active site ligands 
6/14/2006 2HBX ACMSD P. flourescens 1 Co  
6/14/2006 2HBV ACMSD P. flourescens 1 Zn 
N/A 1M7M ADA H. sapiens Theoretical model 
12/22/1992 1ADD ADA M. musculus 1 Zn, 1-deaza-adenosine 
12/2/1994 2ADA ADA M. musculus 1 Zn, 6-hydroxy-7,8-dihydro 
purine adenosine 
1/31/1998 1A4M ADA M. musculus 1 Zn, 6-hydroxy-1,6-dihydro 
purine nucleoside 
1/31/1998 1A4L ADA M. musculus 1 Zn, 2’-Deoxycoformycin 
1/10/2002 1KRM ADA B. taurus 1 Zn, 6-hydroxyl-1,6-
dihydropurine riboside 
12/9/2002 1NDZ ADA B. taurus 1 Zn, 1-((1R)-1-
(hydroxymethyl)-3-(6-((3-(1-
methyl- 1H-benzimidazol-2-
yl)propanoyl)amino)-1H- 
indol-1-yl)propyl)-1H-
IMIDAZOLE-4-carboxamide 
12/9/2002 1NDY ADA B. taurus 1 Zn, 1-((1R)-1-
(hydroxymethyl)-3-(1-
naphthyl)propyl)- 1H-
imidazole-4-carboxamide 
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Table 1.1:  Continued. 
deposition PDB # annotation organism active site ligands 
12/9/2002 1NDV ADA B. taurus 1 Zn, N''-(4-(5-((1H-
benzimidazol-2-
ylamino)methyl)- 2-thienyl)-
1,3-thiazol-2-yl)guanidine 
9/8/2003 1QXL ADA B. taurus 1 Zn, 1-((1R)-1-
(hydroxymethyl)-3-(1-
naphthyl)propyl)- 1H-
imidazole-4-carboxamide 
10/3/2003 1UML ADA B. taurus 1 Zn, 1-((1R)-1-
(hydroxymethyl)-3-{6-[(3-
phenylpropanoyl)amino]- 1H-
indol-1-yl}propyl)-1H-
imidazole-4-carboxamide 
10/5/2003 1O5R ADA B. taurus 1 Zn, 1-[(1R)-3-(6-
{[(Benzylamino)carbonyl]ami
no}- 1H-indol-1-yl)-1-
(hydroxymethyl)propyl]-1H- 
imidazole-4-carboxamide 
12/14/2003 1V7A ADA B. taurus 1 Zn, 1-{(1R,2S)-2-Hydroxy-
1-[2-(2-
naphthyloxy)ethyl]propyl}- 
1H-imidazone-4-
carboxamide  
12/14/2003 1V79 ADA B. taurus 1 Zn, 1-{(1R,2S)-1-[2-(2,3,-
Dichlorophenyl)ethyl]- 2-
hydroxypropyl}-1H-
imidazole-4-carboxamide  
4/16/2004 1VFL ADA B. taurus 1 Zn 
6/22/2004 1W1I ADA B. taurus 1 Zn, Dipeptidyl peptidase 
(IV)  
2/2/2005 1WXZ ADA B. taurus 1 Zn, 1-((1R,2S)-1-{2-[2-(4-
chlorophenyl)-1,3-
benzoxazol- 7-yl]ethyl}-2-
hydroxypropyl)-1H-
imidazole- 4-carboxamide 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
8/10/2005 2AMX ADA P. yeolii 1 Co 
10/30/2006 2E1W ADA B. taurus 1 Zn, 1-{(1R,2S)-2-Hydroxy-
1-[2-(1-
naphthyl)ethyl]propyl}- 1H-
imidazole-4-carboxamide 
4/9/2007 2PGF ADA P. vivax 1 Zn, Adenosine 
4/10/2007 2PGR ADA P. vivax 1 Zn, 2’-Deoxycoformycin 
8/8/2007 2QVN ADA P. vivax Guanosine-5'-monophosphate 
8/20/2007 2Z7G ADA B. taurus 1 Zn (α), (2S,3R)-3-(6-amino-
9H-purin-9-yl)nonan-2- ol  
2/29/1996 1FKW ADA D295E M. musculus 1 Zn, Purine riboside  
2/29/1996 1FKX ADA D296A M. musculus 1 Zn, 6-hydroxy-1,6-dihydro 
purine adenosine 
8/30/1996 1UIO ADA H238A M. musculus 1 Zn, 6-hydroxy-7,8-dihydro 
purine adenosine/ H238A 
8/30/1996 1UIP ADA H238E M. musculus 1 Zn, Purine riboside 
8/17/2008 3E75 ALN E. coli 2 Zn 
8/17/2008 3E74 ALN E. coli 2 Fe 
6/25/2005 2A3L AMPD A. thaliana 1 Zn, Coformycin 5'-
phosphate 
8/1/2007 2QT3 AtzC Pseudomonas sp adp 1 Zn (α)  
4/24/2007 2PNK BH0493 B. halodurans None 
6/25/2007 2QEE BH0493  B. halodurans  1 Zn (α) 
2/28/2009 3GGM Bt9727_2919 B. thuringiensis None 
3/13/2008 3CJP CAC3332 C. Acetobutylicum 2 Zn 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
10/17/2001 1K70 CDA E. coli 1 Fe, 4-hydroxy-3,4-dihydro-
1H-pyrimidin-2-one inhibitor 
10/17/2001 1K6W CDA E. coli 1 Fe 
10/31/2003 1RA5 CDA D314A E. coli 1 Fe, 5-fluoro-4-(S)-hydroxy-
3,4-dihydropyrimidine  
10/31/2003 1R9Y CDA D314A E. coli 1 Fe 
10/31/2003 1RA0 CDA D314G E. coli 1 Fe, 5-fluoro-4-(S)-hydroxy-
3,4-dihydropyrimidine 
10/31/2003 1R9X CDA D314G E. coli 1 Fe 
10/31/2003 1RAK CDA D314S E. coli Fe, 5-fluoro-4-(S)-hydroxy-
3,4-dihydropyrimidine 
10/31/2003 1R9Z CDA D314S E. coli 1 Fe 
1/24/2008 2VM8 Crmp-2 D-HYD 
like 
H. sapiens None 
7/22/2002 1M7J DAA A. faecalis 2 Zn, Acetate 
11/20/2003 1V51 DAA A. faecalis 2 Zn, Acetate 
11/20/2003 1RK6 DAA A. faecalis 1Zn, 1 Cd, Acetate 
11/20/2003 1RJP DAA A. faecalis 1 Zn, 1 Cu, Acetate 
11/20/2003 1RK5 DAA D366A A. faecalis 1 Zn, 1 Cu, Acetate 
11/20/2003 1RJR DAA D366A A. faecalis 2 Zn, Acetate 
11/20/2003 1RJQ DAA D366A A. faecalis 1 Zn, Acetate 
11/20/2003 1V4Y DAA H220A A. faecalis 1 Zn, AcetateLigand free/ 
Mutant  
7/31/2008 3E0L Designed 
Ammelide 
Deaminase 
 
 
H. sapiens 1 Zn (α)  
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
9/17/2004 1XGE DHO  E. coli 2 Zn, N-Carbamoyl-L-
aspartate, 4(s)-2,6-
dioxohexahydro pyrimidine-
4-carboxylate 
10/14/2004 1XRF DHO  A. aeolicus 2 Zn, Sulfate 
10/15/2004 1XRT DHO  A. aeolicus 2 Zn 
5/4/2006 2GWN DHO  P. gingivalis 2 Zn, β-mercaptoethnol, 
chloride, sulfate, glycerol, 
cacodylate ion 
2/28/2007 2EG8 DHO  E. coli 2 Zn, 5-flouroorotate 
2/28/2007 2EG7 DHO E. coli 2 Zn, 2-oxo-1,2,3,6-
tetrahydropyrimidine-4,6-
dicarboxylate 
2/28/2007 2EG6 DHO E. coli 2 Zn 
5/6/2007 2Z00 DHO  T. thermophilus 2 Zn 
5/20/2008 3D6N DHO A. Aeolicus 1 Zn, Citrate 
3/25/2009 3GRI DHO S. Aureus 1 Zn (α)  
5/17/2007 2Z2B DHO  del. 107-
116 
E. coli 2 Zn 
5/17/2007 2Z29 DHO T109A  E. coli 2 Zn, N-Carbamoyl-L-
aspartate, 4(s)-2,6-
dioxohexahydro-pyrimidine-
4-carboxylate  
5/17/2007 2Z2A DHO T109G E. coli 2 Zn, N-Carbamoyl-L-
aspartate, 4(s)-2,6-
dioxohexahydro pyrimidine-
4-carboxylate 
11/8/2006 2E25 DHO T109S E. coli 2 Zn, 5-Flouroorotate 
5/17/2007 2Z27 DHO T109S E. coli 2 Zn, N-Carbamoyl-L-
aspartate, 4(s)-2,6-
dioxohexahydro pyrimidine-
4-carboxylate 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
5/17/2007 2Z26 DHO T110A  E. coli 2 Zn, N-Carbamoyl-L-
aspartate, 4(s)-2,6-
dioxohexahydro pyrimidine-
4-carboxylate 
5/17/2007 2Z24 DHO T110S E. coli 2 Zn, N-Carbamoyl-L-
aspartate, 4(s)-2,6-
dioxohexahydro pyrimidine-
4-carboxylate 
5/17/2007 2Z25 DHO T110V E. coli 2 Zn, N-Carbamoyl-L-
aspartate, 4(s)-2,6-
dioxohexahydropyrimidine-4-
carboxylate 
1/5/2007 2OGJ DHO-like A. tumefaciens 2 Zn, Imidazole 
1/25/2006 2FTY DHP S. kluyveri 2 Zn 
1/25/2006 2FTW DHP  D. discoideum  2 Zn 
1/31/2006 2FVM DHP S. kluyveri 2 Zn, N-carbamoyl-β-alanine 
1/31/2006 2FVK DHP S. kluyveri 2 Zn, Dihydrouracil 
3/25/2008 2VR2 DHP H. sapiens 2 Zn 
6/3/2008 3DC8 DHP S. meliloti 2 Zn 
4/26/2006 2GSE DHP-like H. sapiens None 
11/11/2001 1KCX DHP-related M. musculus None 
7/30/2007 2QS8 Dipeptidase 
(Xaa-Pro) 
A. macleodii 1 Mg (α) , Methionine 
8/24/2006 2I5G Dipeptidase like 
T56A, K300E 
P. aeruginosa None 
1/3/2005 2BGN Dipeptidyl 
dipeptidase IV 
and ADA 
H. sapiens and B. taurus Tat N-terminal nonapeptide 
and Zn 
11/30/2008 3FEQ eah89906 Unidentified 2 Zn 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
5/27/2008 2VUN ENA E. barkeri 1 Fe, 1 Zn, 1Cl 
9/6/2006 2I9U GDA C. acetobutylium 1 Fe, Guanine 
1/25/2007 2OOD GDA B. japonicum 1 Zn, Guanine 
4/26/2007 2UZ9 GDA H. sapiens 1 Zn, Xanthine 
4/26/2007 2YXO HisJ T. thermophilus 2 Fe, 1Zn, Sulfate 
5/3/2007 2YZ5 HisJ T. thermophilus 2 Fe, 1Zn, Phosphate 
6/17/2007 2Z4G HisJ T. thermophilus 2 Fe, 1Zn 
10/16/2005 2BB0 HutI B. subtilis 1 Zn, acetate 
2/19/2006 2G3F HutI B. subtilis 1 Zn, substrate analogue 
imidazole-4-acetate 
4/13/2006 2GOK HutI A. tumefaciens 1 Fe 
1/25/2007 2OOF HutI Unidentified 1 Fe 
5/9/2007 2PUZ HutI A. tumefaciens 1 Fe, N-formimino-L-
glutamate product 
5/21/2007 2Q09 HutI Unidentified 1 Fe, 3-(2,5-Dioxo-
imidazolidin-4-yl)-propionic 
acid inhibitor 
8/20/2001 1GKR HYD A. aurescens 2 Zn 
8/20/2001 1GKQ HYD Thermus sp. 2 Zn 
8/20/2001 1GKP HYD Thermus sp. 2 Zn 
9/25/2001 1K1D HYD B. stereothermophilus 2 Zn 
12/14/2002 1NFG HYD B. pickettii 2 Zn 
1/26/2005 1YNY HYD Bacillus sp. 2 Mn 
3/2/2003 1ONX IAD E. coli 2 Zn, Aspartate 
3/2/2003 1ONW IAD E. coli 2 Zn 
6/15/2003 1POK IAD E. coli 2 Zn, Asparagine 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
6/15/2003 1PO9 IAD E. coli 2 Zn 
12/21/2004 1YBQ IAD D285N E. coli 2 Zn, L-β-aspartylhistidine 
8/18/2005 2AQO IAD E77Q E. coli 2 Zn 
8/18/2005 2AQV IAD Y137F E. coli 2 Zn 
11/16/2007 3BE7 KRCP Unidentified Arginine 
7/17/2008 3DUG KRCP Unidentified 2 Zn, Arginine 
6/15/2007 2QAH LigI S. paucimobilis None 
5/4/2006 2GWG LigJ R. palustris 1 Zn 
11/29/2005 2F6K Lp24 L. plantarum 1 Mn (α) 
10/15/2002 1O12 NagA T. maritima 1 Fe 
1/21/2005 1YMY NagA E. coli  None 
2/4/2005 1YRR NagA E. coli Phosphate 
3/14/2007 2P50 NagA E. coli 1 Zn 
11/22/2007 2VHL NagA B. subtilis 2 Fe, glucosamine-6-
phosphate,  
11/22/2007 2VHL NagA B. subtilis 2 Fe, Glucosamine-6-
phosphate product 
9/10/2008 3EGJ NagA V. cholerae 1 Ni (β) 
3/14/2007 2P53 NagA  D273N E. coli 1 Zn,  N-
methylphosphonamidate-
glucosamine-6-phosphate 
inhibitor 
8/23/2007 2R1O OpdA PTE 
S92A 
A. tumefaciens 1 Co, 1 Fe, Diethyl 
thiophosphate product, 1,2-
ethanediol 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
8/23/2007 2R1P OpdA PTE 
S92A, K185R 
A. tumefaciens 1 Co, 1 Fe , Diethyl 
thiophosphate product, 1,2-
ethanediol 
8/23/2007 2R1N OpdA PTE 
S92A, N265D 
A. tumefaciens 1 Co, 1 Fe, Diethyl 4-
methoxyphenyl phosphate 
slow substrate,  
8/23/2007 2R1M OpdA PTE 
S92A, N265D 
A. tumefaciens 1 Co, 1 Fe, Diethyl phosphate 
product, 1,2-ethanediol 
8/23/2007 2R1L OpdA PTE 
S92A, N265D 
A. tumefaciens 1 Co, 1 Fe, Diethyl 
thiophosphate, 1,2-ethanediol  
8/23/2007 2R1K OpdA PTE 
S92A, N265D 
A. tumefaciens 1 Co, 1 Fe, Diethyl 
phosphate, 1,2-ethanediol 
5/27/1998 1BF6 PHP E. coli 2 Zn, Glycerol, (4S)-2-
Methyl-2,4-pentanediol 
8/11/2005 2ANU Predicted PTE 
TM0559 
T. maritima 4 Zn, 2Cl  
7/7/1994 1PTA PTE  B. dimunita None 
4/25/1995 1PSC PTE  B. dimunita 2 Cd, Diethyl-4-
methylbenzylphosphonate 
2/13/1996 1DPM PTE  B. dimunita 2 Zn, Diethyl-4-
methylbenzylphosphonate 
5/9/2000 1EZ2 PTE  P. dimunita 2 Zn, diisopropylmethyl 
phosphonate 
5/9/2000 1EYW PTE  P. dimunita 2 Zn, triethylphosphate 
1/26/2001 1HZY PTE  B. dimunita 2 Zn, Ethanediol, Formate, 2-
phenyl-ethanol 
1/29/2001 1I0D PTE  B. dimunita Zn, Cd, Ethanediol, Formate, 
2-phenyl-ethanol 
1/29/2001 1I0B PTE  B. dimunita 2 Mn, Ethanediol, Formate, 2-
phenyl-ethanol 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
9/1/2003 1QW7 PTE  B. dimunita 2 Co, Diethyl-4-
methylbenzylphosphonate 
9/8/2005 2D2G PTE  A. tumefaciens 2 Co, Dimethylthiophosphate 
9/8/2005 2D2J PTE A. tumefaciens 2 Co 
9/8/2005 2D2H PTE A. tumefaciens 2 Co, Trimethylphosphate 
11/2/2007 2ZC1 PTE D. radiodurans 2 Co 
2/20/2008 3CAK PTE B. diminuta 2 Co, Ethylphosphate 
12/4/2006 2O4Q PTE G60A P. dimunita 2 Zn, Dimethylarsenate 
4/8/2008 3CS2 PTE G60A B. diminuta 2 Co, Dimethylarsenate 
(cacodylate) 
4/29/2003 1P6B PTE 
H254G/H257W/ 
L303T 
Flavobacterium sp. 3 Zn, Diethyl-4-
methylbenzylphosphate, ethyl 
dihydrogenphosphate 
4/29/2003 1P6C PTE 
H254G/H257W/
L303T 
Flavobacterium sp. 2 Zn, Diisopropyl methyl 
phosphonate, Diethyl-4-
methylbenzyl phosphonate 
1/31/2007 2OQL PTE 
H254Q/H257F 
P. dimunita 2 Zn, 2-[Bis-(2-hydroxy-
ethyl)-amino]-2-
hydroxymethyl- propane-1,3-
diol 
8/7/2008 3E3H PTE H254R, 
H275F 
B. dimunita 2 Co, Diethyl 4-methylbenzyl 
phosphonate  
12/18/2006 2OB3 PTE 
H257Y/L303T  
B. dimunita 2 Zn 
12/4/2006 2O4M PTE 
I106G/F132G/H
257Y 
P. dimunita 2 Zn, Dimethylarsenate, 
Acetate, Glycerol 
9/13/2006 2ICS Putative ADE E. faecalis 1 Zn, Adenine 
3/27/2007 2PAJ Putative CDA / 
GDA 
Unidentified 1 Zn (α) 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
12/19/2005 2FFI Putative LigI P. putida Phosphate 
10/23/2007 3B40 Putative 
peptidase K44Q, 
I62V, P64L, 
E69T, F73V, 
N79G, N195S, 
S203A, T215S, 
A216P, N314D 
P. aeruginosa None 
3/24/2007 2P9B Putative 
prolidase 
B. longum None 
7/31/2008 3E0F Putative PTE B. adolescentis 2 Fe, 1Zn, acetate, phosphate 
8/1/2006 2DVX RDC Rhizobium sp. 1 Zn, 2,3-
dihydroxybenzaldehyde 
8/1/2006 2DVU RDC Rhizobium sp. 1 Zn, 2,6-dihydroxybenzoate 
8/1/2006 2DVT RDC Rhizobium sp. 1 Zn 
2/2/2002 1ITQ RDP H. sapiens 2 Zn 
2/3/2002 1ITU RDP H. sapiens 2 Zn, Cilastatin 
11/25/2008 3FDG RDP R. sphaeroides 2 Mg  
7/9/2002 1J6P SAHD T. maritima 1 Ni 
4/12/2003 1P1M SAHD T. maritima 1 Ni, Methionine 
4/20/2007 2PLM SAHD T. maritima 1 Zn , inosylhomocysteine 
10/4/2006 2IMR SAHD-like  
DR_0824 
D. radiodurans 1 Zn 
9/18/2007 2VC7 SsoPox  S. solfataricus 1 Fe, 1Co,  (4S)-4-
(decanoylamino)-5-hydroxy-
3,4-dihydro- 2H-thiophenium 
9/18/2007 2VC5 SsoPox  S. solfataricus 1 Fe, 1Co 
11/2/2004 1XWY TatD  E. coli 1 Zn 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
8/6/2008 3E2V TatD like S. cerevisiae 1 Mg 
5/12/2006 2GZX TatD MW0446 S. aureus 2 Ni 
2/27/2009 3GG7 TatD-like D. radiodurans 1 Mn (α) 
3/30/2009 3GUW TatD-like  A. Fulgidus 2 Zn 
7/9/2002 1J6O TatD-related T. maritima None 
7/25/2007 2QPX Unknown L. casei atcc 334 2 Zn  
10/8/2008 3ETK Unknown P. furiosus 2 Mg  
4/21/2009 3HPA Unknown Unidentified 1 Zn  (α) 
11/25/2008 3FDK Unreleased  Unidentified Unknown 
2/16/1995 2KAU URE K. aerogenes 2 Ni 
6/20/1995 1KRA URE  K. aerogenes None 
4/23/1997 1FWJ URE K. aerogenes 2 Ni 
1/21/1998 1UBP URE  B. pasteurii 2 Ni, β-mercaptoethanol 
11/4/1998 2UBP URE  B. pasteurii 2 Ni, Sulfate 
12/16/1998 3UBP URE  B. pasteurii 2 Ni, Diamidophosphate  
2/25/1999 4UBP URE  B. pasteurii 2 Ni, Acetohydroxamate 
2/5/2000 1EF2 URE  K. aerogenes 2 Mn  
11/1/2000 1E9Z URE  H. pylori 2 Ni 
11/1/2000 1E9Y URE  H. pylori 2 Ni, Acetohydroxamate 
4/9/2001 1IE7 URE  B. pasteurii 2 Ni, Phosphate 
1/14/2004 1S3T URE B. pasteurii 2 Ni, Sulfate, Borate 
3/4/2000 1EJX URE at 100K K. aerogenes 2 Ni 
3/4/2000 1EJW URE at 298K K. aerogenes 2 Ni 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
4/23/1997 1FWB URE C319A pH 
6.5 
K. aerogenes 2 Ni 
4/23/1997 1FWA URE C319A pH 
7.5 
K. aerogenes 2 Ni, Carbonate 
4/23/1997 1FWC URE C319A pH 
8.5 
K. aerogenes 2 Ni 
4/23/1997 1FWD URE C319A pH 
9.4 
K. aerogenes 2 Ni 
4/23/1997 1FWF URE C319D K. aerogenes 2 Ni 
4/23/1997 1FWG URE C319S K. aerogenes 2 Ni 
4/23/1997 1FWH URE C319Y K. aerogenes 2 Ni 
3/4/2000 1EJR URE D221A K. aerogenes 2 Ni 
4/23/1997 1FWI URE H134A K. aerogenes 1 Ni (β) 
6/20/1995 1KRB URE H219A K. aerogenes 2 Ni 
3/4/2000 1EJS URE H219N K. aerogenes 2 Ni 
3/4/2000 1EJT URE H219Q K. aerogenes 2 Ni 
6/20/1995 1KRC URE H320A K. aerogenes 2 Ni, Carbon Dioxide 
3/4/2000 1EJU URE H320N K. aerogenes 2 Ni 
3/4/2000 1EJV URE H320Q K. aerogenes 2 Ni 
2/17/1998 1A5N URE K217A K. aerogenes 2 Ni, Formate  
2/17/1998 1A5M URE K217A K. aerogenes None 
2/17/1998 1A5L URE K217C K. aerogenes None 
2/17/1998 1A5O URE K217C K. aerogenes 2 Ni, Formate 
2/17/1998 1A5K URE K217E K. aerogenes None 
7/2/2002 1J5S URI  T. maritima None 
5/18/2007 2Q01 URI C. cresentus None 
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Table 1.1: Continued. 
deposition PDB # annotation organism active site ligands 
6/5/2007 2Q6E URI B. halodurans 1 Zn (α) 
7/12/2002 1M65 YCDX  E. coli 1 Zn, 2 Na 
7/14/2002 1M68 YCDX  E. coli 3 Zn, 1 Sulfate 
5/14/2003 1PB0 YCDX  E. coli 3 Zn 
1/13/2005 1YIX YcfH TatD-like E. coli 1 Zn 
Diverse Active Sites within the AHS. The binuclear active site type I is the best 
characterized and most versatile architecture within the AHS.  It contains the α-metal 
which is coordinated by the Nε of two histidines from β-strand 1, a carboxylated lysine 
from strand 4, and an aspartate from strand 8. The β-metal is bound by the carboxylated 
lysine, the Nδ of a strand-5 histidine and the Nε of a strand-6 histidine. From this point, 
unless stated otherwise, metals are coordinated to histidine through the Nε atom. The 
type I  binuclear metal is utilized by the enzymes: PTE (51), DHO (31), URE (58) IAD 
(40), HYD (35, 36), ALN (37), DHP (34), carboxypeptidase (42) and SsoPox (77).   
The type II active site used by PTE from D. radiodurans (PDB code: 2ZC1) 
differs from type I only by the presence of the β-metal coordinating tyrosine located 5 
residues after the last histidine from strand 1. ENA (41) and the enzymes of unknown 
function; PHP (78) and TatD (PDB code: 2GZX) utilize the active site type III structure. 
The difference between the type III and type I active site is the substitution of the 
bridging carboxylated lysine for a bridging glutamate.  RDP (45) utilizes active site type 
IV. In that site, the Mα site is formed through interactions from an HxD motif from 
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strand 1 and a glutamate from strand 4.  The Mβ site consists of the bridging glutamate 
and the histidines from strands 5 and 6. The aspartate from strand 8 is hydrogen bonding 
with a bridging hydroxide, but is not coordinated to the metal.  
NagA from B. subtilis (69) represents active site type V, which utilizes the strand 
1 HxH motif, a bridging glutamate from strand 3 and an aspartate from strand eight to 
form the Mα site. The Mβ site is formed by the bridging glutamate and two histidine 
residues from strands 5 and 6. NagA from T. maritima represents type VI, and has all of 
the same metal ligands as type V, however, the crystal structure (PDB code: 1O12) 
shows a single iron bound in the Mβ site, coordinated to the glutamate from strand 3 and 
the histidines from strands 5 and 6. Instead of the α-metal, a histidine from a mobile loop 
after strand 3 is found nearby.  It has been shown that only a single metal is necessary 
for catalysis (66) Those studies will be further discussed in Chapter III. Type VII is 
represented by E. coli NagA, which has the same active site as type VI, except it is 
missing the superfluous HxH motif.  That enzyme was found to utilize a single metal for 
catalysis with the aid of the mobile loop histidine from strand 3 (66, 67).  The 
characterization of that enzyme is discussed further in Capters II and III.  
Type VIII provides a novel subset of the AHS and consists of DAA (PDB code: 
1RJQ). It has an active site similar to the previous binuclear sites I, II and III and may 
bind two metals. However, there are several differences; a cysteine from strand 2 
replaces the bridging carboxylate residue and only the β-metal is required for catalysis 
(73). The active site of RDC comprises type IX.  In this example, the α-mononuclear 
active site is formed by a unique ExH motif from strand 1, a histidine from strand 5 and 
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an aspartate from strand 8. It should be noted that the histidine commonly seen in strand 
6 is present, and it has been determined to be necessary for catalytic activity (55). 
 Deaminases dominate the type X active site structure which is defined by the 
strand 1 HxH motif, the strand 5 histidine and the strand 8 aspartate metal ligands.  A 
histidine from strand 5 is also present which is involved in catalysis. Included among the 
members are: CDA (23), GDA (PDB code: 2UZ9), ADA (17), AMPD (18), Tm0936 (7), 
HutF (79), AtzC (PDB code: 2QT3)  and even the recently discovered decarboxylase 
ACMSD (56). LigJ (PDB code: 2GWG) has a similar α-mononuclear active site, yet it is 
the first amidohydrolase found which does not have an aspartate at the end of strand 8. 
In its place is a glutamate from strand 8 which helps form the type XI active site. 
Uronate isomerase utilizes active site type XII, where a Zn can be seen bound to the 
strand 1 HxH motif and the strand-8 aspartate. Notably absent in the structure for B. 
halodurans are the histidines from strands 5 and 6. However, URI from E. coli and T. 
maritima have the strand-5 histidine (62).  
Active site types XIII-XVII all share similar characteristics, as they all bind three 
or more active site metals and possess an overall fold which takes on a (β/α)7 barrel fold 
appearance, while maintaining a close relationship to the typical (β/α)8 structures. HisJ 
(9) possesses the type XIII active site, which has two Fe ions in the Mα and Mβ sites, as 
well as a Zn in the newly defined Mγ site. The α-metal ligands come from the strand 1 
HxH motif, a glutamate from strand 3, and an aspartate from strand 7 which is analogous 
to the strand 8 aspartate found in the other AHS enzymes. The β-metal ligands are: the 
bridging glutamate from strand 3 and two histidines from strands 4 and 5, which are 
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related to the strand 5 and 6 histidine residues found in the other AHS enzymes. The Zn 
binding γ-metal ligands are: a histidine located on a loop after strand 1, a histidine from 
strand 2 and a histidine present two amino acids after the strand-7 aspartate.  
Active site type XIV with two Fe ions and a Zn ion, is found in the putative 
metal-dependent phosphoesterase from B. adolescentis ATCC 15703 (PDB code: 3E0F). 
The strand-1 HxH motif, a bridging strand-3 glutamate and an aspartate from strand 7 
form the α-metal Fe binding site. The β-metal Fe binding site consists of the bridging 
glutamate from strand 3, the Nδ of the histidine from strand 4 and the histidine from 
strand 5. The γ-metal Zn binding site is made from contributions by: an aspartate from 
the loop after the strand 1, a histidine from strand 2 and the histidine from strand 7 found 
two amino acids after the aspartate.  
Active site type XV is found in the YCDX protein of unknown function. In that 
protein the α-metal Zn binding site is formed by the HxH motif from strand 1, a bridging 
glutamate from strand 3 and an aspartate from strand 7.  The β-metal Zn binding site has 
the bridging glutamate and two histidines from strands 4 and 5. Four histidines are found 
to bind the γ-site Zn ion in the ligand free structure (PDB code: 1PB0). They are: the 
histidine found six amino acids after the strand-1 HxH motif, the histidine from strand 2, 
a histidine from strand 6 and a histidine from strand 7, found two amino acids after the 
aspartate.   
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The final and most extreme active site type of the AHS is type XVI.  This is 
found in the predicted metal dependent phosphoesterase Tm0559 (PDB code: 2ANU). 
This active site is found with 4 Zn ions.  The strand-1 HxH makes up the α-site along 
with a bridging glutamate from strand 3 and an aspartate from strand 7. The β-site is 
formed by the bridging glutamate from strand 3and the Nδ of a strand-4 histidine. The γ-
site ligands are an aspartate found five amino acids after the strand-1 HxH, a histidine 
from strand 2, and another histidine from strand 7 found two amino acids after the 
strand-7 aspartate. The rare δ-metal site is formed from interactions with two aspartates.  
One aspartate is found after strand 5 and the other is the bridging aspartate from strand 7. 
Table 1.2 summarizes these active site-variations. Histidine residues which utilize the Nδ 
atom for metal coorination are denoted with an Nδ subscript. All other hisidine ligands 
were found to coordinate the metal with the Nε atom. Lower-case x is used to imply a 
lack of residue conservation.  
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Table 1.2 : Active Site Variations in the AHS. 
   beta-strands 
type  positions 1 2 3 4 5 6 7 8 
I  α, β HxH   K HNδ H  D 
II  α, β HxHxxxxY   K HNδ H  D 
III  α, β HxH   E HNδ H  D 
IV  α, β HxD   E H H  db 
V  α, β HxH  E  H H  D 
VI  β hxha  E...hb       H H  db 
VII  β   E...hb    H H  db 
VIII  β hxha C   HNδ H  db 
IX  α ExH    H hb  D 
X  α HxH    H hb  D 
XI  α HxH    H hb  E 
XII  α HxH       D 
XIIIc  α, β, γ HxH(x)5 H  H E H H  DxH  
XIVc  α, β, γ HxH(x)4 D H E HNδ H  DxH  
XVc  α, β, γ HxH(x)5 H H E H H H DxH  
XVIc  α, β, γ, ε HxH(x)4 D H E HNδ D  DxH  
aMetal binding may be possible, but does not appear to be required for activity. bNot coordinated to a 
metal, but may be involved in water or substrate activation.  c(β/α)7 fold related to the (β/α)8 fold. 
Additional details are provided in the text. 
 
A general mechanism adopted from the proposed mechanisms of DHO (31, 33) 
PTE (49, 51, 80) and IAD (40) for the α/β binuclear metal assisted hydrolysis is shown 
below in Scheme 1.2. This is based on crystallographic evidence with substrate, product, 
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and inhibitors as well as theoretical calculations. In the resting state, two metals 
coordinate a bridging nucleophilic hydroxide molecule. An aspartate from β-strand eight 
helps orient the hydroxide, while coordinating the α-metal as well. Upon substrate 
coordination to the β-site metal, coordination to the hydroxide is weakened, resulting in 
aspartate assisted hydroxide attack at the reaction center that is followed by oxyanion 
formation at the β-metal. The resulting anionic tetrahedral transition-states are stabilized 
through a bridging complex with both metals. Collapse of the tetrahedral intermediate is 
facilitated through reversed flow of electrons from the oxyanion and proton transfer to 
the leaving group from the aspartate.  
For PTE, the mechanism is slightly different. In that case, aspartate assisted 
hydroxide attack results in the rapid loss of the leaving group, forming an anionic 
tetrahedral metal bridging phosphodiester complex. The reactive state of the active site is 
regenerated upon dissociation of the resulting product and then the binding of another 
nucleophilic water molecule. QM/MM simulations have been used to suggest another 
mechanism for PTE (81). In that study, it was proposed that instead of a phosphodiester 
anion coordinating both metals in a bridging complex, the bridging hydroxide attack 
results in the rapid displacement of the leaving group product and that a single P=O 
oxygen is coordinated to the β-metal while the bound phosphodiester product remains 
neutral. The binding and deprotonation of a second water aids in the displacement of the 
neutral phosphodiester product, which then spontaneously deprotonates in solution. In 
another and very different mechanism for bacterial PTE, it was proposed, based on 
structural and docking data,  that the bridging hydroxide acts as a base for the activation 
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of another hydrolytic solvent molecule which is terminally bound to the α-metal (82).  
Differing mechanisms have also been proposed for the URE mechanism. 
Yamaguchi et al have utilized crystallographic, mutagenesis and pH profile studies to 
propose a reverse protonation mechanism which uses a histidine to protonate the leaving 
group amine and that no base is required to deprotonate the bridging hydroxide. They 
also propose that a cysteine residue is being used to bind the non-leaving group amine of 
urea (83). A different mechanism has been proposed by Benini et al, where crystal 
structures with bound inhibitors were used to suggest that the carbonyl oxygen 
coordinates to the β-Ni, while the non-leaving group amine coordinates to the α-Ni. The 
bridging hydroxide then becomes the acid, which protonates the leaving group amine, 
possibly through the aspartate (58). Lippard and co-workers have used synthetic dinickel 
urease models to suggest that an elimination mechanism might occur in urease (84). 
Quantum mechanical and molecular dynamics simulations and quantum chemical 
calculations of Merz and co-workers have been used to try to reconcile the opposing 
mechanisms of urease.  From those studies, they found that both hydrolysis mechanisms, 
and the elimination mechanisms are possible, depending on the hydrogen bonding 
network present (60, 85, 86). Marlier and Cleland have used heavy isotope effects 
studies with formamide and semicarbazide substrates to support a reverse protonation 
mechanism which utilizes a histidine to help stabilize oxyanion formation near the β-
metal in the transition state while a second histidine is used to protonate the leaving 
group amine (61, 87). 
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Scheme 1.2 
 
The β-mononuclear enzymes of the amidohydrolase superfamily comprise a 
second sub-class of enzymes, which includes NagA from Escherichia coli, NagA from 
Thermotoga maritima, and D-aminoacid deacetylase (DAA). They all utilize a single 
metal bound only to the β-site through the use of two histidines from β-strands five and 
six. Each of these three enzymes represent distinct types of β-mononuclear active sites, 
because they possess variations in the active site residues which were previously 
discussed. In all of these active sites, the β-metal is held in a tetrahedral coordination 
state which includes a coordinated hydroxide that is hydrogen-bonded to the conserved 
aspartate residue from the end of β-strand eight.  It is proposed for these enzymes that a 
fifth metal ligation site is created upon binding of substrate, creating a trigonal 
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bipyramidal coordination state of the active site metal. A proposed general mechanism 
for β-metal assisted hydrolysis of an amide bond is shown in Scheme 1.3.  In this 
mechanism, the resting enzyme is coordinated through a glutamate from strand three, 
two histidines from strands five and six, in addition to a nucleophilic water molecule.  
An aspartate from strand eight removes a proton from the water, which is then activated 
for nucleophilic attack on the carbonyl carbon of the substrate.  A tetrahedral 
intermediate is then formed and is stabilized through bi-dentate coordination to the 
active site metal. Collapse of the resulting tetrahedral intermediate is initiated by proton 
transfer from the strand-eight aspartate to the leaving group amine. Dissociation of the 
amine product is followed by dissociation of the newly formed carboxylate product. 
Regeneration of the active site may then occur upon the binding of another water 
molecule. This mechanism is highly analogous to that determined for the binuclear 
enzymes (31, 33, 40, 49). 
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The third class of amidohydrolase enzymes binds one metal at the α-position. 
This metal is ligated with the aid of the two histidine residues from β-strand one, the 
histidine from strand five and the aspartate from strand eight. The fifth coordination site 
of the divalent transition metal is occupied by a nucleophilic hydroxide which is also 
hydrogen-bonded to the indispensable strand-eight aspartate. Some of the members of 
this α-mononuclear group of amidohydrolases that have been identified are the enzymes: 
cytosine deaminease (CDA) (23), adenosine deaminase (ADA) (17), AMP deaminase 
(AMPD) (88), S-adenosylhomocysteine deaminase(SAHD) (7) and guanine deaminase 
(GuaD). These enzymes all share an HxxE motif found at the end of strand 5. The 
histidine present in this motif is analogous to the metal binding histidine from strand five 
that can be found in the binuclear and β-mononuclear classes of enzymes.  
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A general mechanism for α-metal assisted deamination of an aromatic compound 
is shown in Scheme 1.4. The mechanistic details of this reaction are based on the 
crystallographic studies of adenosine deaminase (16, 17), cytosine deaminase (22, 23) 
and earlier reports of QM/MM calculations for ADA, which indicated that the resting 
state contains a protonated glutamic acid residue and that histidine was the active base 
(89).  In this proposed mechanism, the resting state of the enzyme contains a metal-
coordinated nucleophilic water molecule which is also hydrogen bonded to aspartate 
from strand eight and histidine from strand six. Prior to, or upon substrate binding, the 
water is deprotonated by the hydrogen-bonding histidine. This promotes the nucleophilic 
attack of the resulting hydroxide anion upon the sp2 carbon bearing the leaving group 
amine. Electrons move to the adjacent nitrogen N-3, abstracting a proton from the H-
bonded strand-five glutamate. The movement of these electrons enables the formation 
and stabilization of the resulting tetrahedral transition state. A second proton abstraction 
from the nucleophilic water, now a transition state hydroxyl group, results in the collapse 
of the tetrahedral intermediate through the formation of a ketone and the release of 
ammonia which gets a proton from the histidine from strand six. Regeneration of the 
resting state occurs upon product release, which is followed by the binding of a new 
water molecule and proton transfer from strand-five glutamate to strand-eight aspartate.  
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Scheme 1.4 
  
  
The primary focus of the research presented here was to evaluate, compare and 
contrast two enzymes representative of the less understood β- and α-mononuclear classes 
of amidohydrolase enzymes.  The second goal of the research presented here was to use 
the structural, mechanistic and genomic information available, and apply it toward the 
discovery of function of previously uncharacterized enzymes.  NagA and CDA were 
chosen as model representatives for mechanistic characterizations, based on previous 
reports that both of the enzymes were soluble and had only been partially characterized. 
NagA (a β-mononuclear enzyme) is a necessary participant in the metabolism of 
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aminosugars, where a number of different pathways may produce the substrate for this 
enzyme. NagA catalyzes the deacetylation of N-acetyl-D-glucosamine-6-phosphate 
(GlcNAc6P) to form D-glucosamine-6-phosphate (Gln6P) and acetate as shown in 
Scheme 1.5.  CDA is an α-mononuclear enzyme and catalyzes the deamination of 
cytosine, forming uracil and free ammonia as shown in Scheme 1.6.  This is an 
important reaction in the recycling and metabolism of pyrimidine nucleotides.  The 
cytosine substrate for CDA may come from the degradation of DNA and RNA and 
cytidine nucleotides. 
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The deacetylation of GlcNAc6P provides a source of carbon and nitrogen and 
prepares this substrate for entry into the glycolysis pathway. GlcNAc may be produced 
as a product of chitobiose degradation by the enzyme NagZ. Extracellular GlcNAc can 
become phosphorylated and transported into the cell with the help of a 
phosphoenolpyruvate utilizing phosphotransferase called NagE.  Cellular GlcNAc6P can 
also be produced from the phosphorylation of GlcNAc from cell wall murein by a 
specific kinase named NagK (90).  Another branch of the murein recycling pathway 
produces N-acetylmuramic acid-phosphate which is then modified by MurQ Etherase to 
form GlcNAc6P (91). These reactions are summarized in Scheme 1.7.   
  
Once in the cell, GlcNAc6P performs several functions, in addition to being 
deacetylated by NagA.  In one function, GlcNAc6P binds to the transcription regulator 
NagC, preventing it from binding to its operator in the NagE-NagABCD operon.  This 
results in the initiation of transcription for NagE, NagA, and NagB, which are 
sequentally responsible for the transportation and phosphorylation of GlcNAc, the 
deacetylation of GlcNAc6P and the deamination and isomerization of GlcN6P to form 
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fructose-6-phosphate.  GlcNAc6P is also an allosteric K-type activator of NagB, which 
is the final step before entry into the glycolysis pathway.  In a competing reaction, if 
sources of aminosugars are unavailable, GlcN6P can be produced by GlcN6P synthase 
from glutamine and fructose-6-P. 
A previous study has analyzed the forward and reverse kinetics and mechanism 
of NagA from E. coli (68).  In the forward reaction, it was determined that substrate 
inhibition is present for GlcNAc6P, while the products GlcNAc and acetate are non-
competitive and competitive inhibitors, respectively. This is explained as the possible 
result of an ordered release of products. The substrate inhibition may arise from the 
addition of substrate to the enzyme with acetate still in the active site.  In this study 
however, little attention was focused on the involvement of metal in the active site.  The 
role of a metal cofactor is of particular interest in NagA from E. coli, because it contains 
a QxN motif at the carboxyl end of β-strand 1, which replaces the HxH Mα binding motif 
that is found in NagA from T. maritima and B. subtilis.  The likely result of the QxN 
motif is an inability to bind metal at the α-metal binding site, resulting in a mononuclear 
metal center in the β-metal binding site bound with a water molecule and three amino 
acid ligands.   
The effects of this active site deviation may be seen in Figure 1.1, which shows 
an alignment of the active site residues for NagA from T. maritima (PDB code: 1o12), B. 
subtilis (PDB code: 1un7) and E. coli (PDB code: 1ymy).  While the active site residues 
are in similar positions, the α-metal binding site in T. maritima is unoccupied as 
crystallized by The Joint Center for Structural Genomics.  This may be significant in 
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light of the lack of the α-metal and typical α-metal binding motif in the E. coli enzyme.  
The active site QxN motif is also found in NagA from H. sapiens.  In another 
crystallographic study of NagA from E. coli, NagA was crystallized without a metal in 
the active site (65).   
 
 
Figure 1.1: Structural alignment of the catalytic residues of NagA from B. subtilis (PDB code: 1un7, 
green carbons) , T. maritima (PDB code: 1o12, blue carbons) and E. coli (PDB code: 1ymy, grey carbons).  
Residue assignments correspond to E. coli NagA.  
 
Prior to the work presented here, there was a lack of information pertaining to the 
mechanism of catalysis for NagA. It had not yet been demonstrated which active site 
residues were responsible for the formation of the metal center and for binding and 
catalysis. There was also no report on how the active site metal interacts with the 
substrate and how the hydrolytic water molecule becomes activated.  In consideration of 
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D273 
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the absence of the two histidine α-metal ligands from strand 1, it was anticipated that 
NagA from E. coli K-12 utilizes only the β-metal for catalysis. This body of work was 
aimed at achieving a better understanding of how nature has compensated for the loss of 
the α-metal which aids in water activation and transition state stabilization. The second 
chapter of this dissertation will focus on the mechanism of NagA and the third chapter 
will focus on the structure and evolution of the NagA active site. 
The α-mononuclear cytosine deaminase from Escherichia coli K-12 (CDA) 
catalyzes an important reaction in the metabolism of pyrimidines, by performing the 
nucleophilic aromatic substitution by water in the deamination of cytosine to form uracil 
and free ammonia.  Cytosine may be produced from cytidine through the hydrolytic 
action of a pyrimidine nucleosidase, or from CMP through a pyrimidine nucleotide N-
ribosidase. Uracil produced from the deamination of cytosine may then participate in a 
large number of metabolic pathways, which include the production of deoxy-uridine, 
uridine, pseudouridine, β-alanine, or malonate and urea.  
Bacteria, fungi and yeast possess a cytosine deaminase; however, mammals have 
only a cytidine deaminase (92). This aspect has been exploited through the use of 5-
fluorocytosine as a fungicide and in the treatment of solid tumors, where the tumors 
were transfected with a gene for CDA and then treated with 5-fluourocytosine (93).  This 
drug is non-toxic until it is deaminated to 5-fluorouracil, which inhibits DNA 
replication, thus killing the transfected cells.   
A previous study of bacterial CDA found that it requires one equivalent of Fe2+ 
for maximum activity although it was also active with Mn2+ Co2+ and Zn2+.  The Zn2+ 
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containing enzyme was the least active, possessing only 10% of the activity seen for the 
Fe2+ enzyme at pH 7.5 (22). In that study, an attempt to prepare apo-CDA from enzyme 
which contained 0.8 equivalents of Fe and 0.2 equivalens of Zn, yielded enzyme with 
0.2 equivalents of Zn.  Later studies discovered that bacterial CDA oligomerizes as a 
homo-hexamer, with a molecular weight of about 48 kDa per subunit (19).   
CDA utilizes a TIM barrel structural fold and coordinates Fe2+  in a trigonal-
bipyramidal fashion through the histidine residues 62, 64 from the end of β-strand 1, 
His-214 from strand 5, Asp-314 from strand 8 as well as a nucleophilic water molecule. 
It is interesting to note that the structure of yeast CDA forms as a dimer with a 17 kDa 
molecular weight per subunit (94). The yeast CDA utilizes a half-barrel structural fold, 
with a tetrahedrally coordinated Zn2+ bound by two cysteines, a histidine and a water 
molecule.  Bacterial CDA, a member of the amidohydrolase superfamily, is most similar 
in structure to adenosine deaminase (ADA), while the structure of yeast CDA is highly 
similar to that of cytidine deaminase (23). As seen from crystal structure comparisons of 
several deaminases including E. coli CDA with 4-(R)-hydroxyl-3,4-dihydropyrimidine 
(23), murine ADA with 6-hydroxyl-1,6-dihydropurine ribonucleoside (17), and cytidine 
deaminase with bound uridine (95), there were several unifying characteristics: a 
divalent metal is used in the activation of the hydrolytic water, and a glutamate residue is 
located close enough to protonate the endocyclic N3 of the pyrimidine ring (23). This 
may promote the enol to keto tautomerization which may be required for collapse of a 
metal bound tetrahedral intermediate followed by product release.  
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 Prior to this work, there was little explanation for the apparent discrepancies seen 
between the activities of the Fe2+ and the Zn2+  bound enzyme forms, considering that the 
very similar enzymes guanine deaminase (PDB code: 2UZ9) and adenosine deaminase 
(17) were both isolated with a single bound Zn2+ ion. While there was already a crystal 
structure of this enzyme bound with a mechanism based inhibitor, it contains an Fe3+ 
metal ion. It was shown that CDA loses activity during purification and that the loss of 
activity was due to the oxidation of the Fe2+ (23). Therefore, some of the active site 
interactions shown may not be catalytically relevant, due to the charge difference. There 
was also very little known about the active site residues involved in substrate binding 
and catalysis and it was unknown how many and which active site bases are involved in 
the eventual abstraction of two protons from the hydrolytic water and the eventual 
protonation of the N-3 atom of cytosine.  Prior to this work, it was also poorly 
understood which features of the substrate are recognized by the enzyme and are 
required for catalysis to occur.  The fourth chapter of the present study will address the 
mechanism and structure of cytosine deaminase.   
 It was noted by White and co-workers (96) that a deaminase involved in the 
riboflavin and  coenzyme F420 biosynthetic pathways of archaeal organisms has not 
been identified. The work presented in Chapter V describes the experiments performed 
in the search for the unidentified pyrimidine deaminase involved in the riboflavin 
biosynthesis pathway of archaea. The third protein studied in this body of work is a 
protein of unknown function that was selected for study based on sequence comparisons 
and genomic context evaluations. Genomic context evaluations suggested that the genes 
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of unknown function labeled Mm0823, MmarC7 0625 and Sso0398 are associated with 
the riboflavin biosynthesis pathway of archaea and sequence analyses assigned the 
proteins as chlorohydrolases related to SsnA and AtzA. Alignments with known 
members of the AHS show strong similarity to CDA and GDA.  Taken together, these 
observations provide strong support that these proteins of unknown function represent 
the missing archaeal pyrimidine deaminase. The work presented here reports the cloning, 
expression and attempted purification and assay development for those three proteins. 
Chapter VI of this work describes a different route toward the discovery of 
function of two novel 8-oxoguanine deaminases. The genes of unknown function 
Pa0142 and the NYSGXRC target 9236e (PDB code: 3HPA), from an environmental 
sample of the Sargasso Sea, appear to be located in a nucleotide salvage pathway of the 
bacteria, near genes which are very similar to known adenosine and guanine deaminases.  
Annotated as AtzB-like, the sequences of Pa0142 and 9236e are highly analogous to 
AtzB, GDA and to a lesser extent; CDA, SsnA and YahJ.  It can be seen in the crystal 
structure of GDA from H. sapiens (PDB code: 2UZ9), and other GDA enzymes, that 
there is a conserved arginine which forms multiple interactions with the bound product 
xanthine.  In these two proteins of unknown function, the residue found to be in that 
location is identified as a cysteine. That difference, when combined with the presence of 
the GDA-like protein nearby in the genome, suggests that these two unknown enzymes 
utilize a slightly different substrate. Pa0142 and 9236e were tested for deaminase 
activity against a library of pteridines, purines and pyrimidines containing primary 
amines. It was discovered that these enzymes catalyze the deamination of 8-oxoguanine, 
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guanine and isocytosine. 217 genes listed in Appendix A were identified which are 
predicted to deaminate 8-oxoguanine.   
Chapter VII describes the discovery of function of two isoxanthopterin 
deaminases. A small group of 24 bacterial proteins which share a high degree of 
sequence similarity to guanine deaminases and 8-oxoguanine deaminases were 
identified. These enzymes share a critical difference at a location which provides 
substrate recognition for both guanine deaminases and the 8-oxoguanine deaminases. At 
this location, an arginine is conserved among guanine deaminases, a cysteine is 
conserved among 8-oxoguanine deaminases and in this small group of proteins a 
threonine is conserved. From genomic context analyses, these enzymes were found have 
possible pathway involvements with dioxygenases, decarboxylases and 
purine/pyrimidine transporter proteins. From this distinct group of enzymes, the SGX 
targets 9339a (PDB code: 2PAJ) and 9236b were tested for deaminase activity against a 
library of pteridines, purines and pyrimidines containing primary amines. From those 
screens, new enzymatic activities were discovered.  9339a and 9236b catalyze the 
deaminations of isoxanthopterin and pterine-6-carboxylate. These reactions appear to be 
involved in a poorly understood flavin degradation pathway which is proposed to 
involve decarboxylations and oxidations.   
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CHAPTER II 
N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE DEACETYLASE: SUBSTRATE 
ACTIVATION VIA A SINGLE DIVALENT METAL ION* 
N-acetyl-D-glucosamine-6-phosphate deacetylase (NagA) catalyzes the 
hydrolytic cleavage of N-acetyl-D-glucosamine-6-phosphate as illustrated in Scheme 2.1.  
The deacetylation of this compound provides a source of carbon and nitrogen by 
preparing this substrate for entry into the glycolytic pathway.  This reaction is a key step 
in the catabolism of N-acetyl-D-glucosamine, derived from the degradation of chitin, and 
is an essential component of the biosynthesis of lipopolysaccharides and peptidoglycans.  
More recently, the reaction catalyzed by NagA has been shown to be an important step 
in the recycling of cell wall murein (97). 
Scheme 2.1 
 
 
 
 
 
______________ 
* Part of this chapter is reprinted with permission from “Tight Binding Inhibitors of N-Acyl Amino Sugar 
and N-Acyl Amino Acid Deacetylases” by Xu, C., Hall, R., Cummings, J., and Raushel, F., 2006. J. Am. 
Chem. Soc., 128, 4244-4245, Copyright [2006] by American Chemical Society.  
Part of this chapter is reprinted with permission from “N-Acetyl-D-glucosamine-6-phosphate Deacetylase: 
Substrate Activation via a Single Divalent Metal Ion” by Hall, R. S., Xiang, D. F., Xu, C., and Raushel, F. 
M., 2007. Biochemistry,46, 7942-7952, Copyright [2007] byAmerican Chemical Society. 
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The purification of NagA from Escherichia coli was originally reported by White 
and Pasternak (70).  The enzyme oligomerizes as a tetramer and each subunit contains a 
reactive sulfhydryl group near the active site (68).  In the forward reaction, inhibition 
occurs at high substrate concentrations while the products, D-glucosamine-6-phosphate 
and acetate, are noncompetitive and competitive inhibitors, respectively.  A phosphonate 
analogue of the putative tetrahedral intermediate has been synthesized that is a potent 
and tight-binding inhibitor (98).   The structure of apo-NagA from E. coli was first 
reported by a team led by Steve Almo (PDB code: 1YMY) and later by Ferreira et al. 
(65) (PDB code: 1YRR).  The protein folds as a (β/α)8-barrel and is a member of the 
amidohydrolase superfamily (65).  The enzyme binds up to 1.4 equivalents of zinc and 
the metal can be removed with a chelating agent, resulting in the loss of activity that can 
be restored after reconstitution with Zn, Co, Mn or Fe (65). 
The role of a metal cofactor is of particular interest for NagA because the two 
crystal structures available for the enzyme from E. coli have no metal bound in the 
active site.  However, the crystal structures of NagA from B. subtilis and T. maritima 
have been determined with divalent cations bound within the active site (69). The B. 
subtilis enzyme (PDB code: 1UN7) binds two equivalents of Fe2+ (69). One of the metals 
is coordinated to the HxH motif at the end of β-strand 1 and an aspartic acid from the 
end of β-strand 8.  This site has been designated as the Mα-position (10).  The second 
metal (Mβ-site) is coordinated to two histidine residues from the ends of β-strands 5 and 
6, respectively.  The two metal ions are bridged to one another by a glutamate from the 
end of β-strand 3 and a hydroxide (or water) from solvent.   
 51
The active site of the T. maritima enzyme is quite similar to that of the B. subtilis 
structure except that a single metal ion is bound to the Mβ-site (PDB code: 1O12).  The 
metal ligation scheme in the NagA from E. coli must be significantly different since the 
HxH motif from the end of stand 1 is replaced by QxN and thus it is highly likely that 
this enzyme can bind only a single divalent cation in the active site.  This fundamental 
divergence in the active sites of NagA from these sources suggests that the mechanism 
for the activation of the hydrolytic water and substrate required for catalysis must differ 
to a significant degree.     
NagA has been characterized as a member of the amidohydrolase superfamily 
based on an exhaustive set of sequence and structural comparisons (10).  This 
superfamily is a diverse group of enzymes that catalyzes the hydrolytic cleavage of 
amide bonds to nucleic acids, amino acids, and sugars (10, 12). Within this superfamily, 
four metal ligation schemes have been identified.  The most prevalent is a binuclear 
metal center where the two divalent cations are bridged by a hydroxide from solvent.  
An additional bridging ligand from the protein may include a carboxylated lysine from 
the end of β-strand 4, a glutamate from the end of β-strands three or four, or a cysteine 
from the end of β-strand 2 (10, 12). Enzymes of this type include dihydroorotase (31), 
the phosphotriesterase homology protein (78), renal dipeptidase (45) and D-amino acid 
deacetylase (69).  Many members of the amidohydrolase superfamily bind a single 
divalent cation, including cytosine (23) and adenosine deaminase (17).  This class of 
enzymes binds one metal at the α-position via ligation to the HxH motif from β-strand 1, 
a histidine from the end of β-strand 5 and an invariant asparate from β-strand 8.  The 
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third ligation scheme, which may include NagA from E. coli and T. maritima, utilizes a 
single metal bound exclusively to the β-site.  The most extreme example within the 
amidohydrolase superfamily is uronate isomerase from E. coli.  This enzyme catalyzes 
the isomerization of glucuronate to fructuronate and a metal ion is not required for 
catalytic activity (63).   
There are a significant number of issues regarding the mechanism for substrate 
hydrolysis by NagA that are unresolved.  It is unclear how the divalent cation binds 
within the active site of NagA and how the water molecule is activated for nucleophilic 
attack on the amide bond.  The disparity in the metal ligation schemes between the E. 
coli and B. subtilis forms of NagA suggests a divergence in the evolution of this enzyme 
at a significant locale within the active site.  In this paper, we have systematically 
interrogated the mechanism of substrate hydrolysis by NagA from E. coli with a battery 
of substrate analogues and active site mutants using a host of metal-substituted forms of 
the enzyme.  We conclude from these studies that NagA from E. coli can bind up to one 
divalent cation for the activation of the hydrolytic water molecule.  This water molecule 
is further activated by general base catalysis through the abstraction of a proton by Asp-
273.  There is no evidence to suggest that Glu-131 plays any role in catalysis other than 
to help coordinate the single divalent cation.  The enzyme is rate limited by the cleavage 
of the amide bond.   
MATERIALS AND METHODS 
 Materials.  N-Acetyl-D-glucosamine-6-phosphate (1), N-acetyl-D-glucosamine-6-
sulfate (3), and all buffers and purification reagents were purchased from Sigma-Aldrich. 
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The substrates N-acetyl-D-galactosamine-6-phosphate (2) N-thioacetyl-D-glucosamine-
6-phosphate (4), N-Formyl-D-glucosamine-6-phosphate (5), N-trifluoroacetyl-D-
glucosamine-6-phosphate (6), as well as the N-methylphosphonamidate-D-glucosamine-
6-phosphate inhibitor (7) were prepared by Dr. Chengfu Xu as reported elsewhere (67, 
98). Chromatographic columns and resins were purchased from G. E. Healthcare.  
Chelex 100 resin was purchased from BioRad.  Slide-A-Lyzer dialysis cassettes were 
purchased from Pierce.  ICP standards were obtained from Inorganic Ventures Inc.  
Cloning, Expression, and Purification. The gene from E. coli encoding NagA 
was cloned into a pET-30a (+) expression vector through the use of the NdeI and EcoRI 
restriction sites by Dr. Daofeng Xiang. Mutants of NagA were prepared in accordance 
with procedures published in the Quikchange Site-Directed Mutagenesis Kit. Gene 
sequences were verified by the Gene Technologies Lab at Texas A&M University. The 
expression plasmids were inserted into BL21 (DE3) cells through electroporation. The 
transformation solution was then transferred into 1 mL of LB growth medium for 
incubation at 37 °C for 30 min, which was followed by plating onto LB agar containing 
50 µg/mL kanamycin. The cells were allowed to grow overnight at the same 
temperature. Single colonies were selected for inoculation into 50 mL of LB/kanamycin 
for use as overnight starter cultures for inoculation into 2 L of LB/kanamycin. Prior to 
induction with 1.0 mM IPTG at an A600 nm of 0.6, 1.0 mM ZnCl2 was added to 
supplement the growth medium. The cells grew overnight at a temperature of 30 °C, 
after which they were centrifuged at 3400g for 12 min. The cells were then resuspended 
and disrupted by sonication in 10 × (v/w) 50 mM Tris buffer, pH 7.5, containing 1.0 mM 
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DTT and 100 µg/mL of the protease inhibitor phenylmethanesulfonyl fluoride. Insoluble 
cell debris was removed by centrifugation at 13900g for 12 min, after which 1% w/v 
protamine sulfate from salmon sperm was used to precipitate the nucleic acids. The 
precipitate was removed by centrifugation and the protein fractionated with ammonium 
sulfate to 50% of saturation. The precipitated protein was isolated by centrifugation at 
13900g for 12 min. The protein was then resuspended in a minimal amount of 50 mM 
Tris buffer, pH 7.5, containing 1.0 mM DTT and then passed through a 0.2 µM pore 
filter prior to loading onto a pre-equilibrated HiLoad 26/60 Superdex 200 prep grade gel 
filtration column. The pooled fractions containing NagA were diluted to 50 mL in the 
same buffer and loaded onto a 6 mL Resource Q anion exchange column. The column 
was washed with several column volumes of buffer and the protein eluted with a linear 
gradient of 1 M NaCl, 50 mM Tris, pH 7.5. The appropriate fractions were pooled after 
analysis with SDS PAGE for purity. Protein concentrations were determined using the 
calculated extinction coefficient of 18,490 M-1 cm-1 at 280 nm 
(www.scripps.edu/_cdputnam/protcalc.html). 
 Measurement of Enzymatic Activity. Kinetic assays were performed at 30 °C 
using a 96 well quartz plate in conjunction with a SpectraMax 384-Plus 
spectrophotometer from Molecular Devices. The data were analyzed using Softmax Pro 
version 4.7.1. Extinction coefficients for the different substrates were determined from 
plots of absorbance versus substrate concentration before and after total enzymatic 
hydrolysis. 
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 Metal Analysis. Metal determination and quantification were performed with an 
Elan DRC II ICP-MS from Perkin-Elmer. An analog detection mode was used with three 
averaged replicates per reading. External calibration standards were prepared through the 
serial dilution of a single 10 ppm stock mixture of Zn, Cd, Co, Cu, Mn, Ni, and Fe in 2% 
nitric acid. Freshly prepared standards generally contained 2, 20, and 200 ppb of the 
metal ions in 1% Trace Select nitric acid from Fluka, diluted in MilliQ deionized water. 
The masses of the isotopes detected were 55Mn, 57Fe, 59Co, 60Ni, 66Zn, and 111Cd. 115In 
was used as an internal standard for 111Cd whereas 69Ga was used as an internal standard 
for all other isotopes. 
 Metal Chelation and Reconstitution. Apoenzyme was prepared by dialysis of 
NagA against buffer A (20 mM dipicolinate, 10 mM β-mercaptoethanol, 50 mM MES, 
pH 6.0). After 3 × 300-fold buffer changes with buffer A over 2 days, the chelator was 
removed by dialysis with Chelex-treated HEPES buffer, pH 8.0. For the metal 
reconstitution studies, 100 µL of apo-NagA at 8.23 mg/mL was mixed with 
3 equiv of various metal solutions. The metal solutions consisted of freshly prepared 
NiCl2, CdCl2, CoCl2, MnCl2, or ZnCl2 in water, and Fe(NH4)2(SO4)2 in 1% HCl. 
Reconstitution of the apoenzymes was conducted overnight at 4 °C before removal of 
unbound metal by passage through a PD-10 column. The PD-10 column was pretreated 
with dipicolinate to remove traces of unbound metal and then washed with five column 
volumes of metal free HEPES buffer, pH 8.0. After elution, the concentration of the 
metal reconstituted enzyme was determined by UV absorbance and the metal content of 
the samples determined by ICP-MS. 
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 Inhibitor Studies. A methyl phosphonamidate analogue of the tetrahedral 
intermediate for the reaction catalyzed by NagA (I) was synthesized by Dr. Chengfu Xu 
and the structure is presented in Scheme 2. The inhibition constant for NagA was 
determined by incubating variable amounts of I with 10-45 nM of the enzyme for 30 min 
in 50 mM phosphate buffer, pH 7.5. The enzyme activity was determined using 0.5 mM 
N-acetyl-D-glucosamine-6-phosphate as the substrate. The time dependence to the onset 
of inhibition by I with NagA was determined by measuring the rate of bond cleavage as 
a function of time. In these experiments, 10 nM NagA was added to a solution of 0.5 
mM substrate containing 0.4-2.4 µM I. 
 pH Studies. The pH dependence of the kinetic constants, kcat and kcat/Km, were 
determined at intervals of ~0.25 pH units from pH 5.0 to 10 using 20 mM piperazine 
(pH 5-6.25), phosphate (pH 6.25-8), and borate (pH 8-10) with varying amounts of 
substrate.  The pH values of the assays were determined after the assays were completed.   
Solvent Viscosity Analysis.  Solvent viscosity effects were analyzed for Zn-NagA 
with N-acetyl-D-glucosamine-6-phosphate as the substrate using sucrose as the micro-
viscogen in 20 mM phosphate buffer, pH 7.5.  The effect of sucrose was performed 
using 0, 10, 14, 20, 24, 27.5, 32.5 and 35% (w/w) sucrose and the corresponding relative 
viscosities were 1, 1.32, 1.5, 1.88, 2.2, 2.48, 3.06, and 3.42 respectively (99, 100). 
Data Analysis.  All kinetic data were fit to the corresponding equations using the 
nonlinear least-squares curve fitting program SigmaPlot 9.0.  Simple substrate saturation 
curves were fit using equation 2.1 where A is the substrate concentration, v is the 
velocity of the reaction, kcat is the turnover number and Km is the Michaelis constant.  
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When substrate saturation was not achieved, kcat/Km values were determined from fits of 
the data with a straight line.  Saturation curves showing substrate inhibition were fit 
using equation 2.2 were Kis is the apparent inhibition constant for the substrate 
inhibition.  For the analysis of pH-rate profiles, plots of log kcat and log kcat/Km vs. pH 
that indicated the deprotonation of a single group required for maximum activity were fit 
with equation 2.3, where c is the maximum activity and Ka is the acid dissociation 
constant.  pH-rate profiles that showed the loss of catalytic activity at high and low 
values of pH were fit with equation 2.4, where Kb is the dissociation constant of the 
group that must be protonated for full activity. The pH profiles which showed that the 
deprotonation of two acidic groups and the protonation of one basic group are required 
for maximum activity were fitted to equation 2.5 where Ka is the average dissociation 
constant of the two acidic groups and Kb is the dissociation constant of the basic group.  
Equation 2.6 was used to determine the average Ka for two ionizable acidic groups and 
the average Kb for two ionizable basic groups.   
For the evaluation of the inhibition constants (Ki) for the methyl 
phosphonamidate inhibitor (I) of NagA, eq 2.7 was fit to plots of the residual activities 
vs inhibitor concentrations. Et is the total enzyme concentration, I is the inhibitor 
concentration, vo is the activity of the enzyme in the absence of inhibitor, and vi is the 
residual activity of the enzyme in the presence of inhibitor. For the determination of the 
time dependence to the onset of inhibition, time courses corresponding to the change in 
rate of cytosine deamination were fit with eq 2.8, where P is the product concentration, 
vr and vs are the initial and final rates of product formation, and kobs corresponds to the 
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first order rate constants for the onset of the slower rate of product formation.   The 
apparent second-order rate constants (appkobs) for the formation of the inhibited form of 
Zn-CDA, was determined from the slope of the plots of kobs vs the concentrations of 
inhibitors. Correction for the concentration of substrate according to eq 2.9, gives the 
second-order rate constant k1.   
v / Et  =  kcat A / (Km + A)                                                       (2.1) 
v / Et = kcat  A / (Km + A + (A2 / Kis))                                                  (2.2) 
y  =  log(c / (1 + [H+] / Ka))                                                       (2.3) 
y = log(c / (1 + [H+] / Ka + Kb / [H+]))                                                                            (2.4) 
y = log(c / (1 + [H+] / Ka + [H+]2 / Ka2 + Kb / [H+]))                                                      (2.5)   
y = log(c / (1 + [H+] / Ka + [H+] 2 / Ka2 + Kb / [H+] + Kb2 / [H+]2))                                 (2.6) 
vi/vo = ([Et] – Ki – [I] + (([I] + Ki – [Et])2 + (4Ki[Et]))1/2)/(2[Et]) (2.7) 
P = vst + ((vr – vs)/kobs)(1-e(-kobst)) (2.8) 
k1 = appkobs (1 + [S]/[Km]) (2.9) 
RESULTS AND DISCUSSION 
Purification and Properties of NagA.  NagA was the major soluble protein after 
induction by IPTG as estimated from SDS-PAGE.  From 3 grams of cell paste about 100 
mg of homogeneous protein were isolated.  Enzymatic activity was dependent upon the 
presence of disulfide reducing reagents such as dithiothreitol or β-mercaptoethanol 
during storage and purification.  The native molecular weight of the purified enzyme 
was estimated to be 180 kDa based upon the elution volume through a calibrated gel 
filtration column (data not shown).  The molecular weight of a single subunit from the 
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derived amino acid sequence of NagA is 40,951 Da.  These results confirm that NagA 
adopts a tetrameric quaternary structure in the presence of disulfide reducing agents (65, 
68). 
Metal Dependence of Enzyme Activity.  The initial purification of NagA resulted 
in enzyme with a turnover number of 35 s-1.  This protein contained 0.4 equivalents of 
Zn2+ and 0.05 equivalents of Fe2+ as determined by ICP-MS.  NagA was subsequently 
expressed in LB medium supplemented with 1.0 mM ZnCl2 and the protein purified from 
these cells contains 0.95 equivalents of Zn per subunit with a specific activity of 96 s-1.  
The role of the bound metal on the enzymatic reaction rate was addressed by 
characterization of the apo-enzyme.  The metal was removed from the enzyme via 
dialysis against 20 mM dipicolinate and the resulting protein solution was verified to be 
metal-free by ICP-MS.  However, during the time course for measurement of catalytic 
activity by the apo-enzyme, the rate of substrate turnover increased with time.  The 
activation of the apo-enzyme was apparently due to the binding of trace metals in the 
assay solution since the activity of the apo-enzyme in the presence of 500 μM EDTA 
was less than 2% of the activity exhibited by the native enzyme.  These results are 
consistent with an absolute requirement for a bound divalent cation for the expression of 
catalytic activity by NagA. 
Incubation of the apo-enzyme with one equivalent of Zn2+ for 30 minutes fully 
restored catalytic activity.  The titration of apo-enzyme with varying amounts of ZnCl2 is 
shown in Figure 2.1. These results demonstrate that NagA from E. coli has a maximum 
catalytic activity with a single divalent cation bound to the active site.  These results are 
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consistent with the absence of the two histidines at the end of strand one and the 
determination of the x-ray structure of the Zn-NagA that shows a single Zn bound to the 
Mβ-site (66). The apo-enzyme was reconstituted with three equivalents of Fe2+, Mn2+, 
Ni2+, Cd2+, Co2+ or Zn2+ and the metal substituted forms of NagA were found to contain 
approximately one equivalent of metal per protein subunit after removal of the excess 
metal by dialysis.  The metal content and the corresponding kinetic parameters for the 
metal substituted variants of NagA are listed in Table 2.1. 
    
 
Figure 2.1: Reconstitution of apo-NagA (0.5 μM) with varying amounts of Zn. The rate of substrate 
hydrolysis was determined after diluting the enzyme to a concentration of 30 nM in 1.0 mM N-acetyl-D-
glucosamine-6-phosphate, 1.0 μM EDTA and 25 mM Tris at pH 7.5 and 30 ºC. 
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Table 2.1:  Kinetic Parameters for Metal-Reconstituted Forms of NagAa. 
Metal Metal/subunit kcat (s-1) Km  (mM) kcat /Km (M-1s-1) 
Zn 0.9 102 ± 2 0.08 ± 0.01 (1.2 ± 0.2) × 106 
Cd 0.8 163 ± 3 0.20 ± 0.01 (8.2 ± 0.4) × 105 
Co 1.0 227 ± 5 0.15 ± 0.01 (1.2 ± 0.1) × 106 
Ni 0.8 41 ± 3 0.64 ± 0.12 (6.4 ± 1.3) × 104 
Mn 0.7 92 ± 2 0.10 ± 0.01 (9.2 ± 0.9) × 105 
Fe 0.5 58 ± 2 0.23 ± 0.03 (2.5 ± 0.5) × 105 
aThe kinetic parameters were determined at pH 7.5, 30 ºC from fits of the data to eq 1 using N-acetyl-D-
glucosamine-6-phosphate (1) as the substrate. 
 
Kinetic Constants for NagA.  The effect of metal substitution on the catalytic 
constants for NagA can be utilized to evaluate the contributions made by these divalent 
cations on enzymatic activity (38, 51).  The relationship on the value of kcat/Km observed 
for the different metals follow the trend: Zn = Co > Mn > Cd > Fe > Ni .  The Fe 
containing enzyme was not fully reconstituted with metal and thus the kinetic constants 
may be larger if  the metal site was fully occupied.  The values for kcat follow the trend 
Co > Cd > Zn > Mn > Fe > Ni.  The Ni enzyme has the highest Km while the Zn enzyme 
has the lowest.  Similar trends in the range of the catalytic constants were reported 
previously for the Co, Zn, Mn and Fe reconstitutions of apo-NagA from E. coli (65).  
Substrate Specificity.  The structures of the compounds tested as substrates for 
NagA are presented in Scheme 2.2.  Cd- and Zn-NagA were used to address the 
occurrence of direct interactions of the carbonyl oxygen/sulfur and the metal ion through 
a comparison of the kinetic constants for N-acetyl-D-glucosamine-6-phosphate (1) and 
N-thioacetyl-D-glucosamine-6-phosphate (4) as substrates.  The Cd-NagA catalyzes the 
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hydrolysis of the thioacetyl substrate about an order of magnitude faster than does the 
Zn-substituted enzyme (Table 2.2).  The ratio of (kcat/Kthio) / (kcat/Kacetyl) is 0.78 (6.4 × 
105 M-1s-1/8.2 × 105 M-1s-1) for the Cd-enzyme whereas the corresponding ratio for the 
Zn-NagA is only 0.036 (4.3 × 104 M-1s-1/1.2 × 106 M-1s-1).  These results are consistent 
with the hard and soft interactions of metals and ligands, since the relatively soft thio-
carbonyl group is potentially a better ligand for the softer cadmium ion than it is for zinc 
(101).  If the softness of the carbonyl group is the only factor affecting these differences, 
then Mn, which is harder than Zn, should yield an even smaller ratio.  However, the ratio 
of kcat/Km for the two substrates with Mn-NagA is essentially the same as it is for the Zn-
substituted enzyme (0.050 vs. 0.036)).  
 
Scheme 2.2 
 
 
 
 
 
       
 
 
These results differ slightly from those observed for carboxypeptidase A, where 
thioamide substrate analogues were compared to the corresponding oxo-amides with the 
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Zn-, Cd-, and Mn-substituted enzymes (102).  For carboxypeptidase the Zn-enzyme was 
the best catalyst for the hydrolysis of oxo-amides, while the Cd-enzyme was the least 
efficient.  For the thioamide substrates, the Cd-enzyme was the best and the Mn-enzyme 
was the poorest catalyst.  Nevertheless, the catalytic constants for the Zn- and Cd-
substituted forms of NagA support the conclusion that the carbonyl group of the 
substrate is polarized by a direct interaction with the single divalent cation bound to the 
Mβ-position in the active site. 
In addition to N-acetyl-D-glucosamine-6-phosphate (1) and the thioacetyl 
analogue (4), NagA can hydrolyze N-trifluoroacetyl-D-glucosamine-6-phosphate (6), N-
acetyl-D-glucosamine-6-sulfate (3) and N-formyl-D-glucosamine-6-P (5).  The kinetic 
constants for NagA with these substrate analogues are listed in Table 2.2.  The N-
trifluoroacetyl substituted substrate is hydrolyzed 26 times faster than the natural 
substrate at saturating conditions but the N-formyl substrate is hydrolyze more slowly by 
a factor of 15. 
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Table 2.2:  Kinetic Parameters for Substrates with Metal and Mutant Variant Forms of NagAa. 
Substrate Enzyme kcat (s-1) Km (mM) kcat/Km (M-1s-1) 
1 Zn 102 ± 2 0.08 ± 0.01 (1.2 ± 0.2) × 106 
1 Cd 163 ± 3 0.20 ± 0.01 (8.2 ± 0.4) × 105 
1 Mn 92 ± 2 0.10 ± 0.01 (9.2 ± 0.9) × 105 
2 Zn 154 ± 15 1.2 ± 0.2 (1.2 ± 0.2) × 105  
3 Zn 64 ± 4 4.9 ± 1.0 (1.3 ± 0.3) × 104 
3 Cd 23 ± 1 11 ± 1 (2.1 ± 0.2) × 103 
3 Zn-K139M 60 ± 4 9.7 ± 1.3 (6.2 ± 0.9) × 10 
4 Zn 10 ± 0.2 0.24 ± 0.02 (4.3 ± 0.4)  × 104 
4 Cd 128 ± 5 0.20 ± 0.03 (6.4 ± 1.0) × 105 
4 Mn 11 ± 0.3 0.23 ± 0.03 (4.8 ± 0.6) × 104 
5 Zn 6.9 ± 0.2 0.13 ± 0.02 (5.3 ± 0.8) × 104 
6 Zn 2612 ± 60 0.40 ± 0.04 (6.6 ± 0.7) × 106 
aThe kinetic parameters were determined at pH 7.5, 30 ºC  from fits of the data to equation 1. 
 
Inhibitor Studies. The enzymatic hydrolysis of acetate N-acetylglucosamine-6-
phosphate may proceed via the direct attack on the amide bond by an activated water 
molecule. Compounds that mimic the structure and geometric constraints of the 
tetrahedral intermediate have proven to be useful probes of the reaction mechanism and 
tight binding enzyme inhibitors (103). Phosphonamidates are particularly useful 
structural surrogates because of the tetrahedral geometry at the phosphorus center and 
the similarities in charge and bond lengths to those predicted to occur during the 
hydrolysis of amide bonds (104-107). 
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The methyl phosphonamidate transition-state analog inhibitor (I) was selected as 
a probe of the affinity for the transition state by NagA for the deacetylation of  1.  The 
effectiveness of the inhibitor shown in Scheme 2.3 was evaluated with the Zn2+ 
containing NagA  at pH 7.5. Inhibition constants were determined through inhibition 
pattern fits to John Morrison’s quadratic equation for tight binding inhibitors (108, 109) 
as shown in eq 2.7.   
Scheme 2.3 
 
 
The methyl phosphonamidate analog of the tetrahedral intermediate for the 
reaction catalyzed by NagA (I) is a potent and time-dependent inhibitor of NagA. After 
incubation of NagA with variable amounts of I the residual activity was plotted versus 
the inhibitor concentration, and the results for 25 nM NagA are presented in Figure 2.2. 
A fit of the data to eq 2.7 for the entire data set gave an average inhibition constant, Ki, 
of 34 ± 5 nM. This inhibitor is a close mimic of the transition state for the deacetylation 
of 1 by NagA and as such, the inhibition constant for compound I is 4 × 103 -fold smaller 
I 
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than the Michaelis constant for the deacetylation of 1 by NagA. This Ki value is among 
the lowest ever measured for the inhibition of deacetylases (110, 111). 
 
Figure 2.2: Inhibition of NagA by I. The kinetic data were fit to eq 2.7 to obtain a dissociation 
constant of 34 nM . Additional details are given in the text. 
 The time courses for the changes in the rates of deacetylation of 1 by NagA as 
seen below in Figure 2.3 were fit to eq 2.8, yielding the observed first-order rate 
constants (kobs) for the slow onset of inhibition by I. The obtained rates (kobs) were then 
plotted vs inhibitor concentrations yielding the apparent second-order rate constants 
(appkobs) as seen below in Figure 2.4. The linearity of these plots indicate that inhibition 
follows a simple model for inhibitor binding shown below in Scheme 2.4.  
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Figure 2.3: Time dependence for the onset of inhibition by 1 with NagA. The concentrations of  I are: 
0.40 µM (circle), 0.80µM (square), 1.6 µM (downward triangle), 2.4µM (upward triangle). The time 
courses were fit to eq 2.8 to obtain the first-order rate constants for the formation of the enzyme-inhibitor 
complex. 
 
Figure 2.4: Effect of inhibitor concentration on the onset of inhibition by I with NagA. Additional details 
are provided in the text. 
Scheme 2.4 
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 From the slope of the plot of kobs versus the concentration of I in Figure 2.4, the 
apparent second-order rate constant is 1.3 × 103 M-1 s-1. Correction of the apparent 
second-order rate for the concentration of substrate according to eq 2.9 gave a value for 
k1 of 6.1 × 103 M-1 s-1 (see Scheme 2.4). The inhibitor was found to be reversibly 
inhibitory upon a 1:100-fold dilution of 500nM NagA which was pre-incubated with 1 
µM of the inhibitor.   
pH Rate Profiles. The effect of pH on the kinetic constants for the hydrolysis of 
substrates by NagA was measured in an attempt to identify those functional groups in 
the substrate and active site that are required to be in a specific state of protonation.  The 
log kcat vs. pH-profile shown in Figure 2.5 A for Zn-NagA was fit to equation 2.3 and 
these results indicate that the deprotonation of a single acid with a kinetic pKa of 5.6 is 
required for catalytic activity in the enzyme-substrate complex.  The log kcat/Km vs. pH-
profile for Zn-NagA is shown in Figure 2.5 B.  In this profile, catalytic activity is lost at 
high and low values of pH and the data were fit to equation 2.4 where two groups, in 
either the substrate or free enzyme, with identical pKa values of 6.4 are required to be 
ionized.  An additional group must be protonated with a pKa of ~9.3.  Similar results 
were obtained for the effect of pH on the kinetic constants for the hydrolysis of 
compound 1 by Cd-NagA (data not shown).  From the log kcat vs. pH profile, a single 
group must be ionized with a kinetic pKa of 6.4.  From the log kcat/Km pH-rate profile 
activity is lost at low and high pH with limiting slopes of 2 and -2, respectively, and the 
data were fit to equation 2.5.  
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For the log kcat vs. pH profile, a single ionization is observed for either Zn- or 
Cd-NagA.  This ionization must represent the protonation of the metal bound hydroxide 
that is utilized for substrate hydrolysis or, alternatively, the general base that is utilized 
to deprotonate the metal bound water molecule prior to substrate hydrolysis.  The pKa 
value is slightly higher for Cd-NagA than for Zn-NagA, as expected from the tendency 
of zinc to lower the pKa of water relative to cadmium (76).  For the log kcat/Km profiles, 
two ionizations are observed at low pH for both metal-substituted forms of the enzyme.  
One of these ionizations must be from the free enzyme and likely reflects the state of 
protonation for the group that must activate the metal-bound water molecule. From the 
x-ray crystal structure of NagA and homologous active site structures for other members 
of the amidohydrolase superfamily this residue must be the invariant carboxylate group, 
Asp-273, from the end of β-strand 8 (12, 66). The second ionization observed in the log 
kcat/Km profile could originate from other residues within the active site of NagA but it 
could also arise from the protonation of the substrate itself since the phosphate moiety 
has a pKa of ~6.1 (112). If the enzyme requires (or highly prefers) a doubly ionized 
phosphate substituent for binding then a diminution in activity will be observed in the 
kcat/Km plot but not the kcat vs. pH profile (113). 
To address this issue experimentally, the pH-rate profiles for the hydrolysis of 
the sulfate analogue of the substrate (3) were measured. The sulfate derivative is a 
monoanion above pH 5, and thus no ionizations can originate from the protonation of 
this compound in the pH range available for the characterization of NagA (pH 5-10).  
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Figure 2.5:  pH-rate profiles for the hydrolysis of substrates by NagA.  (A) log kcat  vs. pH profiles for Zn-
NagA with N-acetyl-D-glucosamine-6-phosphate (○) and N-acetyl-D-glucosamine-6-sulfate (●).  The 
solid lines represent fits of the data to equation 2.3.  (B) log kcat/Km vs. pH profiles for Zn-NagA with N-
acetyl-D-glucosamine-6-phosphate (○) and N-acetyl-D-glucosamine-6-sulfate (●).  The solid lines 
represent fits of the data to equations 2.5 and 2.3, respectively.  Additional details are provided in the text 
and the dissociation constants from fits of the data to the appropriate equations are listed in Table 2.3. 
 
 
Table 2.3: Kinetic pKa Values from pH – Rate Profiles of Metal-Substituted Variants and Mutant. 
Enzyme Metal Substrate 
kcat vs. pH 
pKa 
kcat/Km vs. pH 
pKa 
kcat/Km vs. pH 
pKb 
Wild type Zn 1 5.6 ± 0.1 6.4 ± 0.1a 9.3 ± 0.4 
Wild type Cd 1 6.4 ± 0.1 6.1 ± 0.1a 9.1 ± 0.2b 
K139M Zn 1 5.4 ±  0.2 7.0 ± 0.1 9.1 ± 0.4 
Wild type Zn 3 6.5 ± 0.1 6.2 ± 0.1 - 
aAverage value of pKa for two ionizations. bAverage value of pKb for two ionizations. 
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At saturating substrate the sulfate analogue (3) is hydrolyzed at approximately half the 
rate of the physiological substrate (1), although the Km value is significantly higher 
(Table 2.2). For the pH-rate profiles (Figures 2.5 A and 2.5 B) a single ionization of pKa 
6.5 is observed in the log kcat vs pH profiles and a single ionization of pKa 6.2 is 
observed in the log kcat/Km profile (Table 2.3). These results are fully consistent with the 
conclusion that the second ionization observed in the pH rate profile for log kcat/Km with 
compound 1 is due to the protonation of the phosphate moiety to a monoanion. It is also 
curious to note that the ionization that is observed at high pH in the log kcat/Km vs pH-
rate profiles for the natural substrate is not observed during the hydrolysis of the sulfate 
derivative. These results suggest that the monoanionic sulfate derivative does not require 
the interaction with an enzyme group that apparently ionizes in this pH range. The likely 
candidates for this group include Lys-139 and Tyr-223, based on the structure of D-
glucosamine-6-phosphate bound to the enzyme from B. subtilis (69), and the inhibitor 
bound form of the D273N mutant from E. coli (66).  
Mutation of Active Site Residues. Site specific mutants of NagA were constructed 
in order to ascertain the roles of specific residues in substrate recognition and catalytic 
function. The metal content and the kinetic parameters for the mutants of NagA 
constructed for this investigation are presented in Table 2.4. Residues Q59 and N61 were 
mutated together to a pair of histidine residues to create an HxH motif that is analogous 
to that found in NagA from B. subtilis and T. maritima. This alteration resulted in a 
decrease in kcat, a large increase in Km, and an increase in the average amount of Zn 
bound to the protein, suggesting that an additional metal ion can bind to this mutant. The 
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drop in catalytic activity may result from the binding of this second metal ion or may be 
due to steric crowding within the confines of an active site that has apparently evolved to 
operate with a single divalent cation. For the single histidine substitutions, the N61H 
mutant is similar in catalytic activity to the double mutant whereas the Q59H mutant is 
diminished by less than an order of magnitude relative to the wild type enzyme. For the 
substitutions at Asn-61, the replacement with an alanine is significantly less disruptive 
than the change to a histidine. 
The X-ray structures of NagA from E. coli (66), T. maritima (PDB code: 1O12), 
and B. subtilis (69) indicate in each case that a glutamate from the end of β-strand 3 of 
the (β/α)8-barrel interacts with one or both of the divalent cations bound within the active 
site. Mutation of this residue to either glutamine or alanine results in mutant enzymes 
that have lost a significant amount of catalytic activity. The value of kcat is reduced 
approximately 2 orders of magnitude, and the Km for the E131Q mutant is increased to 
3.6 mM. A significant portion of this reduction in catalytic efficiency has arisen because 
the metal content of the purified proteins is relatively low. Incubation of 25 µM E131A 
mutant with 15 equiv of ZnCl2 enhanced the catalytic activity of this enzyme by a factor 
of 3.  
In the crystal structure of the D273N mutant of NagA, the side chain of His-143 
is 3.0 Å away from the phosphonate oxygen of the mimic of the tetrahedral intermediate 
(66). This result suggests that this group could facilitate the activation of the carbonyl 
group of the substrate in conjunction with an interaction with the metal ion bound within 
the active site. Mutation of H143 to an asparagine resulted in the dramatic loss of 
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catalytic activity and a moderate increase in the Km, producing a 6000-fold decrease in 
kcat/Km. The H143Q mutant was more active, with a decrease in the value of kcat/Km of 
greater than 2 orders of magnitude. The H143Q mutant was isolated with 0.6 equiv of 
Zn, while the H143N mutant contained only 0.3 equiv. Overall; these results are 
consistent with the participation of H143 in the polarization of the substrate carbonyl 
group. 
Table 2.4: Metal Content and Kinetic Parameters of NagA and Mutantsa. 
Mutant Zn/Subunit kcat (s-1) Km (mM) kcat/Km (M-1s-1) 
Q59H/N61H 1.5 1.2 ±  0.1 5.4  ±  0.5 (2.2 ± 0.3) × 102 
Q59H 1.3 32 ±  3 0.31 ± 0.06 (1.0 ± 0.2) × 105 
Q59A 0.9 10 ±  0.4 0.08 ± 0.01 (1.3 ± 0.2) × 105 
N61H 1.0 2.6 ± 0.1 1.7 ± 0.2 (1.5 ± 0.2) × 103 
N61A 0.9 24 ± 1 0.80 ± 0.05 (3.0 ± 0.2) × 104 
E131Q 0.1 0.7 ± 0.1 3.6 ± 1.1 (1.9 ± 0.6) × 102 
E131A 0.2 1.9  ± 0.3 0.15 ± 0.06 (1.3 ± 0.6) × 104 
K139M 0.9 49 ± 2 2.0 ± 0.2 (2.5 ± 0.3) × 104 
H143Q 0.3 2.4 ± 0.1 0.33 ± 0.04 (7.3 ± 0.9) × 103 
H143N 0.6 0.43 ± 0.02 2.1 ± 0.1 (2.1 ± 0.2) × 102 
Y223F 0.8 167 ± 15 0.76 ± 0.11 (2.2 ± 0.4) × 105 
H251N 0.9 6.8 ± 0.4 2.7 ± 0.4 (2.5 ± 0.4) × 103 
D273N 0.7 < 0.02 - - 
D273A 0.8 < 0.02 - - 
aKinetic parameters were determined at pH 7.5 and 30 ºC from fits to equation 1 using compound 1 as 
the substrate. 
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The most significant reduction in catalytic activity occurs with the mutation of 
the invariant aspartate (Asp-273) from the end of β-strand 8. In the X-ray crystal 
structure of NagA from E. coli this residue is hydrogen bonded to the lone water 
molecule (or hydroxide) that is coordinated to the metal ion bound to the Mβ-site (66). 
Therefore, it is expected that this residue will function in catalysis by abstraction of a 
proton from water prior to, or concomitant with, the attack of hydroxide on the amide 
bond of the substrate. Within the detection limits of our assay for product formation, we 
were unable to measure any catalytic activity for either the D273N or D273A mutant. 
The loss of activity is not due to a diminished capacity to bind divalent cations since the 
metal content of the purified mutants was identical to that of the wild type enzyme. The 
catalytic properties of these mutants are fully consistent with the proposed role of this 
residue in the chemical mechanism as the primary general base for activation of the 
hydrolytic water molecule and the subsequent protonation of the leaving group amine.  
The crystal structure of NagA from B. subtilis bound with the product, D-
glucosamine-6-phosphate, indicates that an invariant arginine residue (equivalent to Arg-
227 in the E. coli enzyme) from the adjacent subunit ion-pairs with the phosphate moiety 
of the substrate (69). It is unlikely that this arginine residue could contribute to the 
diminution in kcat/Km at high pH since the pKa value for the ionization of the guanidino 
group is expected to exceed 12. However, in NagA from E. coli there are tyrosine 
(Y223) and lysine (K139) residues that may also be contributing to the interaction with 
the phosphate moiety of the substrate. Deprotonation of either of these residues at high 
pH could result in a drop in the value of kcat/Km. The mutation of Lys-139 to methionine 
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reduces the value of kcat by a factor of 2 and the value of kcat/Km by a factor of ~50 when 
the phosphate derivative (1) is used as the substrate, relative to the wild type enzyme. 
However, there is only a 2-fold drop in kcat/Km relative to the wild type enzyme when 
K139M is used to hydrolyze N-acetyl-D-glucosamine-6-sulfate (3). The pH-rate profile 
for K139M still exhibits a drop in activity at high pH when N-acetyl-D-glucosamine-6-
phosphate (1) is used as the substrate, and thus it is unlikely that the ionization state of  
this lysine is critical for catalytic activity. Mutation of Y223 to phenylalanine resulted in 
a mutant with nearly the same catalytic activity as the wild type enzyme, and thus this 
residue is not significant for the binding of substrate in NagA. 
The structure of the D273N mutant of the E. coli NagA in the presence of the 
phosphonate inhibitor indicates that H251 interacts with the anomeric hydroxyl group at 
carbon 1 (66). The H251N mutant has a kcat of 6.8 s-1 and a Km of 2.7 mM. The value for 
kcat/Km is 1/400 of that measured for the wild type enzyme. These results confirm the 
importance for the role of H251 in the binding of substrate within the active site of 
NagA. The homologous residue was found to interact with D-glucosamine-6-phosphate 
in the structure of NagA from B. subtilis. This histidine residue (H258) was found to be 
2.7 Å from the oxygen atom on the anomeric carbon in the α-conformation (69). 
Rate Limiting Steps. Three experimental probes were marshaled with NagA to 
unveil the source of the rate limitation for this enzyme. The first of these experiments 
compared the rates of substrate hydrolysis in H2O and D2O. Using Zn-NagA with N-
acetyl-D-glucosamine-6-phosphate as the substrate, initial velocity kinetics were 
measured at a pH/pD of 7.5 as shown in Figure 2.6. At concentrations of substrate up to 
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4 mM there is evidence for substrate inhibition, and the data were therefore fit to eq 2.2 
to yield kinetic constants of kcat (78 s-1), Km (0.14 mM), and kcat/Km (5.7 × 105 M-1 s-1) for 
the results in H2O. The corresponding values in D2O under identical conditions with the 
same enzyme stock were the following: kcat = 69 s-1, Km = 0.12 mM, and kcat/Km = 5.6 × 
105 M-1 s-1. The solvent isotope effect for the substitution of D2O for H2O on kcat/Km is 
1.02, and the value on kcat is 1.1. These relatively modest solvent isotope effects indicate 
that proton transfer is not a significant rate determining step in this transformation.  
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Figure 2.6:  Solvent isotope effects for reactions performed in H2O (●) and D2O (○) at pH/pD 7.5.  The 
solid lines represent fits of the data to equation 2.  Additional details are available in the text. 
 
The rate limitation imposed by the chemical cleavage of the amide bond was 
tested by employing the trifluoroacetate derivative of D-glucosamine-6-phosphate (6) as 
a substrate. Viola et al. have demonstrated that the trifluoroacetate analogue of N-acetyl-
L-aspartate is a very good substrate for aspartoacylase from human brain (114). The 
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kinetic parameters for the hydrolysis of 6 with NagA are listed in Table 2.2. This 
substrate is hydrolyzed at a significantly faster rate than is the corresponding N-acetyl 
derivative. Since the pKa of trifluoroacetic acid (0.23) is significantly lower than that of 
acetic acid (4.76), the carbon-nitrogen bond is weaker and the carbonyl group more 
electrophilic. Therefore, the rate of hydrolysis of 6 is expected to be faster than the 
hydrolysis of 1 if NagA is limited by the chemical step in the steady state. This 
assessment does not differentiate whether the rate limiting step is the formation or 
cleavage of the putative tetrahedral intermediate. It could be argued, however, that if 
NagA were limited by product release from the active site, then the dissociation of 
trifluoroacetate could be inherently faster than the release of acetate. This specific 
scenario was addressed by the utilization of changes in solvent viscosity to 
systematically alter the rate constants for the association and dissociation of products 
and substrates with NagA (99, 100). 
The effects of solvent viscosity on the catalytic rate constants for the hydrolysis 
of 1 by Zn-NagA are shown in Figures 2.7 A and 2.7 B using sucrose as the micro-
viscogen. The plot of relative kcat vs relative viscosity was fit to a linear equation 
yielding a slope of 0.008 ± 0.02. The corresponding fit of data for the effect of solvent 
viscosity on kcat/Km gave a slope of 0.065 ± 0.049. These results indicate quite clearly 
that the rate of product dissociation does not limit kcat for the hydrolysis of substrates by 
NagA. These experiments also indicate that the value of kcat/Km is not limited by the 
association rate constant for the formation of the NagA substrate complex. These results 
(together with the enhanced rate of reaction of compound 6 relative to compound 1) are 
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only consistent with the conclusion that NagA is limited by either the formation or 
breakdown of the tetrahedral intermediate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7:  The effect of viscosity on the relative values of kcat (A) and kcat/Km (B) using sucrose as the 
micro-viscogen. Additional details are available in the text. 
Mechanism of Action. A model for the mechanism of amide bond hydrolysis by 
NagA from E. coli is presented in Figure 2.8. In this mechanism the resting state of the 
enzyme has a single divalent cation bound to the active site through ligation with the two 
histidines at the end of β-stands 5 and 6 (His-195 and His-216), and the glutamate (Glu-
131) from the end of β-stand 3 (21). The remaining ligand is a bound water molecule 
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that is, in turn, hydrogen bonded to the invariant aspartate (D273) that originates from 
the end of β-strand 8. The reaction is initiated by the binding of the substrate in the 
active site and polarization of the carbonyl oxygen via ligation to the divalent cation. 
There is a proton transfer from the bound water molecule to Asp-273, and this 
is followed by nucleophilic attack on the carbonyl carbon and formation of the 
tetrahedral intermediate. The collapse of the tetrahedral intermediate is facilitated by 
proton transfer from Asp-273 to the leaving group amine of the product, D-glucosamine-
6-phosphate. The products depart the active site, and another round of catalysis 
commences with the charging of the metal center with a molecule of water from 
the solvent. 
The mechanism of substrate and water activation by NagA from E. coli must be 
different than the mechanism utilized by the same enzyme from B. subtilis. The B. 
subtilis enzyme contains a binuclear metal center whereas the E. coli enzyme can bind 
but a single divalent cation in the active site. For a binuclear metal center, the activation 
of the amide bond and the activation of the solvent water can be distributed separately 
between the two metal ions. However, in the mononuclear metal center, both functions 
must be borne by a single divalent cation. These results highlight the significant 
diversity for the evolution of function within the amidohydrolase superfamily. It is not 
intuitively obvious whether a binuclear or mononuclear metal center represents a more 
“advanced” or sophisticated site of catalytic power. However, it is tempting to speculate 
that the binuclear metal center currently found in NagA in some organisms is in the 
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process of shedding one of the divalent cations to create a fully functional active site that 
operates with a single divalent cation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8:  Proposed mechanism for the substrate hydrolysis by NagA from E. coli. 
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CHAPTER III 
STRUCTURAL DIVERSITY WITHIN THE  
MONONUCLEAR AND BINUCLEAR ACTIVE SITES OF 
N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE DEACETYLASE* 
 NagA (E.C. 3.5.1.25) is a metal-dependent enzyme which catalyzes the 
deacetylation of N-acetyl-D-glucosamine-6-phosphate to form acetate and D-
glucosamine-6-phosphate as presented in Scheme 1. NagA thus catalyzes a key step 
in the catabolism of N-acetyl-D-glucosamine from chitobiose and the recycling of cell 
wall murein (90, 91, 97, 115, 116). Over 300 sequences homologous to that of NagA 
from Escherichia coli K-12 have been identified in the current NCBI databases. 
Nearly all of these sequences are annotated as NagA, but some of them are annotated as 
N-acetyl-D-galactosamine-6-phosphate deacetylase (AgaA). In the genome of E. coli K-
12 there is a deletion which eliminates the genes encoding for the N-acetyl-D-
galactosamine (Aga) and D-galactosamine (GalN) phosphotransferase systems, while 
truncating the gene for AgaA. These deletions prevent the growth of E. coli K-12 on 
either N-acetyl-D-galactosamine or D-galactosamine (117).  
NagA has been characterized as a member of the amidohydrolase superfamily 
(AHS) based on sequence and structural similarities to other enzymes within this 
structural fold (12). The enzymes in this superfamily have been shown to contain αβ- 
______________ 
*Reprinted with permission from “Structural Diversity within the Mononuclear and Binuclear Active Sites 
of N-Acetyl-D-glucosamine-6-phosphate Deacetylase” by Hall, R. S., Brown, S., Fedorov, A. A., Fedorov, 
E.V., Xu, C., Babbitt, P. C., Almo, S. C., and Raushel, F. M., 2007. Biochemistry, 46, 7953-7962, 
Copyright [2007] American Chemical Society.  
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superfamily (10). All proteins of the amidohydrolase superfamily possess a (β/α)8-barrel 
binuclear metal centers (31, 38, 45, 50, 69, 73), α-mononuclear metal centers  (17, 23, 
79), β-mononuclear metal centers (10, 73), or metal independent active sites (63). 
X-ray crystal structures have been reported for NagA from Bacillus subtilis (PDB 
code: 1un7 (69)), Thermotoga maritima (PDB code: 1o12), and the metal-free complex 
of E. coli (PDB code: 1ymy and 1yrr (65)). A comparison of these three X-ray crystal 
structures of NagA highlights the fundamentally different active site motifs for the 
complexation of divalent metal ions within this enzyme. The enzyme from B. subtilis has 
an αβ-binuclear metal center with two iron atoms in the active site. The more solvent 
shielded metal (Mα) is coordinated to two histidine residues from β-strand 1 and an 
aspartate from β-strand 8 while the more solvent exposed metal (Mβ) is coordinated to 
two histidine residues from β-strands 5 and 6. The two metal ions are bridged to one 
another by a glutamate from β-strand 3 and hydroxide or water from solvent (69). In 
contrast, the structure of NagA from T. maritima shows only a single iron bound to the 
Mβ-site and a vacant Mα-site. However, the two histidines from β-strand 1 and the 
aspartate from β-strand 8 are apparently available for binding of a second metal ion. The 
two previously reported structures of NagA from E. coli were solved in the absence of 
any divalent cations, but it is highly probable that NagA from E. coli can bind only a 
single divalent cation at the Mβ-site since the two histidines from β-strand 1, that are 
apparently essential for the binding of metal to this site, are absent and replaced by 
relatively poor metal ligands, asparagine and glutamine. 
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It is therefore uncertain whether the active sites in NagA from E. coli and/or T. 
maritima require one or two metal ions to be fully active. If NagA from either of these 
organisms has a different requirement for the total number of metal ions required for 
catalytic activity than NagA from B. subtilis, then the chemical mechanism for substrate 
hydrolysis must also differ in significant ways. The sites for the binding of metal ions in 
NagA are similar to the other binuclear metal centers found in the amidohydrolase 
superfamily (31, 40, 50, 73). However, in all of these other structures the histidine from 
β-strand 5 that coordinates Mβ interacts with the metal via Nδ, whereas Mβ in NagA 
coordinates to Nε. The structures of the metal centers in the active sites of NagA from B. 
subtilis, T. maritima, and E. coli are presented in Figure 3.1. 
The structure of the wild-type NagA from E. coli has now been solved, and we 
demonstrate that this enzyme binds but a single divalent cation exclusively to the Mβ-
site. In addition, the structure of the D273N mutant has been determined in the presence 
of a transition state inhibitor, and this structure unveils the molecular interactions 
between the substrate and the enzyme within the active site. An extensive bioinformatics 
analysis of the sequences annotated as NagA has shown that there is a correlation 
between the number of metal ions bound in the active site of this enzyme and the 
presence of a histidine or glutamine at the structural position that is equivalent to His-
143 of the enzyme from E. coli. This residue is now postulated to facilitate the formation 
of the tetrahedral intermediate in the mechanism for amide bond cleavage in the active 
site of NagA. 
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Figure 3.1: Top: The active site of NagA from B. subtilis with two Fe ions and a bridging water or 
hydroxide bound between the two metal atoms (PDB: 1un7). Middle: The active site of NagA from T. 
maritima with one Fe ion and a water molecule (PDB: 1o12). Bottom: The active site of NagA from E. 
coli with one Zn ion and a water molecule (PDB: 2p50). In these images the metal ions are represented as 
green spheres and the bound water or hydroxideis shown as a smaller red sphere. 
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MATERIALS AND METHODS 
Materials. N-Acetyl-D-glucosamine-6-phosphate and purification reagents were 
purchased from Sigma-Aldrich. Chromatographic columns and resins were purchased 
from G. E. Healthcare. Chelex 100 resin was purchased from BioRad. Slide-A-Lyzer 
dialysis cassettes were purchased from Pierce. ICP standards were obtained from 
Inorganic Ventures Inc. The N-methyl phosphonate derivative of D-glucosamine-6-
phosphate (I) was prepared according to the procedure of Xu (98). 
Scheme 3.1 
 
Cloning, Expression, and Purification of NagA. The wild type NagA and the 
D273N mutant from E. coli K-12 were purified as previously described (67). The 
enzyme utilized for the crystal structure of apo-NagA was expressed in LB growth 
medium with no additional metal. The NagA gene from T. maritima was amplified from 
genomic DNA using the nucleotide primers 5’-GCAGGAGCCATATGATTGTTGAG-
AAAGTTCTGATCGTTGATCCCATCG-3’ and 5’-CGCGGAATTCATCTGGATCG-
AAAAACTACCTCACCC-3’. The product was gel purified and ligated through NdeI 
and EcoRI cloning sites into a pET-30a(+) vector incorporating kanamycin resistance 
and IPTG inducible overexpression. Plasmid DNA was electroporated into XL1 Blue 
(I) 
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cells and subsequently purified with a Wizard Plus SV miniprep DNA purification 
system. Gene sequences of the purified plasmids were verified through PCR-based 
sequencing inconjunction with the Gene Technologies Laboratory of Texas A&M 
University. 
The NagA from T. maritima was expressed in LB medium supplemented with 
0.5 mM ZnCl2. The IPTG-induced cells grew for approximately 18 h at 30 °C, after 
which they were centrifuged at 3400g for 12 min. The cells were resuspended in buffer 
A (50 mM Tris, pH 7.5 and 1.0 mM DTT) which was supplemented with 100 µg/mL 
phenylmethanesulfonyl fluoride and disrupted by sonication. Insoluble cell debris was 
removed by centrifugation at 13900g for 12 min, after which 1% w/v protamine sulfate 
was used to precipitate nucleic acids. The insoluble material was removed by 
centrifugation. The NagA from T. maritima was precipitated between 50 and 75% 
saturated ammonium sulfate. The precipitated protein was centrifuged at 13900g for 12 
min. The protein was resuspended in a minimal volume of buffer A and loaded onto a 
Hiload 26/60 Superdex 200 prep grade gel filtration column. The NagA containing 
fractions were further purified with a Resource Q anion exchange column via elution 
with a linear gradient of 1.0 M NaCl in buffer A. Throughout the purification, the NagA 
containing fractions were identified and monitored for purity by activity analysis and 
with SDS PAGE. Protein concentrations of NagA from E. coli and T. maritima were 
determined using the calculated extinction coefficients of 18490 M-1 cm-1 and 7680 M-1 
cm-1, respectively (Protein Calculator v3.3 at http://www.scripps.edu /_cdputnam/ 
protcalc.html). 
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Measurement of Enzymatic Activity. The rate of hydrolysis of N-acetyl-D-
glucosamine-6-phosphate was monitored by observing the cleavage of the amide bond at 
215 nm using an extinction coefficient of 254 M-1 cm-1. Kinetic assays were performed 
at 30 °C using a 96-well quartz plate with a SpectraMax 384-Plus spectrophotometer 
from Molecular Devices. 
Reconstitution of NagA from T. maritima. The metal content (Cd, Co, Cu, Fe, 
Mn, Ni, and Zn) in the enzyme preparations was determined with ICP-MS. Metal-free 
NagA from T. maritima was prepared via dialysis of a 2.4 mg/mL enzyme solution 
against 10 mM dipicolinate, 30 mM MES buffer at pH 6.0 using a 10K molecular weight 
cutoff dialysis cassette with three buffer changes over 3 days. The dipicolinate was 
removed with four buffer changes against 30 mM metal-free HEPES at pH 8.0. For the 
metal reconstitution study, aliquots of apoenzyme were incubated with 0 to 3 equiv of 
ZnCl2 per subunit at 4 °C for 24 h with 50 µM enzyme. The enzymatic activity of the 
reconstituted protein was determined after a 5000-fold dilution into a 2.0 mM N-acetyl-
D-glucosamine-6-phosphate assay mixture containing 50 mM Tris buffer at pH 7.5 and 
30 °C. 
Sequence Analysis and X-Ray Crystallography. Extensive searches of the NCBI 
Database for NagA like sequences were collected and thoroughly analyzed by Dr. 
Shoshana Brown of the Dr. Patricia Babbitt Lab in the Departments of 
Biopharmaceutical Sciences and Pharmaceutical Chemistry at the University of 
California-San Francisco. Crystallization, X-ray diffraction, data collection, structure 
determination and refinement were performed by Drs. Alexander and Elena Fedorov of 
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the Dr. Steve Almo Lab in the Albert Einstein College of Medicine.  
RESULTS 
Sequence Analysis.  The AgaA protein sequence from E. coli C was compared to 
simiar sequences in the NCBI database. Of the first 300 sequences, only six distinct 
sequences were annotated as AgaA.  Of these six, all but one of the AgaA enzymes 
belong to different strains of E. coli. The single non-E. coli enzyme annotated as AgaA 
was located next to GlcN related enzymes. The majority of the remaining similar 
sequences correspond to proteins annotated as NagA.  For the NagA annotated enzymes 
with similar sequence to AgaA, several of the organisms including E. coli HS and E. coli 
101-1 contain two NagA annotated sequences with less than 30% identity.  Many of 
these NagA annotated enzymes that are closely related to the sequence of AgaA, like 
that of Vibrio vulnificus and Aeromonas hydrophilla, are actually located in 
chromosomes next to AgaA machinery such as N-acetylgalactosamine 
phosphotransferase components, tagatose 1,6 bisphosphate aldolase tagatose-6-
phosphate kinase and alpha galactosidase. Careful analysis of a sequence alignment of 
the NagA enzymes with the AgaA enzymes indicates that AgaA contains all of the 
important catalytic residues required for NagA from T. maritima.  A smaller, 
representative alignment of the three NagA enzymes discussed here with AgaA from 
E.coli C is shown in Figure 3.2. 
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Ec AgaA   1 MSGRGRNMTHVLRARRLLTEEGWLDDHQLRIADGVIAAIEPIPAG------VTERDAELL 
Bs NagA   1 -----MAESLLIKDIAIVTENEVIKNGYVGINDGKISTVSTERPKEPYSKEIQAPADSVL 
Tm NagA   1 ---------MIVEKVLIVDPIDGEFTGDVEIEEGKIVKVEKR----------ECIPRGVL 
Ec NagA   1 --------MYALTQGRIFTGHEFLDDHAVVIADGLIKSVCPVAELPP-EIEQRSLNGAIL 
 
 
Ec AgaA  55 CPAYIDTHVHGGAGVDVMDDAPDV----LDKLAMHKAREGVGSWLPTTVTTPLNTIHAAL 
Bs NagA  56 LPGMIDIHIHGGYGADTMDASFST----LDIMSSRLPEEGTTSFLATTITQEHGNISQAL 
Tm NagA  42 MPGFVDPHIHGVVGADTMNCDFS-------EMEEFLYSQGVTTFLATTVSTSLEKMKEIL 
Ec NagA  52 SPGFIDVQLNGCGGVQFNDTAEAVSVETLEIMQKANEKSGCTNYLPTLITTSDELMKQGV 
 
 
Ec AgaA 111 KRIAQRCQRGGP---GAQVLGSYLEGPYFTPQNKGAHPPELFRELEIAELDQLIAVSQHT 
Bs NagA 112 VNAREWKAAEESSLLGAELLGIHLEGPFVSPKRAGAQPKEWIRPSDVELFKKWQQEAGGL 
Tm NagA  95 RKARDYILENPS----TSLLGVHLEGPYISKEKKGAHSEKHIRPPSERELSEIDSPA-- 
Ec NagA 112 RVMREYLAKHPN-----QALGLHLEGPWLNLVKKGTHNPNFVRKPD-AALVDFLCENADV 
 
 
Ec AgaA 168 LRVVALAPEKEGALQAIRHLKQQNVKVMLGHRAATWQQTRAAFDACADRLVHCYNRMTGL 
Bs NagA 172 IKIVTLAPEEDQHFELIRHLKDESIIASMGHTDADSALLSDAAKAGASHMTHLYNAMSPF 
Tm NagA 148 -KMLTFAPEIE-SSELLLRLVKRDIVLSAGHSIATFEEFMKFYKEGVKRITHFPNGLKPL 
Ec NagA 166 ITKVTLAPEMVP-AEVISKLANAGIVVSAGHSNATLKEAKAGFRAGITFATHLYNAMPYI 
 
 
Ec AgaA 228 HHREPGIVCAGLTDKRAWLELIADGHHVHPAAMSLCCCCAKER-IVLITDAMQAAGMPDG 
Bs NagA 232 HHREPGVIGTALAHDGFVTELIADGIHSHPLAAKLAFLAKGSSKLILITDSMRAKGLKDG 
Tm NagA 206 HHREIGITGAGLLLDDVKLELICDGVHLSREMVKLVYKVKKANGIVLVTDSISAAGLKDG 
Ec NagA 225 TGREPGLAGAILDEADIYCGIIADGLHVDYANIRNAKRLKGDK-LCLVTDATAPAGANIE 
 
 
Ec AgaA 287 RYTLCGEEVQMHGGVVRTASGGLAGSTLSVDAAVRNMVELTGVTPAEAIHMASLHPARML 
Bs NagA 292 VYEFGGQSVTVRGRTALLSDGTLAGSILKMNEGARHMREFTNCSWTDIANITSENAAKQL 
Tm NagA 266 TTTLGDLVVKVKDGVPRLEDGTLAGSTLFFSQAVKNFRKFTGCSITELAKVSSYNSCVEL 
Ec NagA 284 QFIFAGKTIYYRNGLCVDENGTLSGSSLTMIEGVRNLVEHCGIALDEVLRMATLYPARAI 
 
 
Ec AgaA 347 GVDGVLGSLKPGKRASVVALDSGLHVQQIWIQGQLASF------ 
Bs NagA 352 GIFDRKGSVTVGKDADLVIVSSDCEVILTICRGNIAFISKEADQI 
Tm NagA 326 GLDDR-GRIAEGTRADLVLLDEDLNVVMTIKEGEVVFRSR---- 
Ec NagA 344 GVEKRLGTLAAGKVANLTAFTPDFKITKTIVNGNEVVTQ-----  
Figure 3.2: Protein sequence alignment of AgaA from E. coli C, NagA from B. subtilis, NagA from T. 
maritima, and NagA from E. coli K-12. The eight β-strands are highlighted in gray. The residue positions 
from the end of β-strand 1 that ligate the β-metal  ion are highlighted in yellow. The residue position that 
corresponds to His-143 in NagA from E. coli K-12 is highlighted in green. Fully conserved metal binding 
and catalytic residues are highlighted in red. Fully conserved substrate binding residues are highlighted in 
blue. 
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Metal Dependence and Activity of NagA from T. maritima. The recombinant 
NagA from T. maritima was purified from an E. coli expression system and found to 
contain 0.25 equiv of Zn and 0.35 equiv of Fe per active site. Upon further incubation 
with 3 molar equiv of Zn, values of kcat and Km were determined to be 110 ± 3 s-1 and 
0.04 ± 0.01 mM, respectively, with a value of kcat/Km of 2.8 ± 0.4 × 106 M-1 s-1. At high 
substrate concentrations the activity diminished with an inhibition constant of 3.9 ± 0.5 
mM. After removal of the bound metal, NagA from T. maritima lacked detectable levels 
of activity. The apoenzyme was reconstituted by adding up to 3 equiv of zinc per 
subunit. In these experiments there was a linear increase in the catalytic activity that 
reached a maximum at approximately 1 equiv of zinc per enzyme subunit. The change in 
activity as a function of added zinc is presented in Figure 3.3. These results demonstrate 
that NagA from T. maritima requires only a single divalent cation for maximum catalytic 
activity.   
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Figure 3.3: Reconstitution of apo-NagA from T. maritima (50 µM) with varying amounts of ZnCl2. The 
rate of substrate hydrolysis was determined with 2.0 mM N-acetyl-D-glucosamine-6-phosphate. 
Additional details are provided in the text. 
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Structure of Apo-NagA. The crystal structure of the apo-NagA was determined to 
a resolution of 2.6 Å in the absence of any other ligands. The enzyme adopts a 
homotetrameric oligomerization state in solution as determined by gel filtration 
chromatography (67), SAXS (65) and analytical ultracentrifugation (68). The quaternary 
structure is a dimer of dimers, where each dimer pair has the active sites facing the 
complementary subunit as presented in Figure 3.4 A. Interactions for this active site 
interface occur mainly through a loop and α-helix region located after β-strand 6. Arg-
227 is poised to interact with the phosphate moiety of the substrate molecule which 
would bind to the complementary subunit as shown previously for the NagA from B. 
subtilis (69).  
Other interactions between the two dimers occur between the β-sandwich 
domains formed by residues from the N- and C-termini. The tertiary fold consists of a 
somewhat twisted (β/α)8-barrel made of eight alternating β-strands and α-helices as 
shown in Figure 3.4 B. A small α-helix partially covers the N-terminus (bottom) of the 
barrel. The putative active site residues are located at the C-terminal end of the β- barrel. 
The loop region between β-strands 3 and 4, which contains residues 138-145, is 
conspicuously absent in the structure of the apo-NagA. This is likely due to the mobility 
of these residues in the absence of a bound ligand. A small β-sheet formed by residues 
between β-strand 8 and α-helix 9 forms a putative capping domain near the active site. 
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Figure 3.4: Ribbon diagram of the three-dimensional structure of NagA from E. coli displaying the 
tetrameric oligomerization (A). Ribbon diagram of an individual subunit of NagA (B). 
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Structure of Zn-NagA. The structure of the wild type NagA from E. coli was 
determined in the presence of zinc bound within the active site. Each subunit binds a 
single Zn atom in the Mβ site, through electrostatic interactions with Glu-131, His-195, 
and His-216 as shown in Figure 3.5. The interatomic distances of Zn to these residues in 
the native structure are 2.1, 2.2, and 2.1 Å, respectively. Subunit A possesses two water 
molecules in the active site. One of these water molecules is bound directly to the Zn at a 
distance of 2.4 Å. This water molecule is also interacting with both oxygen atoms of 
Asp-273 at distances of 2.8 and 3.0 Å. A second active site water molecule is 2.9 Å from 
the first water molecule and is hydrogen bonded to δ-O of Asn-61and to one of the 
oxygen atoms from the carboxylate side chain of Glu-131 with distances of 2.5 and 2.7 
Å, respectively. Subunit B also contains two water molecules in the active site with 
similar distances and geometries. 
 
Figure 3.5: The structure of the active site of NagA from E. coli showing the coordination of the single Zn 
in the β-metal site. The zinc is represented as a green sphere, and the bound water molecule is shown as a 
small red sphere. The distances between the zinc and the coordinating ligand are listed in angstroms. 
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Structure of D273N Mutant. The zinc in the active site of the wild type NagA 
from E. coli is coordinated to a single water molecule, and this water molecule is 
hydrogen bonded to the side chain carboxylate of Asp-273 from β-strand 8. Mutation of 
this residue to asparagine results in a protein that is unable to hydrolyze the substrate 
(67). The crystal structure of the D273N mutant was determined in the presence of a 
transition state analogue inhibitor (I) (see Scheme 3.1) in an attempt to unveil the 
molecular interactions between the protein and substrate in a complex that cannot be 
hydrolyzed. The inhibitor, N-methylhydroxyphosphinyl-D-glucosamine-6-phosphate (I), 
is presented in Scheme 3.2 and is bound within the active site of D273N. The active site 
Zn in this structure is coordinated by four ligands in a distorted tetrahedral fashion. One 
of these interactions is from one of the side chain carboxylate oxygens of Glu-131 from 
β-strand 3 at a distance of 1.8 Å. There are additional interactions from His-195 from β-
strand 5 and His-216 from β-strand 6 at distances of 2.1 and 2.2 Å, respectively. The 
fourth interaction is from one of the phosphonate oxygens of the inhibitor at a distance 
of 2.0 Å and is analogous to the water ligand described previously for the wild-type Zn 
structure. There are two other atoms near the active site Zn at slightly longer distances. 
These include the other oxygen from the phosphonate moiety of the inhibitor (analogous 
to the substrate carbonyl) and the second carboxylate oxygen of Glu-131. The oxygen 
from the inhibitor is positioned 3.0 Å away from the zinc and 3.0 Å from the side chain 
of His-143. The second carboxylate oxygen of Glu-131 is 2.9 Å away from Zn and 2.9 Å 
away from His-143. His-251 is hydrogen bonded to the anomeric hydroxyl of the 
inhibitor in the α-conformation at a distance of 2.7 Å. Two of the phosphate oxygens 
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from the inhibitor are positioned 2.8 and 3.0 Å from the guanidino group of Arg-227, 
which originates from the adjacent subunit. The X-ray crystal structure of the active site 
residues with bound Zn and inhibitor ligands is presented in Figure 3.6. A schematic 
drawing of the inhibitor-enzyme interactions is presented in Figure 3.7. 
 
 
Figure 3.6: The structure of the active site of the NagA mutant D273N in the presence of the tight-binding 
transition state inhibitor I. 
DISCUSSION 
Differentiation of AgaA and NagA.  Sequence alignment comparisons of NagA to 
sequences found on the NCBI database from E. coli K-12 indicate that there is a 31% 
identity between NagA and AgaA from E. coli C, a 31% identity between NagA from E. 
coli and from B. subtilis, while there is a 29% identity between NagA from E. coli and T. 
maritima. From sequence alignment comparisons, it is apparent that all of the important 
catalytic residues identified for NagA are conserved in the AgaA sequences, including 
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His143.  AgaA possesses the HxH motif as well, making it most like the T. marima 
NagA with a 33% identity.  It has been determined that NagA from E. coli can hydrolyze 
N-acetyl-D-galactosamine-6-phosphate nearly as well as the natural substrate N-acetyl-D-
glucosamine-6-phosphate, making it appear that the only difference between these two 
enzymes is the respective operon content and transcription regulation.   
T. maritima NagA Metal Requirement. The crystal structure of NagA contained 
only one Fe ion per active site.  The crystal structures shown in Figure 3.1 and the 
sequence alignments shown in Figure 3.2 indicate that it possesses the same metal 
binding residues as NagA from B. subtilis, which contains two Fe ions per active site. If 
there was a loss of metal during purification, then it might be expected that the more 
solvent exposed β-metal binding site (Mβ) would be vacant in the crystal structure (pdb 
code: 112).  However, it was the deeper, more protected α-metal binding site (Mα) that 
was vacant in the crystal structure. We have determined that T. maritima NagA has 
similar metal content, requirement and localization compared to NagA from E. coli.  
E. coli D273N NagA Crystal structure with Transition-State Substrate.  This 
crystal structure of E. coli NagA with the bound transition state, enabled the 
identification of His143. This residue is found on a loop between β-strands 3 and 4 and 
is conserved among the predicted single metal utilizing NagA enzymes which are similar 
in sequence to the E. coli and T. maritma enzymes.  H143 is interacting with the 
carbonyl oxygen of the substrate with a distance of 2.94 Å, thus His143 appears to 
participate with the Zn in the polarization of the amide bond.  Mutagenesis of this 
residue, indicates that the β-Zn (3.02 Å away) is not entirely efficient at polarizing the 
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substrate without this histidine (67).  The sharp angle of 82.9º formed by the carbonyl 
carbon, carbonyl oxygen and Zn, indicates that Zn may bear less of the electron 
withdrawing effect.  The fact that the D273N mutant was crystallized with the transition-
state intermediate bound, indicates that the Zn is capable of activating the water by itself 
to some extent. It is also apparent that the residue Asp273 is the only residue responsible 
for initiating the collapse of the tetrahedral intermediate by shuttling the proton from 
water to the leaving group amine.   
 
Figure 3.7: A schematic drawing of the active site of the D273N NagA mutant from E. coli with the 
bound transition state analogue inhibitor I. The distances between key molecular interactions are listed in 
angstroms. 
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Mechanistic Implications for One and Two Metal Systems.  The substrate 
polarizing Hi-143 residue is conserved among all of the QxN possessing E. coli-like 
NagA enzymes as well as a small group of enzymes similar in sequence to T. maritima 
NagA.  For the much larger class of B. subtilis-like enzymes, this residue is highly 
conserved as Gln.  The identity of this residue may be the identifiable difference 
between mononuclear and binuclear mechanisms for the deacetylation of N-
acetylglucosamine-6-phosphate.  For without this substrate-polarizing His-143 or the α-
metal, which typically has been shown to activate the hydrolytic water, the β-metal 
would need to bear an unprecedented catalytic role, coordinating both the water 
molecule and the carbonyl oxygen, for the withdrawal of electrons from both ligands 
which is necessary for the activation of the water molecule and polarization of the amide 
bond. Amazingly, these two groups of NagA enzymes have evolved to perform the 
deacetylation without the need of a second metal. This may prove to be a paradigm of 
stepwise evolution.  
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Summary.  Based on these metal studies and protein sequence comparisons, we 
propose that the structures of NagA from B. subtilis, T. maritima and E. coli symbolize 
the evolution from the binuclear metal system seen in B. subtilis and similar enzymes to 
the mononuclear metal systems seen in E. coli and in higher organisms such as H. 
sapiens.  We have also shown that AgaA is very similar to NagA and that the only 
apparent differences are the location of the genes within the chromosome.  We have 
verified that the two NagA enzymes from E. coli and T. maritima each need only one 
metal for maximum activity, and that they both may only bind one metal. Therefore, the 
HxH α-metal binding motif used in the B. subtilis NagA, appears to be a vestige of 
evolution present in the T. maritima NagA. The main difference separating the single 
metal T. maritima NagA from the double metal B. subtilis NagA now appears to be 
presence of substrate-polarizing histidine residue or a Gln located between β-strands 3 
and 4.  It has still not been experimentally verified whether the binuclear NagA enzyme 
from B. subtilis actually needs both of the active site metals for catalysis.  Further 
analysis of a binuclear NagA will surely provide insight into the evolution of metal 
dependence for this diverse set of enzymes.  
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CHAPTER IV 
MECHANISTIC CHARACTERIZATION OF THE REACTION CATALYZED BY 
CYTOSINE DEAMINASE 
Cytosine deaminase (CDA) catalyzes the hydrolytic deamination of cytosine, 
forming uracil and ammonia as shown in Scheme 4.1. Based on sequence alignments as 
well as the X-ray crystal structures, CDA has been characterized as a single metal 
dependent member of the amidohydrolase superfamily and possesses much of the typical 
catalytic and metal binding residues common for this superfamily.  Included with these 
conserved residues are the HxH α-metal binding motif at the end of β-strand 1 (H62 and 
H64), two histidines from β-strands 5 (H215) and 6 (H247), as well as an aspartate from 
the end of β-strand 8 (D314).  There is also a glutamate (E218) present three residues 
after the strand 5 histidine, whose interaction with N3 of the pyrimidine ring is of 
interest, as this atom presumably becomes protonated during the course of the 
deamination reaction. The sequence and structure of CDA from E. coli is highly similar 
to that of adenosine deaminase and guanine deaminase, while the crystal structure and 
sequence of S. cerevisiae cytosine deaminase is dissimilar and closely resembles the 
structure of E. coli cytidine deaminase.   
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 Conspicuously absent in the human genome, CDA is a particularly promising 
target for drug development, because it can convert the 5-fluorocytosine to 5-
fluorouracil, which inhibits replication (93). This effect is being exploited to selectively 
kill CDA containing single celled, non-eukaryotic organisms.  It is also under 
investigation for therapeutic use in combination with gene therapy to kill cancer cells 
(92).   
 Previous studies of cytosine deaminase from E. coli K-12 reported enzyme which 
primarily contained Fe along with some Zn.  The enzyme preparations reported specific 
activities of 165 -185 s-1 at pH 7.5 and Michaelis constants of about 0.2 mM (20, 22).  
Cytosine deaminase has been reported to deaminate a number of substrates in addition to 
cytosine (1) including: 5-fluorocytosine (2) , 2-thiocytosine (3), 6-azacytosine (4) and 5-
azacytosine (5).  These are shown below in Scheme 4.2.  
Scheme 4.2  
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2-Hydroxypyrimidine is a potent mechanism-based inhibitor of CDA and has 
been utilized in the structural characterization of CDA through X-ray crystallography 
(23). In that X-ray crystal structure  (PDB: 1K6W) a bound 2-hydroxypyrimidine can be 
seen with the active site Fe3+, after having undergone nucleophilic attack by the active 
site hydroxide, resulting in the formation of 4-(R)-hydroxyl-3,4-dihydroxypyrimidine. 
This dihydroxy pyrimidine serves as an excellent probe of the mechanism of cytosine 
deamination. Fe is coordinated by His-62, His-64, His-215 and Asp-314.  It can be seen 
that Gln-157 is participating in two hydrogen bonds with N-1 and the C-2 carbonyl 
oxygen of the pyrimidine. Glu-218 is interacting with N3 and is adjacent to the leaving 
group pocket of ammonia. His-247 is also nearby and is interacting with the 4-hydroxyl 
group which is a surrogate of the nucleophilic water. Asp-314 is interacting with this 
hydroxyl as well as the metal ion.  A drawing of the observed residue-inhibitor 
interactions is presented below in Scheme 4.3.  
Scheme 4.3 
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 The metal cofactor utilization of E. coli CDA is of particular interest, because of 
the well documented preference for Fe2+ over Zn2+  by the enzyme (19). This preference 
is even more puzzling in light of the presence of a catalytic Zn2+ which is found in the 
active site of close structural homologs, adenosine deaminase (16, 17) and guanine 
deaminase (24).  These enzymes are α-mononuclear metal dependent members of the 
amidohydrolase superfamily and catalyze similar reactions (22).  
In spite of the large amount of structural and substrate specificity related 
information already reported for CDA, there are still a significant number of unresolved 
issues relating to the mechanism of deamination of cytosine by CDA. The nature of 
metal specificities remains a major unanswered question, particularly since Zn2+ is 
considered to be a superior Lewis Acid (118). In the existing crystal structures of wild 
type CDA (PDB codes: 1K6W and 1K70), CDA is crystallized with Fe3+ in the active 
site. CDA is only active with divalent transition metals, and because of the inactivity of 
Fe3+ containing enzyme (22), it is possible that some nearby residues may be in non-
productive orientations.  As a result, it is still uncertain which bases are contributing to 
the abstraction of the two protons from the nucleophilic water molecule and the 
protonation of the leaving group amine and the endocyclic N-3 atom. In this paper, these 
questions were addressed through the use of combinations of metal substitutions, site 
directed mutants, substrate analogs, pH activity profiles, solvent isotope effects, solvent 
viscosity effects and tight binding transition-state inhibitors.  
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MATERIALS AND METHODS  
 Materials. Reagents and buffers were obtained from Sigma-Aldrich unless 
otherwise noted. 3-oxauracil was purchased from Research Organics Inc. 3-
methylcytosine, 4-thiouracil, 4-chlorouracil and the phosphonamidate analogs of 
cytosine and uracil were synthesized by Dr. Chengfu Xu. CDA knockout cells were 
obtained from the Keio Collection of the National Institute of Genetics, Japan. Kinetic 
assays were performed in a 96 well plate with a SPECTRAmax 384 Plus 
spectrophotometer from Molecular Devices.  Protein concentrations were determined 
using the calculated extinction coefficient of 55190 M-1 cm-1 at 280 nm in a 1 cm path-
length quartz cuvette.  The extinction coefficient used was determined from the 
calculated protein sequence through the use of Protein Calculator v3.3 at 
http://www.scripps.edu/~cdputnam/protcalc.html.  
 Cloning, Expression, and Purification of CDA.  The gene from E. coli encoding 
CDA was cloned into a pET-20a(+) expression vector. Mutants of CDA were prepared 
in accordance with the Quickchange mutagenesis kit instructions. Gene sequences were 
verified by the Gene Technologies Lab at Texas A&M University.  The genes were 
transformed via electroporation into E. coli K-12 CDA knockout cells which were made 
electro competent and then lysogenized with the λDE3 STAR lysogenization kit from 
Novagen.   
After growing for 30 minutes at 37 ○C, the cells were plated and grown overnight 
on LB/agarose plates enriched with 100 μg/mL ampicillin. A single colony was then 
selected for inoculation of 1L of LB enriched with 100 μg/mL ampicillin and 1.0 mM 
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ZnCl2. Expression of the protein products was detected by SDS-PAGE only in the 
absence of any IPTG. After incubation for 18 hours with shaking at 20 ○C, the cells were 
harvested by centrifugation at 3400g for 12 min.   
The cells were then re-suspended and disrupted by sonication in 10 × (v/w) 50 
mM HEPES buffer, pH 7.5, containing 1.0 mM ZnCl2 and 100µg/mL of the protease 
inhibitor phenylmethanesulfonyl fluoride.  The cell lysis solution was centrifuged at 
13900g for 15 min to remove insoluble cell debris. A solution of protamine sulfate was 
then added drop-wise to the solution, with stirring, to a final concentration of 2% w/v, 
for the precipitation of nucleic acids.  The solution was again centrifuged at 13900g for 
15 min to remove the precipitated nucleic acids.  The remaining protein was then 
precipitated with solid ammonium sulfate to a final concentration of 50% of saturation. 
The precipitated protein was then removed from solution by centrifugation at 13900g for 
15 min.  The pellet was then re-suspended with a minimal amount of 50 mM HEPES, 
pH 8.0, and then filtered with a 0.45 µm syringe filter and further purified by gel 
filtration with a G.E. HiLoad 26/60 Superdex 200 preparatory grade column.  The CDA 
containing fractions which were identified by SDS- PAGE and cytosine deaminase 
activity, pooled and further purified using a G.E. ResourceQ anion exchange column.  
 Measurement of Enzymatic Activity.  The rate at which cytosine deaminase 
converts cytosine to uracil was determined at 30 ºC using either a coupled assay or a 
direct assay. For the activity screening of substrate analogues with wild type and mutant 
enzymes, a coupled assay was used to detect the release of ammonia through the 
oxidation of NADH.  This assay was modified from the protocol reported previously 
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(79)  and typically contained 7.4 mM α-ketoglutarate, 0.4 mM NADH, 6 units of 
glutamate dehydrogenase in 100 mM HEPES, pH 8.5. The initial velocities were then 
fitted to eqn 4.1. For other activity assays at pH 7.5 a direct assay at 286 nm (Δε286 = -
680 M-1 cm-1) was used as previously reported (22). Mass spectrometry analysis for 
product verification of 3-oxauracil deamination was performed by the staff at the 
Laboratory for Biological Mass Spectrometry (LBMS) in the Department of Chemistry 
at Texas A&M University.  
 For the development and implementation of a direct assay for use at any given 
pH, unique extinction coefficients for the deamination of cytosine to uracil are assigned 
for each unique pH value. Changes in molar extinction coefficients for the total 
deamination of cytosine by CDA were determined at various pH values from 2.5-11.3. 
This was performed by measuring the differences in absorbance of 200 µM cytosine and 
of enzymatically deaminated cytosine in various100 mM buffers of 0.2 pH increments. 
Prior to absorbance measurements, stock solutions of substrate and enzymatic product 
were passed through 10,000 MWCO Centricon membranes and diluted to final 
concentrations of 0.2 mM in the buffers.  The stock solution of cytosine consisted of 1.0 
mM cytosine in 10 mM TRIS, pH 7.5. The stock solution uracil consisted of 1.0 mM 
cytosine reacted completely with 10 nM CDA in 10 mM TRIS buffer at pH 7.5. The 
buffers utilized are as follows: formate, pH 2.5-3.9; acetate, pH 4.1-5.5; MES, pH 5.7-
7.1; PIPES, pH 6.7, 6.9; HEPES, pH 7.1-8.1; TAPS, pH 8.3-8.7; CHES, pH 8.9-10.1; 
CABS, pH 10.1-11.3. The final pH values were established through measurement with a 
pH meter. The differences in absorbance were plotted vs pH and fitted with eq 4.2.  
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The resulting pH specific constants were then used to calculate extinction 
coefficients for the reactions at any pH value. For pH values ranging from 5 to 7.0, 
constants obtained from the low-pH data obtained at 286 nm were used. At pH values 
from 7.0 to 8.2, constants obtained from the high pH data 286 nm were used. At pH 
values of 8.2 and above, the constants obtained at 298 nm were used.   
 Metal Analysis.  Metal determination and quantification was performed with the 
Elan DRC II ICP-MS (inductively coupled plasma - quadrupole mass spectrometer) 
from Perkin Elmer.  The analog detection mode is used with three averaged replicates 
per reading.  External calibration standards were prepared through the serial dilution of a 
single 10 ppm stock mixture of Zn, Cd, Co, Cu, Mn, Ni and Fe in 2% nitric acid, 
purchased from Inorganic Ventures Inc. Freshly prepared standards generally contained 
2, 20 and 200 ppb of all aforementioned analytes in 1% Trace Select Nitric Acid from 
Fluka that is diluted in deionized water.  The isotopes of the analytes measured were 
55Mn, 56Fe, 59Co, 60Ni, 63Cu, 66Zn and 111Cd.  115In was used as an internal standard for 
Cd and 69Ga was used as an internal standard for all other analytes. The detection of 56Fe 
was determined in the dynamic reaction cell (DRC) mode, where NH3 gas is used to 
reduce interfering argon-oxide species. Protein samples were prepared for analysis by 
boiling in concentrated nitric acid for 30 min, followed by dilution with water to 1% 
nitric acid.    
 Metal Chelation and Reconstitution. Apo-cytosine deaminase was prepared by 
dialysis of 3 mL of 1 mg/mL cytosine deaminase with 3 × 300 fold buffer changes over 
24 hours with 10 mM ortho-phenanthroline in 50 mM MES, pH 5.75. Ortho-
 108
phenanthroline was then separated from the protein with a PD-10 column. Prior to use, 
the PD-10 column was washed with 1 column volume of a 10 mM solution of 
dipicolinate, and equilibrated with Chelex treated HEPES buffer, pH 8.0. The resulting 
apo-protein was reconstituted at 1 mg/mL overnight at 4 ºC with varying equivalents of 
ZnCl2 and FeSO4. The Fe reconstitutions were performed anaerobically under argon.  
 pH Dependence on Enzyme Activity.  The pH dependence of  kcat and kcat/Km  
were determined for Zn2+ and Fe2+ containing CDA as well as the Zn containing mutant 
H247Q from pH 5.3-9.9 at ~0.2 pH unit intervals, using 75 mM MES (pH 5.3-6.5), 
PIPES (pH 6.7-6.9),  HEPES (7.1-8.1), TAPS (8.3-8.9) and CHES (pH 9.1-9.9).  The pH 
values of the final solutions were measured after the completion of the assays. Direct 
assays were utilized in which the extinction coefficient at any given pH was calculated 
with eq 1 using the constants obtained for that specific pH range.    
Solvent Kinetic Isotope Effects and Solvent Viscosity Effects.  Steady state rates 
were determined with the coupled assay for ammonia formation using D2O or H2O as 
the solvent and were obtained at the same time in either 100 mM pH 8.5 HEPES or pH 
9.0 CHES at 30 ˚C. The proton inventories were performed in 100 mM HEPES, pH(D) 
8.5 at 30 ˚C using: 0, 0.25, 0.5, 0.75 and 1.0 atom fraction deuterium as the solvent. The 
effects of viscosity on kcat and kcat/Km of Zn2+ containing CDA were determined as 
previously described (67) in 100 mM MES pH 6.0, HEPES pH 7.5 and CHES pH 9.0 at 
30 ˚C. 
 Transition-State Inhibitor Evaluations. Inhibition of Zn-CDA was evaluated 
using the phosphorus based analogs of cytosine and uracil shown below in Scheme 4.4. 
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The inhibitors were prepared according to the method of Paul Bartlett et al (119) by Dr. 
Chengfu Xu in the Frank Raushel Lab of the Chemistry Department at Texas A&M 
University.  The inhibition constants (Ki)  for Zn-CDA with the phosphonocytosine and 
the phosphonouracil transition state inhibitors were determined by incubating variable 
amounts of either inhibitor with 2.5 nM enzyme for 30-120 minutes in 100 mM HEPES 
buffer, pH 7.5 in a volume of 245 µL . Residual activities were then measured by 
initiating the reaction with 5 µL of 10 mM cytosine. Maximum inhibition was reached 
after 30 min. The time dependence to the onset of inhibition (kobs) by the 
phosphonocytosine and phosphonouracil inhibitors with Zn-CDA was determined by 
measuring the rate of deamination as a function of time. In these experiments, 4 nM Zn-
CDA was added to solutions containing either 1-15 µM phosphonocytosine or 0.96-4.33 
mM phosphonouracil and 0.65 mM cytosine in 100 mM HEPES buffer at pH 7.5. The 
time dependence for reversal of inhibition was determined by incubating 1 µM Zn-CDA 
with 5-25 µM phosphonocytosine or 5-25 mM phosphonouracil in 100 mM HEPES 
buffer for 30 min, followed by a 100-fold dilution into 2 mM cytosine and observing the 
time course.  
Scheme 4.4 
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 Data Analysis. All data were analyzed through fits to the corresponding 
equations using the non-linear least squares fitting program SigmaPlot 10.0. For the 
determination of the kinetic parameters; kcat, Km and kcat/Km, saturation curves were fit 
using eq 2.1 where A is the substrate concentration, v is the initial velocity of the 
reaction, kcat is the turnover number and Km is the Michaelis constant. For the 
determination of the relationship between extinction coefficients and pH, plots of Δε vs 
pH were fit with eq 4.2, where Δε is the difference in absorbance between cytosine and 
uracil at a specific pH, min is the theoretical minimum for Δε at low pH, max is the 
theoretical maximum for Δε at high pH and Hill slope is the slope of the transition.  
 For the analysis of pH-rate profiles, plots of log kcat and log kcat/Km vs pH that 
indicated the deprotonation of a single proton required for maximum activity were fit 
with eq 4.3, where c is the maximum activity and pKa is the pH of inflection resulting in 
maximum activity. pH-rate profiles showing a loss of activity at low pH and a wave 
shaped loss of activity at high pH, which transitions to a steady lower level of activity, 
were fit with eq 4.4. In eq 4.4, pKb is the pH where a transition to a lower level of 
activity occurs.  pH rate profiles which showed only the wave-shaped plateau were fit 
ising eq 4.5.  
 The proton inventory which displayed inverse-concave solvent deuterium isotope 
effects was fit with eq 4.6, where vn is the activity at different D2O/H2O ratios  in 
solution, vo is the activity in the absence of D2O, n is the ratio of D2O/H2O, and ΦR is the 
fractionation factor for the reactant-state site. Equation 4.7 was used to fit a proton 
inventory plot which displayed a linear inverse proton inventory. 
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 For the evaluation of the inhibition constants (Ki) for the inhibitors of CDA, eq 
2.7 was fit to plots of the residual activities vs inhibitor concentrations. Et is the total 
enzyme concentration, I is the inhibitor concentration, vo is the activity of the enzyme in 
the absence of inhibitor, and vi is the residual activity of the enzyme in the presence of 
inhibitor. For the determination of the time dependence to the onset of inhibition, time 
courses corresponding to the change in rate of cytosine deamination were fit with eq 2.8, 
where P is the product concentration, vr and vs are the initial and final rates of product 
formation, and kobs corresponds to the first order rate constants for the onset of the 
slower rate of product formation.   The apparent second-order rate constants (appkobs) for 
the formation of the inhibited form of Zn-CDA, was determined from the slope of the 
plots of kobs vs the concentrations of inhibitors. Correction for the concentration of 
substrate according with eq 2.9, gives the second-order rate constant k1 .   
v/Et = kcatA/(Km + A)     (2.1) 
Δε = min + (max - min)/(1 + 10(pH - pKa) × Hillslope)                                                     (4.2) 
y = log(c/(1 + 10(pKa-pH))) (4.3) 
y = log((c + d × 10(pH-pKb))/(1 + 10(pKa-pH) + 10(pH-pKb))) (4.4) 
y = log((c + d × 10(pH-pKb))/(1 + 10(pH-pKb))) (4.5) 
vn = v0/(1 – n + nΦR) (4.6) 
vn = v0(1 – n + nΦT) (4.7) 
vi/vo = ([Et] – Ki – [I] + (([I] + Ki – [Et])2 + (4Ki[Et]))1/2)/(2[Et]) (2.7) 
P = vst + ((vr – vs)/kobs)(1 - e(-kobst)) (2.8) 
k1 = appkobs (1 + [S]/[Km]) (2.9) 
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RESULTS  
 Metal Dependence of CDA.  Initially, wild type CDA from E. coli K-12 was 
expressed in BL-21 λDE3 cells and purified to homogeneity, yielding about 100 mg of 
pure protein from 2 liters of LB. The purified enzyme possessed a maximum activity of 
64 s-1. ICP-MS analysis indicated that the enzyme contained 0.56 equivalents of Zn and 
0.20 equivalents of Fe.  CDA was then expressed in LB enriched with 1.0 mM ZnCl2  
and cells were lysed via sonication in 50 mM TRIS buffer at pH 7.5 enriched with an 
extra 1 mM ZnCl2. The protein was then purified as described earlier in the materials 
and methods. This enzyme preparation had a turnover rate of 132 s-1 with 0.79 
equivalents of Zn, and 0.09 equivalents of Fe.   
 Ortho-phenanthroline treated apo-enzyme yielded a specific activity of 0.5 s-1 
and ICP-MS analysis verified that there was less than 5% contamination with Fe, Zn, 
Mn, Ni, Cu, Cd or Co in the final apo-enzyme containing solution. 50 µM apo-CDA was 
then reconstituted with Zn2+ or Fe2+. A metal titration with various equivalents of ZnCl2 
shows that CDA reaches maximum activity with approximately 1 equivalent of the metal 
as seen in Figure 4.1. The reconstitution with Fe2+ was performed in a septum sealed vial 
under N2 with 50 μM apo-CDA and three equivalents of FeSO4 in 20mM Hepes at pH 
7.5.  
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Figure 4.1: Reconstitution of apo-CDA (8.5 µM) with varying equivalents of Zn. The rates of cytosine 
deamination were determined after dilution of the enzyme incubations to concentrations of 50 nM in 2.0 
mM cytosine and 50 mM TRIS at pH 7.5 and 30 ˚C. Additional details are provided in the text.  
 Mutation of Active Site Residues. Mutants of CDA were prepared in an effort to 
determine the roles of specific residues in substrate recognition and catalytic function. 
Gln-157, Glu-218, His-247 and Asp-314 were selected for mutation based on the 
protein-ligand interactions observed in the crystal structure of CDA with the 
hydroxypyrimidine mechanism based inhibitor as shown earlier. All mutations 
performed resulted in 0.1 % activity or less, in spite of relatively small perturbations in 
metal content. Only two mutants showed significant levels of activity with cytosine (> 
0.005 s-1). These active mutants are:  H247Q, which displayed a kcat of 0.18 s-1, a Km of 
0.25 mM and a kcat/Km of 720 M-1 s-1; and D314N, which has a kcat of 7.5 × 10-3 s-1, a Km 
of 1.9 mM and a kcat/Km of 4.0 M-1 s-1. 
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Table 4.1: Metal Content and Kinetic Parameters for CDA and Active-Site Mutants. 
enzyme metal content kcat (s-1) Km (mM) kcat/Km (M-1 s-1) 
WT 0.79 Zn, 0.09 Fe 132 ± 2 0.97 ± 0.03 (1.4 ± 0.1) × 105 
Q157N 1.40 Zn, 0.04 Fe < 0.005 - - 
Q157A 0.92 Zn, 0.04 Fe < 0.005 - - 
E218Q 0.87 Zn, 0.15 Fe < 0.005 - - 
E218A 0.90 Zn, 0.08 Fe < 0.005 - - 
H247Q 0.31 Zn, 0.33 Fe 0.18 ± 0.01 0.25 ± 0.03 720 ± 95 
H247N 0.53 Zn, 0.29 Fe <0.005 - - 
H247A 0.59 Zn, 0.33 Fe < 0.005 - - 
D314N 1.05 Zn, 0.05 Fe (7.5 ± 0.2) × 10-3 1.9 ± 0.2 4.0 ± 0.4 
D314A 0.57 Zn, 0.32 Fe < 0.005 - - 
 Substrate Specificities of Zn CDA and Mutants. The library of cytosine analogues 
(consisting of various pyrimidines, pyridines, triazines and imidazoles) shown in 
Scheme 4.5 was tested for activity at concentrations of 1.0 mM, with 1 µM Zn-CDA and 
mutants in 75 mM Hepes, pH 7.5 and 30 ˚C. The release of ammonia from these 
compounds by CDA was quantified through NADH oxidation with the glutamate 
dehydrogenase coupled assay as described above. In that screen, it was discovered that 
cytosine deaminase could catalyze the deamination of creatinine (5.6 s-1), isocytosine 
(5.1 s-1) and 3-oxauracil (2.3 s-1). The E218A mutant was also found to be able to 
catalyze the release of ammonia from 3-oxauracil (0.18 s-1). The other compounds 
display insufficient activity (< 0.1 s-1) with the wild-type and mutant enzymes to warrant 
further investigation. A summary of the kinetic constants determined for the active 
compounds are shown below in Table 4.2. 
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Scheme 4.3: Library of pyrimidines, pyridines, triazines and imidazoles. 
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Table 4.2: Kinetic Parameters for Substrates with Zn-CDA. 
Enzyme Substrate kcat (s-1) Km (mM) kcat/Km (M-1 s-1) 
WT cytosine 132 ± 2 0.97 ± 0.03 (1.4 ± 0.1) × 105 
WT isocytosine 5.1 ± 0.1 0.46 ± 0.04 (1.1 ± 0.1) × 104 
WT creatinine 5.6 ± 0.7 25 ± 4 (2.2 ± 0.5) × 102 
WT 3-oxauracil 2.3 ± 0.1 4.1 ± 0.3 (5.6 ± 0.5) × 102 
E218A 3-oxauracil 0.182 ± 0.004 0.85 ± 0.04 (2.1 ± 0.1) × 102 
From the wild-type and E218A CDA catalyzed hydrolysis of 3-oxauracil, it was 
found that 1 equivalent of ammonia was rapidly released from 3-oxauracil. This 
deamination occurred at rates that were linearly dependent on enzyme concentration.  
Malonate semialdehyde was found to be the major product of this hydrolysis as verified 
by a prominent peak present at an m/z of 87 by negative mode ESI-MS. The proposed 
reaction for the hydrolysis of 3-oxauracil to malonate semialdehyde is shown below in 
Scheme 4.5.  
Scheme 4.4 
 
It was also determined that CDA is unable to catalyze the dethiolation of 4-
thiouracil at any measurable rate (< 6 × 10-5 s-1). This was confirmed through a lack of 
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changes in absorbance of the substrate which would be significant as seen from a 
comparison of the spectra of 4-thiouracil and the expected product uracil (data not 
shown). This conclusion was also verified through the use of dithionitrobenzoate 
(DTNB) which is used to indicate the presence of sulfide. It was also determined that 
CDA fails to de-chlorinate 4-chlorocytosine at a measurable rate, (< 2.2 × 10-4 s-1). This 
was determined by comparing the absorbance spectra of 100 µM 4-chlorocytosine and 
uracil at pH 7.5 in 50 mM TRIS buffer (data not shown). 
 pH Studies. Profiles of pH vs. activity were determined with the Fe2+ and the 
Zn2+ containing enzymes using both coupled and direct assays.  The resulting pH vs 
activity profiles were consistent, except the activity for the coupled assays dropped off 
with a slope of ~ -4 at pH values above 9 (data not shown). This loss of activity is due to 
the failure of the coupling system at higher pH values. For the development of a direct 
assay, the pH dependent changes in the ultraviolet absorbance spectra of both cytosine 
and uracil must be taken into account. 
The absorbance maximum of cytosine changes from 275 nm at pH 2.5 to 267 nm 
at pH 11.3, while the greatest change in absorbance occurs near the pKa of cytosine at 
pH 4.5.  The absorbance maximum of uracil changes from 258 nm at pH 2.5 to 284 nm 
at pH 11.3. The greatest changes in the absorbance of uracil occur near its pKa at pH 9.5. 
These ionizations are similar to earlier reported values of 4.57 and 9.26 at 30 ºC (120).  
The spectra of cytosine in buffers of pH 2.5 - 11.3 are shown in Figure 4.2 A and the 
spectra of the product of cytosine and CDA (uracil) in buffers of pH 2.5 - 11.3 are shown 
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in Figure 4.2 B. The reported ionization resonance structures for cytosine and uracil are 
shown below in Scheme 4.6 (120). 
 
 
Figure 4.2: pH dependence of (A) absorbance spectra of 200 µM cytosine in various 100 mM buffers 
ranging from pH 2.5-11.3 at 30 ºC; and (B), absorbance spectra of 200 µM enzymatically prepared uracil 
in various 100 mM buffers ranging from pH 2.5-11.3 at 30 ºC. 
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The differences in extinction coefficients for cytosine and uracil were determined 
at different pH values between 5.0 and 10.5.  The resulting plots of Δε (ε cytosine - ε 
uracil) vs pH yielded sigmoidal plots. The pKa values of cytosine and uracil and the pH 
dependent Δε values for the deamination of cytosine were calculated from eq 4.2. (see 
Figures 4.3, 4.4 and 4.5).  
Activities measured at pH values between 5.0 -7.5 were followed at 286 nm 
using the constants determined from the data shown in Figure 4.3. The constants 
determined from the data in Figure 4.4 were used for activities measured at 286 nm 
within the pH range of 7.3-8.5.  For pH values 8.3-11, the constants obtained from figure 
4.5 were utilized for rates measured at 298 nm. 
   pH
2 3 4 5 6 7 8

 28
6 
nm
-8000
-7000
-6000
-5000
-4000
-3000
-2000
-1000
0
A = -886.0705 +/- 19.4015
B = -0.8964 +/- 0.0155
logC = 4.4755 +/- 0.0093
D = -7565.6500 +/- 37.0664
 
Figure 4.3: Fit of eq 4.2 to differences in absorbance between uracil and cytosine vs pH values 2.6- 7.6, as 
measured at 286 nm. The constants derived [Δε286 = -7566 + (-886+7566)/(1+ 10(pH-4.48) (-0.90))] were 
utilized in the pH profile data from pH 5.0-7.5. 
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pH
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A = 5573.7432 +/- 95.4235
B = -0.8781 +/- 0.0376
logC = 9.4675 +/- 0.0221
D = -998.3262 +/- 60.9512
 
Figure 4.4: Fit of eq 4.2 to differences in absorbance between uracil and cytosine vs pH values 7.2-11.1 as 
measured at 286 nm. The constants derived [Δε286 = -998 + (5574+998)/(1+ 10(pH-9.47)(-0.88))] were 
utilized in the pH profile data from pH 7.3- 8.5. 
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A = 3265.0866 +/- 59.1857
B = -0.8554 +/- 0.0451
logC = 9.4733 +/- 0.0266
D = -95.3919 +/- 42.2624
 
Figure 4.5: Fit of eq 4.2 to differences in absorbance between uracil and cytosine vs pH values 7.4-11.1 as 
measured at 298 nm. The constants derived [Δε298 = -95 + (3265+95)/(1+ 10(pH-9.47) (0.86))] were utilized 
in the pH profile data from pH 7.3-10.5.  
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The log kcat profiles for both the Zn (Figure 4.6 A) and the Fe containing CDA 
(Figure 4.7 A) show a loss of activity at low pH, while there is virtually no loss of 
activity up to pH 10.  The pKa for this loss of activity at low pH was determined to be 
7.3 ± 0.1 for the Zn2+ enzyme, and 6.0 ± 0.1 for the Fe2+ enzyme as determined by fitting 
the data sets to eq 4.3. The log kcat/Km pH rate profiles (Figures 4.6 B and 4.7 B) show a 
loss of activity for Zn2+ CDA at low pH with a pKa of 5.5 ± 0.2 while there is no 
observable loss in activity at low pH for Fe2+ CDA.  In those kcat/Km profiles, both 
enzymes show a slight wave shaped plateau with a transition to a steady, slightly lower 
activity level at pH values above 8, resulting from small increases in Km.  The drop in 
kcat/Km occurs with a pKb of pH 7.9 ± 0.4 for Zn2+ and 8.2 ± 0.2 for Fe2+ CDA. The Zn 
CDA dataset was fitted to eq 4.4, while the Fe CDA log kcat/Km dataset was fitted to eq 
4.5.  The profiles for H247Q mutant show a low level of activity which is independent of 
pH between pH 5 and 10 for either the log kcat or the log kcat/Km as seen in Figure 4.8.  
These results are summarized below in Table 4.3. 
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Figure 4.6: pH-rate profiles for the deamination of cytosine by Zn-CDA. (A) log kcat vs pH profile for Zn-
CDA. The solid line represents a fit of the data with eq 2.3 yeilding a kinetic pKa of 7.3. (B) log kcat/Km  vs 
pH profile for Zn-CDA. The solid line represents a fit of the data with eq 4.4 yeilding a kinetic pKa of 5.5 
and a pKb of 7.9. 
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Figure 4.7 pH-rate profiles for the deamination of cytosine by Fe-CDA. (A) log kcat vs pH profile for Fe-
CDA. The solid line represents a fit of the data with eq 2.3 yeilding a kinetic pKa of 6.0. (B) log kcat/Km  vs 
pH profile for Fe-CDA. The solid line represents a fit of the data to eq 4.5 yeilding a pKb of 8.2. 
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Figure 4.8: pH-rate profiles for the deamination of cytosine by Zn containing H247Q CDA. (A) log kcat vs 
pH profile for Zn containing H247Q-CDA. (B) log kcat/Km  vs pH profile for Zn containing H247Q-CDA. 
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Table 4.3: Kinetic pKa Values from pH-Rate Profiles of Zn and Fe Substituted CDA and Mutant. 
  pKa pKb 
enzyme metal kcat vs pH kcat/Km vs pH kcat/Km vs pH 
wild type Zn2+ 7.3 ± 0.1 5.5 ± 0.2 7.9 ± 0.4 
wild type Fe2+ 6.0 ± 0.1 none observed 8.2 ± 0.2 
H247Q Zn2+  none observed none observed none observed 
 Solvent D2O Kinetic Isotope Effects and Proton Inventories.  Solvent deuterium 
isotope effects are expressed as ratios of rate constants measured in H2O (kH) and in D2O 
(kD). The rate constants for the deamination of cytosine by Zn-CDA was found to 
depend highly on D2O content, resulting in a large inverse solvent isotope effect (kH/kD) 
of 0.70 for kcat and 0.43 for kcat/Km in 100 mM HEPES, pH 8.5. This pH(D) was chosen 
after evaluation of the pH rate profiles to avoid pKa perturbations arising from the 
different isotopes. Similar effects of 0.62 and 0.40 for kcat and kcat/Km respectively, were 
also measured at pH(D) 9.0.    
For an enzyme catalyzed reaction, the ratios of the rate constants kH and kD share 
a relationship with the isotopic fractionation factors for the reactant state site (ΦR) and 
the transition state site (ΦT), where kH/kD =  ΦR /ΦT . The magnitude of a fractionation 
factor measures the deuterium preference of a particular site compared to solution (121).  
For the deamination of cytosine by Zn-CDA, the atom ratio of deuterium in water was 
varied using 0, 25, 50, 75 and 100% D2O in 100 mM HEPES buffer pH(D) 8.5 at 30 ˚C.  
The data for kcat were best fit to eq 4.6, (the Gross-Butler equation for a loose reactant 
state) yielding ΦR = 0.70 +/- 0.01 as shown in figure 4.9 A. A straight line (dashed line) 
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would indicate a single “tight” transition site with ΦT = 1.43.  Figure 4.9 B shows that 
the data for kcat/Km best fit to eq 4.7 (the Gross-Butler equation for a single “tight” 
transition state) with a ΦT = 2.3 +/- 0.1.  
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Figure 4.9: Proton inventories for the deamination of cytosine by Zn-CDA. This was performed in 100 
mM HEPES pH(D) 8.5 at 30 ˚C. (A) kcat vs atom fraction D fit to the Gross-Butler equation for a single 
loose reactant state site (eq 4.6). The straight dashed  line serves to emphasize the degree of curvature. (B) 
kcat/Km vs atom fraction D fit to the Gross-Butler straight line equation for a single tight transition state site 
(eq 4.7). 
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 Solvent Viscosity Studies:  The effect of viscosity on the kcat and kcat/Km for the 
deamination of cytosine by Zn CDA was measured with sucrose as the micro viscogen at 
pH 6.0, 7.5 and 9.0.  At pH 6.0, a slope of 0.11 was obtained for the relative kcat (Figure 
4.10 A), while there was a greater effect for the relative kcat/Km (Figure 4.10 B) with a 
more pronounced slope of 0.27.  For pH 7.5 there was a negligible slope of 0.04 for kcat 
(Figure 4.11 A) and a larger slope of 0.37 for kcat/Km (Figure 4.11 B). However, on the 
kcat/Km (B) plot, a single data point at high viscosity appears to be out of place and may 
be pulling the slope to an artificially high value. Values obtained at pH 9.0 were less 
pronounced at 0.08 and 0.09 for the relative kcat (Figure 4.12 A) and kcat/Km (Figure 4.12 
B) plots respectively. Viscosity effects were also measured in D2O, in an effort to see if 
the slight viscosity effects observed could be enhanced as a result of rate limiting step 
perturbation (data not shown). However, there was no increase in viscosity effects seen 
with D2O.   
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Figure 4.10: Viscosity effects on the relative values of kcat (A) and kcat/Km (B) for Zn-CDA using sucrose 
as the micro-viscogen at pH 6.0. Additional details are available in the text. 
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Figure 4.11: Viscosity effects on the relative values of kcat (A) and kcat/Km (B) for Zn-CDA using sucrose 
as the micro-viscogen at pH 7.5. Additional details are available in the text. 
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Figure 4.12: Viscosity effects on the relative values of kcat (A) and kcat/Km (B) for Zn-CDA using sucrose 
as the micro-viscogen at pH 9.0. Additional details are available in the text. 
 Transition-State Inhibitors.  Two phosphorus based transition-state analog 
inhibitors were selected as probes CDA’s affinity for the transition-state of cytosine 
deamination (see Scheme 4.8). The effectiveness of the inhibitors was evaluated with the 
Zn2+ containing CDA at pH 7.5. Inhibition constants were determined through inhibition 
A 
B 
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pattern fits with a quadratic equation for tight binding inhibitors (108, 109) as shown in 
eq 2.8.   
Scheme 4.6 
 
 Figure 4.13 A shows the Ki determination of the phosphonocytosine inhibitor.  
Phosphonocytosine serves as an excellent slow, tight binding inhibitor of Zn-CDA with 
a Ki of 52 ± 5 nM. Figure 4.13 B shows inhibition of Zn-CDA with the phosphonouracil 
inhibitor at pH 7.5, where Ki was determined to be 84 ±7 µM.  The inhibitor 
phosphonocytosine is the closest mimic of the transition state and as such, is more than a 
thousand times better inhibitor than the inhibitor which resembles uracil 
(phosphonouracil). The large difference in the inhibition constants underscores the 
subtleties involved in substrate binding and transition state stabilization employed by 
CDA. 
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Figure 4.13: Inhibition of 2.5 nM Zn-CDA in 50 mM TRIS at pH 7.5 with (A) phosphonocytosine and 
(B) phophonouracil. Solid lines represent fits of the data with eq 4.8. Enzyme and inhibitor solutions were 
pre-incubated together for 30 min at 30 ˚C prior to initiating the reactions with 0.2 mM cytosine.   
 Eq 2.9 was fit to time courses for the changes in the rates of cytosine 
deamination, yielding the observed first-order rate constants (kobs) for the slow onset of 
inhibition by phosphonocytosine and phosphonouracil. The obtained rates (kobs) were 
then plotted vs inhibitor concentrations yielding the apparent second-order rate constants 
(appkobs) as seen below in Figure 4.14 for phosphonocytosine and in Figure 4.15 for 
phosphonouracil. The linearity of these plots indicate that inhibition follows the simple 
model for inhibitor binding shown below in Scheme 4.9.  
Scheme 4.9 
 
 Correction for substrate concentration according to eq 2.10 yields the second 
order rate constant, k1. These rate constants were determined using cytosine at a 
concentration equal to the Km, therefore according to the equation, k1 = appkobs. For the 
inhibition of Zn-CDA by phosphonocytosine, k1 = 69 ± 7 M-1 s-1. For the inhibition of 
A B 
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Zn-CDA by phosphonouracil, k1 = 0.18 ± 1 M-1 s-1. Both inhibitors were found to be 
reversibly inhibitory after a 100 fold dilution into 2.0 mM cytosine. Extrapolation of the 
linear fit in Figure 4.14 to the y-axis gives an estimate of k2 of (1.4 ± 0.6) × 10-4 s-1for 
phosphonocytosine. The y-intercept in Figure 4.15 yields a k2 of (2.5 ± 0.4) × 10-4 s-1 for 
phosphonouracil.  
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Figure 4.14: Determination of the second order rate constant (k1) for the onset of inhibition of Zn-CDA by 
phosphonocytosine at pH 7.5. 
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Figure 4.15: Determination of the second order rate constant (k1) for the onset of inhibition of Zn-CDA by 
phosphonouracil at pH 7.5. 
DISCUSSION 
Metal Requirement of CDA. CDA has been described as an Fe2+ dependent 
enzyme, due to what was considered to be low activity when Zn2+ is bound. From the 
metal studies shown here and in previous studies (22) it is evident that cytosine 
deaminase has a high affinity with both Fe2+ and Zn2+. The metal chelation and 
reconstitution results demonstrate the absolute requirement of divalent transition metals 
for CDA activity and that exactly 1 molar equivalent of Zn2+ provides maximum 
activity. This Zn2+ containing CDA reaches maximum activity above pH values of 7.3, 
while the Fe2+ containing enzyme possesses maximum activity down to pH 5.9. 
Active Site Mutants. Mutants were expressed in CDA knockout cells to eliminate 
any ambiguities from slightly active mutants.  As a result the Q157N, Q157A, E218Q, 
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E218A, H247A and D314A mutants failed to yield activity detectable by our assay 
methods.  The activity seen for the H247Q and D314N mutants presents a dilemma 
because it appeared that they are essential components of catalysis. Evaluation of the 
crystal structure shows that His-247 and Asp-314 may both be involved in activation of 
the active site water. Perhaps the reason why there is some residual activity for both 
mutants is that the remaining residue may be able to compensate for the mutation in 
some unknown way.   
 The structural requirement of the substrate by CDA was addressed through 
evaluations of the substrate analogues in conjunction with site directed mutagenesis. 
From an examination of the only substrates displaying activity and the very similar 
structural patterns they possess, it appears that this enzyme maintains strict substrate 
specificity through the use of a small, highly cooperative active site, which is not 
accommodating to variations in structure.   
As seen in the crystal structure of PDB 1K70, Glu-218 is hydrogen bonding with 
N-3 of the pyrimidine. It is expected that N-3 becomes protonated by this glutamate 
during the reaction. This was also concluded for  ADA (17) and AMP deaminase (88)  
The lack of detectable activity seen for the Glu-218 mutations show that this residue is 
required except when no protonation is needed at N-3. 3-oxauracil served as an excellent 
mechanistic probe of the active-site mutants. When 3-oxauracil is used as a substrate, no 
protonation is needed, and hydrolysis of 3-oxauracil was found to proceed with the 
E218A mutant at nearly wild-type levels.  
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pH Studies. The pH dependencies of the extinction coefficients of cytosine and 
uracil were evaluated for the design of a direct assay for use during the evaluation of the 
pH profiles. On the extinction coefficient plots, there are two inflections which 
correspond to the pKa of cytosine at pH 4.5 and the pKa of uracil at pH 9.5.  This 
effectively eliminated the effects of the catastrophic loss of coupling system activity at 
pH values greater than 9.  
The pH profiles indicate that the Fe2+ containing enzyme is better at activating 
the hydrolytic water molecule, as evidenced by the broader range of activity seen for the 
Fe2+ containing enzymes where the log kcat pH profiles showed a pKa which was lower 
by more than 1.3 pH units as compared to the Zn2+ enzyme. These results are counter to 
previous model studies of the effectiveness of various metals toward the activation of 
water. In those studies Zn2+ is the better Lewis acid (118).  
When His-247 is mutated to glutamine, there is a level of activity an order of 
magnitude lower than the lowest activities measured for wild type enzyme at pH 5.0. 
The lack of pH effect on the profile with H247Q and the low level of activity detected, 
supports that His-247 is responsible for the ionization seen in the pH profiles.  His-247 
seems to be an important catalytic base that needs to be de-protonated for maximum 
activity. Perhaps if the wild type enzyme could be measured at pH values lower than 5, 
the activity would level out at this mutant level of activity. If Asp-314 or Glu-218 were 
required to be protonated in the resting state, then it would be expected to see a loss of 
activity before pH 10. There was no great loss of activity at high pH for any pH profile 
performed. This clearly supports that both glutamate and aspartate are de-protonated in 
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the resting state of CDA. It may still be possible that protonated residues are stabilized 
by the enzyme in the active site and there is no general consensus for the protonation 
state of ADA.  In different reports, it has been concluded either that both glutamate and 
aspartate are protonated (89) or glutamate and histidine are protonated (17).  
Solvent Kinetic Isotope Effects and Proton Inventories. In D2O, CDA catalyzes 
the deamination of cytosine at rates about twice as fast as those in water, yielding 
isotope effects (kH/kD) of 0.70 for kcat and 0.43 for kcat/Km .The relatively large inverse 
isotope effects seen here are indicative of a compressed hydrogen bond in the rate-
limiting step. Inverse isotope effects of comparable magnitudes were previously reported 
for AMP deaminase (88) and adenine deaminase (122, 123) where it was attributed to 
short hydrogen bonds between proton donors and acceptors with similar pKa values.  
The proton inventory data for kcat were fit with the Gross-Butler equation 
showing a single proton in a loose reactant site, with ΦR = 0.70  These results are 
consistent with those seen for ADA, where it was concluded that a single proton site 
which has its fractionation factor changed during catalysis is responsible for this type of 
inverse isotope effects (122). It was concluded that the effects are likely to be the result 
of a proton transfer from Glu-217 to N1 of adenosine (123). The data for kcat/Km best fit 
the equation for a single proton in a tight transition state with ΦT = 2.3.  If there were 
multiple sites experiencing a tightened potential as the transition state was formed, a line 
of intermediate curvature would provide a better fit (121), as was the observation for 
AMP deaminase with dAMP (88). In that study, it was proposed that multiple proton 
 138
transfers could occur in a relay between Zn-bound water, Asp-707, His-652, Glu-633 
and the departing NH3. 
Inverse solvent isotope effects arise from pre-transition state equilibrium effects, 
and in this case they may be the result of a compressed hydrogen bond between Glu-218 
and N3 of cytosine, which is analogous to the proposal for ADA. This could also explain 
why the inverse effects are much more pronounced in kcat/Km if that specific interaction 
were the major contributor for binding and catalysis under sub-saturating conditions, but 
not saturating conditions. Under saturating conditions, in mostly H2O, the compressed 
hydrogen bond in question may not be so dominating a feature of the reaction 
coordinate, but may become more pronounced under increasing D2O concentrations. 
Viscosity Effects. The viscosity effects observed were slight and there was a 
slightly larger viscosity effect at pH 6 compared to pH 9, indicating that diffusion is not 
rate limiting at high pH, but may become more of a factor at low pH.  This effect may be 
related to the lowering of the Km at low pH. Small viscosity effects were seen using 
sucrose as a microviscogen indicating that the deamination of cytosine by Zn-CDA is 
not diffusion limited. It was demonstrated above that Zn-CDA turns over cytosine at 
rates that are about two times faster in D2O. If the slight viscosity effects seen in H2O 
were significant, they should be more pronounced in D2O if the chemical step was no 
longer the rate limiting step.  However, the studies carried out in D2O failed to increase 
any viscosity effect, indicating that the turnover is still dictated by the chemical step.  
Any effect seen with the viscogen was probably not due to perturbation of diffusion and 
possibly arose from some low level inhibition of CDA by high levels of sucrose.   
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Inhibitor Studies. Phosphonocytosine proved to be an excellent inhibitor, 
yielding a Ki that was about a 1600 times lower than the inhibition constant of 
phosphonouracil and is 20,000 times lower than the Michaelis constant for cytosine. The 
phosphonouracil inhibitor yielded a Ki that is only 12 times lower than the Michaelis 
constant. The inhibition studies of these two transition state analogs show that the closer 
mimic of the transition state is a much more effective inhibitor of the reaction as well. 
From an evaluation of the individual rate constants, k1 and k2, it appears that there is an 
appreciable amount of error associated with them. This can be seen by comparing the 
ratios of k2/k1 to Ki. For phosphonocytosine, Ki = 52 nM, while k2/k1= 2.0 µM. For 
phosphonouracil, Ki = 84 µM, while k2/k1= 1.4 µM. These large differences most likely 
arise from the uncertainties in the determination of k2, because small errors in the 
determination of k1, have a larger effect on the error of k2.  
Mechanism of Cytosine Deamination. The mechanism for the deamination of 
cytosine by CDA has been evaluated through a host of mechanistic studies to identify 
the enzyme substrate interactions and their characteristics. From the studies presented in 
this report, several principles can be concluded. The active site metal has a large 
influence on the activation on the active site water, as seen from the large differences of 
kinetic pKa values (1.3 pH units) observed between the Fe2+ and Zn2+ containing enzyme 
preparations. Steady activities up to pH 10 indicate that the catalytic residues are 
deprotonated. The low-level, pH independent activity seen for H247Q, indicate that His-
247 is a major catalytic base responsible for pH dependent loss of activity at low pH. 
The activity of E218A with 3-oxauracil, shows that Glu-218 protonates N-3 of cytosine. 
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The extremely low activity (< 0.006 %) of the Asp-314 mutants, support the role of this 
residue as a major catalytic base as well.  
A proposed mechanism for the deamination of cytosine by CDA is presented 
below in Figure 4.16. This is based on the interactions observed in the crystal structure 
of FeCDA (PDB: 1K6W), the crystal structure of Fe CDA with bound 2-oxopyrimidine 
inhibitor (PDB 1K70), and the results of these mechanistic studies. Based on 
experimental evidence showing activity up to a pH of 10, it is proposed that in the 
resting state, Glu-218, His-247 and Asp-314 are all deprotonated. A water molecule is 
coordinated to the divalent cation, and is hydrogen-bonded to Asp-314 and His-247 at 
nearly equal distances.  
Prior to, or upon substrate binding, the hydrolytic water becomes deprotonated 
and Glu-218 becomes protonated. His-247 is reasonably positioned to perform this 
proton abstraction and subsequent transfer to Glu-218. The glutamate ε-O is 3.7 Å away 
from the histidine Nδ; however this distance can be decreased by axial rotation of either 
or both side chains. This initial deprotonation by His-247 is supported by the pH-activity 
profiles in several ways. First, the loss of activity which occurs at low pH has pKa values 
ranging from 5.5-7.3, which are consistent with a histidine protonation. Second, with the 
H247N mutant, there is no discernible loss of activity at low pH.   
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The hydroxide then initiates the nucleophilic attack upon the sp2 carbon bearing 
the leaving group amine. This is likely aided by the final deprotonation by Asp-314. N3 
of cytosine then abstracts a proton from the H-bonded Glu-218. It was concluded for 
ADA that this interaction produces the inverse isotope effects due to the similar pKas of 
the donor (~4) and acceptor (4.5), resulting in a low barrier H-bond (123). Given the 
typical H-bond distance of 2.8 Å between N3 and Glu-218, it could be possible that the 
solvent isotope effects arise from Zn-water deprotonation as proposed for AMP 
deaminase (88).  
The resulting interactions fromGlu-218, His-247, Asp-314 and Mα, enable the 
formation and stabilization of the resulting tetrahedral transition state. Collapse of the 
tetrahedral intermediate is facilitated through protonation of the leaving group ammonia. 
While there is no obvious residue poised to perform this protonation, Asp-314 appears to 
be the most probable candidate at 3.6 Å away from the carbonyl carbon. Glu-218 is 
another possible participant for this action and is 3.7 Å away from the carbonyl carbon. 
Regeneration of the resting state occurs upon product release and the binding of water.   
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Figure 4.16: Proposed mechanism for the deamination of cytosine by CDA. Distances shown in the 
resting state are obtained from the crystal structure 1K6W of Fe-CDA with bound water. Distances shown 
in the transition state are obtained from the crystal structure 1K70 of Fe-CDA with bound mechanism 
based inhibitor 2-oxopyrimidine. 
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CHAPTER V 
ATTEMPTS AT IDENTIFYING THE MISSING ARCHAEAL RIBOFLAVIN 
BIOSYNTHESIS PYRIMIDINE DEAMINASE 
Riboflavin biosynthetic pathway genes are found in most plants, fungi, bacteria, 
and archaea but not in humans, as we rely on riboflavin absorption from our diet. The 
redox-active flavin cofactors produced from riboflavin are involved in many essential 
cellular processes (124). Specific examples are: one and two electron transitions, 
photorepair of thymidine dimers in photodamaged DNA and dehydration reactions. 
Flavins also function in light photoreception, bioluminescence and circadian time 
keeping (125). In archaea, the early steps of riboflavin biosynthesis may also be 
responsible for the biosynthesis of hydride carrier coenzyme F420. Coenzyme F420 is 
essential for methanogenesis, sulfite reduction and oxygen reduction essential for 
archaeal survival (126).  
It has been discovered that there are several similar pathways which are utilized 
for the biosynthesis of riboflavin, depending on which type of organism is performing 
the synthesis. These reactions are summarized below in Scheme 5.1. For example, in 
bacteria and yeast, the first step in riboflavin biosynthesis is catalyzed by the Mg2+ 
dependent  GTP cyclohydrolase II (RibA), which converts GTP (1) to 2,5-diamino-6-
ribosylamino-4(3H)-pyrimidinone 5’-phosphate (3) by the release of formate and 
pyrophosphate. After the first step, the pathways diverge. In yeast, the second step is the  
NADPH dependent reduction of the sugar sidechain, producing NADP and 2,5-diamino- 
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6-ribitylamino-2,4(1H,3H)-pyrimidinone 5’-phosphate (4 a). The third step in yeast 
riboflavin biosynthesis is the deamination at the C-2 of the pyrimidine by a separate 
enzyme, resulting in the formation of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinone 
5’-phosphate (5) (127). In bacteria, the second and third steps are catalyzed by a 
bifunctional deaminase/reductase called ribD. It was determined that the deamination of 
3 occurs first, producing 4 b. This is then followed by the reduction of 4 b, producing 5 
(124, 128). 5 is presumably the substrate for an unidentified phosphatase which should 
produce 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinone (6). Lumazine synthase 
catalyzed condensation of 6 with 3,4-dihydroxy-2-butanone 4-phosphate (7) yields 6,7-
dimethyl-8-ribityllumazine (DMRL) (8), the substrate for riboflavin synthase. Riboflavin 
synthase then catalyzes the dismutation of DMRL, yielding riboflavin (9) and 5-amino-
6-ribitylamino-2,4(1H,3H)-pyrimidinone (6). These reactions are shown below in 
Scheme 5.2. 
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Scheme 5.1 
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Scheme 5.2 
  
In archaea, riboflavin biosynthesis pathway is similar to that of yeast with a few 
exceptions. The first reaction is catalyzed by a different type of hydrolase, GTP 
hydrolase III (ArfA), which does not de-formylate the resulting pyrimidine (2). It was 
recently discovered that the release of formate from compound 2 required an additional 
enzyme (ArfB) which is an Fe2+ dependent formamide hydrolase (126). A reductase 
(ArfC) similar to the one in yeast has been identified which reduces the deformylated 
product 3 (96). The enzyme responsible for the next catalytic step in archaeal riboflavin 
biosynthesis remains unidentified and may catalyze the deamination of compound 4a to 
compound 5.  
All known pyrimidine deaminases share a common fold, which is similar to yeast 
cytosine deaminase or bacterial cytidine deaminase that forms a fusion partner with the 
pyrimidine reductase.  However, in archaea, this pyrimidine reductase has been 
identified and it is found in the absence of any identifiable deaminase (96). There is a 
group of three similar amidohydrolases in archaea, which are annotated as 
chlorohydrolase-like/ssna like/cytosine deaminase like.  Though they share a generally 
low sequence identity, there are some common critical sequence characteristics. These 
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sequence similarities are shared with the SAH deaminase Tm0936 as well as other 
deaminases such as CDA as seen in Figure 5.1.   While it is possible that any of these 
putative archaeal deaminases are a cytosine deaminase, a guanine deaminase or an SAH 
deaminase; the genomic context comparison centered on Sso0398 as shown in Figure 5.2 
provides support that Sso0398 and the homologous enzymes Mm_0823, Mmp 1380, and 
mmarC7_0625 possibly represent the missing archaeal pyrimidine deaminase.  While 
these enzymes are highly dissimilar from the bacterial pyrimidine deaminase, they are 
much like the bacterial cytosine deaminase, which catalyzes a similar deamination.  This 
would provide an example of two different folds performing the same reaction in 
different organisms. This chapter describes the cloning, expression and the attempted 
purification of three putative deaminases from archaeal microorganisms which are 
predicted to be involved in riboflavin biosynthesis. Also included in this chapter are the 
cloning, expression and purification of the enzymes RibA and ArfC that are required to 
make the substrate 4a for the missing putative deaminase. Lastly, the production of 
compound 4a and the attempted detection of the production of compound 5 are 
discussed. 
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Mmp1380 - - - - l k f i c k l v n - - k k i l s i h a n e h k g s v q y s k e k y g i s e i e r l i n l n i k - 225 
Sso0398 - - - - i e l i k h v f n - - n k i r s v h v s e t i k h w l r - - - - - - - - d d l e y v m k r y e - 223 
Tm0936 - - - - l k r v f d t a k s l n a p v t i h l y e t s k e e y d - - - - - - - l e d i l n i g l k e v - 222 
CDA - v e s l h k t f a l a q k y d r l i d v h c d e i d d e q s r f v e t v a a l a h h e g m g a r v t - 244 
                                                      
Mm0823 - p d l l i ---h l t h a - - g k k d l d e i a q a k i p v v v c p r s n f v t g - - - - - - - - - a - 259 
Mmp1380 - p d f l i--- h a t h s - - s s d d l s l l n e n k i p v v v c p r a n a s f n - - - - - - - - - v - 262 
Sso0398 - p n l i i--- h g t y l - - s e e e i d i m r y r k a s i v y c p r s n l w f s - - - - - - - - - v - 260 
Tm0936 - k t i a a ---h c v h l - - p e r y f g v l k d i p f f v s h n p a s n l k l g - - - - - - - - - n - 259 
CDA - a s h t t a m h s y n g a y t s r l f r l l k m s g i n f v a n p l v n i h l q g r f d t y p k r r - 294 
                                                      
Mm0823 - g m a p i a e m l e a g i r v a a g t d n v m l n - s v n m f a e m e f m s k i f s i d d - - - - - - 303 
Mmp1380 - g l p d i p k m l e y n l k l g i g t d n f m a n - s p s i f k e m d f i y k i y h v d p - - - - - - 306 
Sso0398 - g i p k v i n g l k s g v n l l i g t d n g g v l - d p d m w k e m e t l l l i s r v q d p l s d h - 309 
Tm0936 - g i a p v q r m i e h g m k v t l g t d g a a s n n s l n l f f e m r l a s l l q k a q n p r n l d - 309 
CDA - g i t r v k e m l e s g i n v c f g h d d v f d p w y p l g t a n m l q v l h m g l h v c q l m g y - 344 
                                                       
Mm0823 - - r q v f k i c t l n g s f v m g p d s m c s i e k g n k a n l m i l n g d s n n l a g i q d p v g - 352 
Mmp1380 - - k e i l k m a t i n g a e i l g l q n t g v i k e g y i p t f t f i k - n g n i l k t s k n i a a - 354 
Sso0398 - s l q i l k a s t i n a y k f l g i r g w i e e g n p i e a g l l v l e g d s t g i l n s n n k y i - 359 
Tm0936 - v n t c l k m v t y d g a q a m g f k - s g k i e e g w n a d l v v i d l d l p e m f p v q n i k n - 358 
CDA - g q i n d g l n l i t h h s a r t l n l q d y g i a a g n s a n l i i l p a e n g f d a l r r q v p - 394 
                                                      
Mm0823 - g i t k r a r p d d i l a v l h s - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -   - 369 
Mmp1380 - s v v t r l e n g d v d s k f l v c - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -   - 372 
Sso0398 - g i i k r g n k i i y n l g a i q k i i - - - - - - - - - - - - - - - - - - - - - - - - - - - -   - 379 
Tm0936 - h l v h a f s g e v f a t m v a g k w i y f d g e y p t i d s e e v k r e l a r i e k e l y s s   - 406 
CDA - v r y s v r g g k v i a s t q p a q t t v y l e q p e a i d y k r - - - - - - - - - - - - - - -   - 427 
                                                      
Figure 5.1: Multiple sequence alignment of three possible riboflavin deaminases from the archaea M. 
mazei, M. maripaludis and S. solfataricus, with the closely related SAH deaminase from T. maritima and 
CDA from E. coli. 
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Figure 5.2: Genomic context tree of the putative deaminase from S. solfataricus obtained from 
Microbesonline.org. The center gene (teal) is the putative archaeal pyrimidine deaminases from Sulfolobus 
solfataricus which is labeled as trzA-like or COG-SsnA. COG2429 (dark orange) corresponds to ArfA. 
RibH (dark blue) corresponds to lumazine synthase. RibC/COG-1731 (purple) corresponds to riboflavin 
synthase.  RibA/COGRibB (royal blue) corresponds to the domain responsible for synthesis of 3,4-
dihydroxy-2-butanone 4-phosphate from ribulose-5-phosphate. 
MATERIALS AND METHODS 
Materials. All chemicals and buffers were obtained from Sigma-Aldrich unless 
specified otherwise. The genomic DNA for Methanococcus maripaludis C7, 
Methanosarcina mazei GO1 and Sulfolobus solfataricus were purchased from the 
American Type Culture Collection (ATCC). The oligonucleotide primer syntheses and 
DNA sequencing results were obtained from the Gene Technology Laboratory at Texas 
A&M University. A bacterial cell line expressing GTP cyclohydrolase II from E. coli 
(Rib A) was obtained as a frozen permanent culture containing the His6-RibA 
expression plasmid from the ASKA collection at the National Institute of Genetics, 
Japan. The pET20a(+) and pET28b(+) expression vector were acquired from Novagen 
along with the XL1 Blue and Rosetta PlysS DE3 cells. All restriction enzymes, as well 
as the pMAL-C4X maltose binding fusion protein expression vector, were purchased 
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from New England Bio-Labs. The Pfu-turbo DNA polymerase was purchased from 
Stratagene. For PCR clean-up and gel purification, the QIAquick Gel Extraction Kit was 
purchased from Qiagen. For miniprep purifications, the Wizard Plus SV Minipreps DNA 
Purification System was purchased from Promega.  
Cloning and Expression and Purification. The putative pyrimidine reductase 
Mmp1348 from Methanococcus maripaludis was cloned into the pET28b(+) expression 
vector through the use of NcoI and BamHI restriction sites. Methanosarcina mazei 
reductase Mm0826 was successfully cloned into the pET-30b(+) expression vector 
through the use of NdeI and EcoRI restriction sites. The putative pyrimidine deaminase 
enzymes Mm0823 from M. mazei, MmarC7_0625 from M. maripaludis and Sso0398 
from S. solfataricus were all cloned into a pET-20b(+) vector encoding for ampicillin 
resistance and IPTG inducible expression through the use of NdeI and XhoI restriction 
sites.  For the PCR amplification reactions of these low GC content archaeal genes, a 
two- fold excess of MgSO4  and the use of the polymerase PFU turbo in conjunction with 
45 ○C  and 68 ○C  annealing and extention temperatures were successfully utilized for 
gene amplification. Once the sequences were verified through the use of T7 promoter 
and terminus primers in the forward and reverse directions respectively, the plasmids 
were transformed into BL21 DE3 Rosetta PlysS DE3 and Rosetta-gami DE3 cells, which 
provide rare codon expression and tight control over expression. For the production of 
C-terminal (His)6 fusion tags, the stop codon was eliminated with Quickchange 
mutagenesis. For the production of N-(His)10 factor Xa cleavable fusion proteins, the 
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genes were digested with NdeI and XhoI restriction enzymes and ligated into a pET-
16b(+) vector.    
For the production of RibA from E. coli, cells harboring the (His)6RibA gene 
were used to inoculate a 5 mL overnight starter culture enriched with 25 µg/mL 
chloramphenicol. This was then grown overnight at 37 ºC. The entire overnight culture 
was then used to inoculate 1 L LB enriched with 25 µg/mL chloramphenicol. This was 
grown with shaking at 37 ºC until an absorbance at 600 nm of 0.6 was reached. At this 
time the heater was turned off and 1.0 mM IPTG was used to induce protein expression. 
The cell culture was allowed to grow overnight at room temperature with shaking after 
which they were centrifuged at 3400g for 12 minutes. 5 grams of the cells were then re-
suspended in 50 mL buffer A (20 mM TRIS at pH 7.9, 5 mM imidazole, 500 mM NaCl 
and 100 µg/mL PMSF) and disrupted by sonication. Insoluble cell debris was removed 
by centrifugation at 25,000g for 15 minutes and then filtered with a 0.45 micron syringe 
filter. The entire protein solution was then loaded by gravity onto an Amersham Ni 
Sepharose 6 Fast Flow column pre-loaded with 1 column volume of 50 mM NiCl2 and 
equilibrated with buffer A. After loading, the column bound protein was washed with 
100 mL buffer A and eluted with a gradient of buffer B (20 mM TRIS at pH 7.9, 1 M 
imidazole, and 500 mM NaCl. The RibA containing fractions, as determined by SDS 
PAGE, were then pooled and concentrated with a 10,000 MWCO Centricon protein 
concentrator. The extinction coefficient of 12090 M-1 cm-1 was used to determine the 
final concentration. This was calculated based on the gene sequence through the use of 
Protein Calculator v3.3 at http://www.scripps.edu/~cdputnam/protcalc.html. 
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For production of the pyrimidine reductase from Methanococcus maripaludis, 
purified Mmp1348 containing pET28b(+) plasmid DNA was transformed into electro-
competent Rosetta PlysS DE3 cells, followed by plating onto 50 µg/mL kanamycin 
containing agarose/LB plates.  A single colony was used to inoculate a 5 mL overnight 
LB culture, which was then used to inoculate a 2 L culture. This was grown at 37 ○C to 
an absorbance of 0.6 at 600 nm, after which 1.0 mM IPTG was added to induce 
expression. After 18 hours at 30 ºC, the cells were harvested by centrifugation and lysed 
by sonication in 50 mM HEPES, pH 8, 1.0 mM of the disulfide reducing tris-
carboxyethylphosphine (TCEP) and 10 µg/mL PMSF. The nucleic acids were removed 
with 2% protamine sulfate, and then the protein was precipitated with ammonium sulfate 
at 50% of saturation.  Lastly, the protein was purified by gel filtration and ion exchange 
chromatography. The reductase containing fractions were identified by SDS-PAGE and 
pooled. The sequence derived extinction coefficient of 19770 M-1 cm-1 was used to 
calculate the final concentration of protein.  
The putative deaminases Mm0823 and MmarC7_0625 and Sso0398 were 
prepared with and without C-terminal (His)6 fusion tags through the use of modified 
XhoI cloning primers lacking a stop codon and standard cloning methods described 
above. MmarC7_0625 was also prepared as an N-terminal (His)10 Xa cleavable fusion 
protein by ligation into a pET-16b(+).  Sso0398 was also cloned into the N-terminal, 
Factor Xa cleavable, cytoplasmic maltose binding protein fusion system pMAL-c4X 
through the use of XmnI and BamHI restriction sites.  
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The various putative deaminase expression vector constructs were expressed and 
purified as described above, but with additional modifications. Protein expression was 
induced at 17, 25, or 37 oC in BL21 λ DE3, Rosetta PLysS DE3, Rosetta-gami DE3 and 
BL21 λ DE3 cells harboring the PGro-7 vector encoding for the molecular chaperones 
GroEL and GroES. SDS-PAGE analysis of the lysis solution and lysis pellets showed 
clearly that every protein formed insoluble inclusion bodies.  Notably, even the 
molecular chaperones GroEL and GroES were rendered insoluble upon expression of the 
putative deaminases.  
High temperature expression at 45 oC was also attempted with the Sso0398 
constructs in order to induce a heat shock response resulting in the production of natural 
chaperone proteins. This was achieved by growing the cells to an absorbance of 1.0 at 
600 nm at a temperature of 37 oC, followed by the addition of 0.1 mM IPTG and 
subsequent incubation at 45 oC overnight.  Additionally, growth and expressions were 
attempted for the various constructs in LB enriched with 500 mM NaCl and 1.0 mM 
glycine betaine at 25 oC.   
The pMAL-c4X-Sso0398 fusion protein was transformed into BL21 λ DE3, 
Rosetta PLysS DE3 and Rosetta-Gami DE3 cells. SDS-PAGE analysis of small (5 mL) 
protein expression trials indicated that fusion protein expression was only observed in 
the Rosetta PLysS DE3 cells. An overnight culture of the Rosetta PLysS DE3 cells 
harboring the fusion protein was used to inoculate 1 L of rich media (LB + 0.2% 
glucose) enriched with 100 µg/mL ampicillin. The cells were grown with shaking at 37 
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ºC until an absorbance of 0.5 was reached at 600 nm.  0.3 mM IPTG was then used to 
induce expression of the fusion protein and the cells were grown with shaking overnight.  
The cells were then harvested by centrifugation at 4000g for 20 min. 5 grams of 
cells were then lysed by sonication in 80 mL of 50 mM TRIS, pH 7.5 and 1 mM DTT. 
Insoluble debris was removed by centrifugation at 9000g for 30 min. The supernatant 
was then applied to 15 mL amylose resin column by gravity at a rate of 1 mL/min.  The 
amylose resin bound fusion protein was then washed with 12 column volumes of buffer 
and the soluble fusion protein was eluted with 10 mM maltose containing buffer.  The 
fractions containing the fusion protein were pooled and the concentration was 
determined using the entire fusion protein sequence derived extinction coefficient of 
107000 M-1 cm-1. The fusion protein was cleaved by incubating a 3 mg/mL solution of 
the maltose binding protein-Sso0398 fusion protein with 10 µL factor Xa in the Xa 
cleavage buffer, as directed by the instructions in the Factor Xa cleavage kit, overnight 
at 37 ºC.   
Inclusion Body Extractions and Characterizations. For the attempted purification 
of the proteins which were expressed as inclusion bodies, the proteins were at least 
partially unfolded with either 9 M urea or 3.5 M guanidine HCl at pH 8.0 in 50 mM 
HEPES. The proteins were then dialyzed into less-denaturing levels of urea (5 M) at 
either 0 oC, room temperature, or 60 oC in the presence or absence of reducing agents 
tris-carboxyethylphosphine, DTT or BME and divalent cations, Fe2+, Zn2+ or Mn2+. The 
reduction in denaturant consistently resulted in the immediate precipitation of all 
proteins.   
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Dialysis at 60 ºC was attempted for the thermophilic Sso0398, which resulted in 
the production of a soluble and pure protein of the appropriate size.  This protein was 
submitted for N-terminal protein sequence analysis by Dr. Larry Dangott at the Protein 
Chemistry Lab at Texas A&M University. The resulting N-terminal sequence was A(D)-
E-I-Y-N-K-D this sequence was clear and consistent with that of outer membrane 
protein C from E. coli. 
Production of 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5’-phosphate 
(2)and 2,5-diamino-6-ribitylamino-2,4(1H,3H)-pyrimidinone 5’-phosphate (3). Typical 
preparation of 2 was performed as reported elsewhere (124) but with some 
modifications. Reactions containing 50 mM HEPES, pH 8, 5 mM MgCl2, 1 mM GTP 
and 100 µM RibA and 5 mM DTT were incubated at 37 ºC for 30 min. Shifts in the 
absorbance spectrum from a λmax of 260 nm to 296 nm confirmed the completion of the 
reaction. Enzyme was then removed upon passing the solution through a 30,000 MWCO 
Amicon membrane. The NADPH dependent reduction of 3 by Mmp1348 was monitored 
at 340 nm with an extinction coefficient for the formation of NADP+ of 6220 M-1 cm-1. 
Detection of 5-Amino-6-ribitylamino-2,4(1H,3H)-pyrimidinone 5’-phosphate (4). 
Production of 5 in reactions containing compound 4a and preparations of the putative 
deaminases were monitored through the coupled assay for ammonia release as described 
previously (79). Reactions containing compound 4a and the putative deaminases were 
quenched with 40 mM 2,3-butanedione at 30 ºC for 30 min. The derivatized products 
were then separated by anion exchange in 20 mM TRIS with a gradient of 0-1M NaCl 
using an Amersham MonoQ anion exchange chromatography column. The products 
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were evaluated by comparison of UV spectra to those previously established (124) and 
submitted to the Department of Chemistry Laboratory for Biological Mass Spectrometry 
at Texas A&M University.   
RESULTS AND DISCUSSION 
 GTP cyclohydrolase II (RibA) from E. coli has been purified and the GTP 
cyclohydrolase activity was used to create the substrate (3) for the archaeal pyrimidine 
reductase (ArfB) Mmp1348. This compound was found to be stable at 0 ºC for 1 day.  
When flash-frozen in a dry ice / acetone bath and stored at -80 ºC, it was found to be 
stable for at least 1 month.  
The reductase Mmp1348 has been cloned, purified and found to oxidize NADPH 
and NADH in the presence of the product of RibA. When combined with 120 µM of the 
RibA product (3), Mmp1348 was found to oxidize an equal amount of NADPH. The 
initial rate of NADPH oxidation by Mmp1348 as determined with 120 µM of compound 
3 was determined to be 0.85 s-1.  This rate is roughly 2.7 times faster than the kcat of 19 
min-1 that was determined for the E. coli pyrimidine reductase reaction of ribD with 
compound 4b (124). 
The product of this reduction reaction (4a) was derivatized with diacetyl to 
dimethylribitylpteridine-5-phosphate (10) shown in Scheme 5.1 and purified via anion 
exchange HPLC chromatography using 20 mM ammonium bicarbonate and a linear 
gradient of 1 M ammonium bicarbonate.  The derivatized product was verified through a 
comparison to the published λmax of the de-phosphorylated compound 10. The 
established peak absorbance wavelength values at pH 7 were 268, 325 and 414 nm (129) 
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and all agreed well with the experimental values obtained for a scan of the HPLC 
purified product in 20 mM TRIS buffer at pH 7.5. A spectrum of compound 10 is shown 
in Figure 5.3. Samples of the product were analyzed by Maldi-TOF +/- MS and 
Electrospray +/- MS using standard procedures by the Laboratory for Biological Mass 
Spectrometry in the Department of Chemistry.  Results obtained failed to confirm the 
presence of compound 10. These inconclusive results were possibly due to instabilities 
of the compound or from matrix and ionization interferences.    
Scheme 5.3 
 
 
Figure 5.3: Spectrum of dimethylribitypterin-5-phosphate, pH 7.9 (compound 10).  
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The putative pyrimidine deaminase enzymes from M. mazei and M. maripaludis 
C7 over-express well in the Rosetta PlysS DE3 cells at 17 ○C with 1 mM additional 
ZnCl2, however the protein products proved to be unyieldingly insoluble. The (His)10 
factor Xa cleavable MmarC7_0625 fusion protein did not express well in Rosetta-gami 
DE3 cells.  The expression and purification of the protein products from inclusion bodies 
was attempted under the conditions listed in the Materials and Methods, but failed to 
yield soluble and active protein product of the proper sequence under any circumstance. 
The N-terminal protein sequences of the soluble protein were of the sequence 
DEIYNKD or AEIYNKD as verified using three different conditions. The sequence 
AEIYNKD is found near the N-terminus of an E. coli outer membrane porin C protein.  
The pMAL-c4X-Sso0398 protein fusion did yield soluble fusion protein of 
appropriate molecular weight (85 kDa). The resulting protein solution which was 
purified using the amylose column was tested for metal content by ICP-MS. The protein 
was found to contain 0.02 eq Mn, 0.06 eq Zn and 0.08 eq Fe.  It is possible that the 
maltose binding protein was somehow blocking the active site of Sso0398. To address 
this possibility, the maltose binding protein was removed from the N-terminus of 
Sso0398 by overnight incubation by the site-specific protease factor Xa, producing un-
modified wild-type protein. Upon cleavage, some protein precipitation was visible. SDS-
PAGE of the soluble cleavage products showed a single band which was consistent with 
either Sso0398 (42.65 kDa), the cleaved pMal protein (42.48 kDa) or factor Xa (42.32 
kDa).  N-Terminal sequencing of the major band indicated that the maltose binding 
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protein was present at greater than 95 % purity, indicating that if it was expressed, then 
Sso0398 had precipitated.  
The crude cell extracts and the re-suspended inclusion bodies were tested for 
activity against 4a with the glutamate dehydrogenase coupled assay, yet no ammonia 
release was detected. The HPLC purification and characterization of the derivatization 
products was also applied to the crude cell extracts and protein preparations in an effort 
to detect the slightest changes in the visible spectra expected if any amount of compound 
7 were formed. Compound 4a was treated with the putative deaminases for up to 24 
hours. The subsequent derivatization and purification yielded products with spectra 
which are identical to those obtained without the putative deaminases (compound 10). 
 In conclusion, the archaeal enzyme Mmp1348 from Methanococcus maripaludis 
annotated as topoisomerase/primase-like and dihydrofolate reductase-like by the NCBI, 
was successfully cloned and purified. This enzyme was effective at reducing the product 
of RibA as evidenced from the NADPH reduction observed. The UV/Vis absorbance 
spectrum of the diacetyl derivatized product, is consistent with the structure of 2-amino-
6,7-dimethyl-8-ribityl lumazine 5’-phosphate (6). This evidence supports Mmp1348 
production of 4b from compound 3 and functioning as ArfC in archaea in the riboflavin 
biosynthesis pathway.  
The wild type and His-tagged versions of the putative archaeal pyrimidine 
deaminases Mm0823, MmarC7_0625 and Sso0398, have proven to be insoluble and 
inactive against compound 4a, as expressed under a wide variety of growth and 
purification conditions in several different strains of E. coli. The maltose binding protein 
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fusion construct prepared with Sso0398 and expressed in Rosetta pLysS cells resulted in 
soluble protein of the proper size that was successfully purified with an amylose resin 
column. The resulting fusion protein had poor metal content in spite of  
attempts to grow the protein in media enriched with metal and at various temperatures  
with various levels of inducing agent.  
Visible protein precipitation upon incubation with factor Xa indicated that the 
deaminase was precipitating upon cleavage. This hypothesis was supported by N-
terminal sequence analysis of the remaining soluble protein which showed that the 
maltose binding protein was the only protein present. A band of size which is consistent 
with the archaeal protein was visible by SDS-PAGE. Attempts at measuring deamination 
of 4a were unsuccessful with all crude cell extracts and protein preparations. This was 
determined from the lack of ammonia detected by the glutamate dehydrogenase assay in 
addition to a lack of any evidence supporting the formation of compound 7. While it is 
still very possible that any of these three putative deaminases are involved in riboflavin 
biosynthesis, they may require additional interactions with unknown proteins or 
cofactors for solubility and activity. 
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CHAPTER VI 
DISCOVERY OF 8-OXOGUANINE DEAMINASE  
Oxidative damage by reactive oxygen species to nucleotides, cofactors, 
metabolites and structural components can pose a significant problem to the metabolism 
of any organism if not promptly dealt with. As a result, it should not be surprising that 
there exist enzymes which have a specific purpose of recycling or converting the 
damaged compounds to more useful or common components of metabolism. Enzymes of 
this kind are typically not found in well established biological pathways making the 
purpose-driven identification of these unknown repair and salvage enzymes very 
challenging.  
It is established that 8-oxoguanine is one of the most prevalent products of 
oxidative stress in cells (130). DFT calculations show that superoxide radical (O.2-), and 
singlet oxygen (1O2) readily react with guanine, producing the extremely mutagenic 8-
oxoguanine (131). Inflammatory cytokines have been shown to increase NO levels, 
which has then been associated with mitochondrial guanine oxidation that may 
contribute significantly to neurological disorders such as multiple sclerosis (132). 8-
oxoguanine readily pairs with adenine, producing mutations associated with many types 
of disease (133). It has been observed that there are specific enzymes (glycosylase/AP 
lyase) specific for the removal of oxidized guanine in DNA (130, 134), however the fate 
of the resulting 8-oxoguanine has not yet been described.   
This chapter describes the discovery of function of two uncharacterized bacterial 
enzymes Pa0142 (gi: 9945972) from Pseudomonas aeruginosa PA01 and the New York 
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SGX Research Center for Structural Genomics (NYSGXRC) protein target NYSGXRC- 
9236e (gi: 44264246). The crystal structure of NYSGXRC-9236e has been solved and 
assigned the PDB code: 3HPA. This enzyme was cloned from an environmental sample 
of the Sargasso Sea and the closest homolog from a sequenced organism (98% identical) 
is Bcep18194_A5267 from Burkholderia sp. 383. This is annotated by NCBI as a 
hydroxydechloroatrazine ethylaminohydrolase based on sequence similarities. Pa0142 
has also been annotated as a hydroxydechloroatrazine ethylaminohydrolase.  
Genomic context evaluations similar to the one shown below in Figure 6.1, show 
that Pa0142 and 9236e belong to a previously uncharacterized group of bacterial 
enzymes that are found near nucleotide salvage pathway enzymes including guanine 
deaminase, adenosine deaminase and xanthine/uracil permease. This context provides 
support that the unknown enzymes are involved in nucleotide metabolism, This 
information, when combined with the sequence similarities to known deaminases, 
indicated that these two enzymes may be deaminating compounds similar to pyrimidines 
and purines.   
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Figure 6.1: Genomic context tree of Pa0142 (center) obtained from Microbesonline.org. Nearby are 
nucleotide salvage enzymes including; the non-specific nucleoside hydrolase nuh (gray), xanthine/uracil 
permease UraA (teal), xanthine dehydrogenase xdhB (indigo), guanine deaminase guaD/COG-SsnA (pink) 
and adenosine deaminase add (brown).  
 
Sequence evaluations enabled the identification of a group of genes that are 
similar to guanine and cytosine deaminase, yet the probable genes for guanine 
deaminase and cytosine deaminase are already present in these genomes.  In 
Pseudomonas aeruginosa, Pa0142 is one of these genes. In fact, P. aeruginosa contains 
two additional genes Pa0134 and Pa1521, which are more like the known guanine 
deaminases than Pa0142.  In an effort to resolve the function of these apparently 
redundant genes, these proteins of unknown function were selected for deaminase 
activity screening against a library of pteridines, purines and pyrimidines. The activity 
screening resulted in the discovery of activity for the nucleotides isocytosine, guanine 
and 8-oxoguanine.  
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In previous unpublished studies of Pa0142, Dr. Ricardo Marti-Arbona measured 
kcat/Km values of  5.7 × 103 M-1 s-1 for isocytosine, 2.0 × 103 M-1 s-1 for guanine, 2.0 × 103 
M-1 s-1 for ammeline, 40 M-1 s-1 for pterine, and 30 M-1 s-1 for isoxanthopterin. In this 
chapter, the substrate specific activities of Pa0142 and SGX-9236e will be discussed and 
compared to the probable GDA (Pa0134) from Pseudomonas aeruginosa (gi: 15595332) 
and the similar E. coli proteins; GDA (gi: 89109663), SsnA (gi: 89109659), and YahJ 
(gi: 89107197). 
MATERIALS AND METHODS 
Materials. 8-oxoguanine was purchased from Toronto Research Chemicals Inc. 
All other chemicals and buffers were obtained from Sigma-Aldrich unless specified 
otherwise. Kinetic assays were performed in a 96 well plate with a SPECTRAmax 384 
Plus spectrophotometer from Molecular Devices. 
 Cloning, Expression, and Purification.  The unknown amidohydrolase protein 
NYSGXRC-9236e from an unknown organism in an environmental sample of the 
Sargasso Sea was cloned, expressed and purified by SGX Pharmacueticals. Pa0142 was 
cloned, expressed and purified by Dr. Ricardo Marti-Arbona.  The E. coli proteins GDA 
(gi: 89109663), SsnA (gi: 89109659), and YahJ (gi: 89107197) were cloned, expressed 
and purified by Dr. Dao Feng Xiang. Pa 0134 was cloned by Jennifer Cummings.   
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Metal Content Analysis. Metal determination and quantification was performed 
with the Elan DRC II ICP-MS (inductively coupled plasma - mass spectrometer) from 
Perkin Elmer.  The analog detection mode is used with three averaged replicates per  
reading.  External calibration standards were prepared through the serial dilution of a 
single 10 ppm stock mixture of Zn, Cd, Co, Cu, Mn, Ni and Fe in 2% nitric acid, 
purchased from Inorganic Ventures Inc. Freshly prepared standards generally contained 
2, 20 and 200 ppb of all analytes in 1% Trace Select Nitric Acid from Fluka that is 
diluted in deionized water.  The isotopes of the analytes measured were 55Mn, 56Fe, 59Co, 
60Ni, 63Cu, 66Zn and 111Cd.  115In was used as an internal standard for Cd and 69Ga was 
used as an internal standard for all other analytes. The detection of 56Fe was determined 
using the dynamic reaction cell (DRC) mode, using NH3 gas to reduce the high level of 
interference from argon-oxide species. Protein samples were prepared for analysis by 
boiling in concentrated nitric acid for 30 min, followed by dilution with deionized water 
to 1% nitric acid.    
 Activity Screening. A coupled assay was used for the detection of ammonia 
release in the screening of the library of pteridines, purines and pyrimidines shown in 
Scheme 6.2. Most compounds were present at concentrations of 1 mM. The pteridine 
compounds and 8-oxoguanine were used at concentrations of 0.1 mM. This assay was 
modified from the protocol reported previously (79) and typically contained 7.4 mM α-
ketoglutarate, 0.4 mM NADH, 6 units of glutamate dehydrogenase in 100 mM HEPES 
pH 8.5. Mass spectrometry analysis for reaction verification was performed by the staff 
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at the Laboratory for Biological Mass Spectrometry (LBMS) in the Department of 
Chemistry at Texas A&M University. 
X-Ray Crystallography. The crystallization, X-ray diffraction, data collection and 
structure determination and refinement of NYSGXRC-9236e were performed by a group 
led by Dr. S. Almo of the Department of Biochemistry at the Albert Einstein College of 
Medicine. This structure was deposited in the protein data bank on 06/03/2009 and 
assigned the PDB code: 3HPA. The structures illustrated were created using the program 
WebLab Viewer Pro 4.0. 
 Data Analysis. The steady-state kinetic data were analyzed using Softmax Pro 
version 4.7.1. For the determination of the kinetic parameters; kcat, Km and kcat/Km, 
saturation curves were fit to equation 2.1 using the non-linear least squares fitting 
program SigmaPlot 10.0 where A is the substrate concentration, v is the velocity of the 
reaction, kcat is the turnover number and Km is the Michaelis constant.  
v/Et = kcatA/(Km + A)            (2.1) 
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Scheme 6.1: Continued. 
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RESULTS AND DISCUSSION 
 Metal Content Analysis. The enzymes Pa0134, Pa0142, E. coli GDA, E. coli 
SsnA and E. coli YahJ were evaluated for metal content by ICP-MS.  Due to limited 
protein availability and the observation of Zn in the crystal structure 3HPA, SGX-9236e 
was not evaluated for metal content by ICP MS. The Pa0142 preparation assayed in this 
manuscript was found to possess 0.25 molar equivalents of Zn and 0.05 equivalents of 
Fe. Pa0134 contains nearly a full metal content with 0.78 equivalents of Zn and 0.09 
equivalents of Fe. GDA from E. coli contained 1.0 equivalents of Zn2+, SsnA was found 
with 0.16 and 0.44 equivalents of Zn and Fe, respectively. 0.38 equivalents of Zn and 
0.50 equivalents of Fe were detected in each subunit of YahJ.  It is expected that each of 
these enzymes should require 1.0 equivalents of Zn2+, Fe2+ or Mn2+ for full catalytic 
activity. 
 Substrate Specificity The guanine/cytosine deaminase–like enzyme SGX-9236e 
and Pa0142 were both screened against a library of pteridines, purines and pyrimidines. 
Pa0142 was previously tested by Dr. Ricardo Marti-Arbona with a smaller library of 
compounds that lacked 8-oxoguanine. Both enzymes were found to have significant 
activity with isocytosine (1) and guanine (2). Additionally, a novel enzymatic activity 
was discovered. These enzymes were found to have significant 8-oxoguanine (3) 
deaminase activity, 8-oxoguanine (3) was the best substrate for these two enzymes by 
about one order of magnitude, yielding kcat/Km constants of 2.0 × 104 for Pa0142 and 2.7 
× 105 M-1s-1 for 9236e. It was not possible to determine the individual kinetic constants 
kcat and Km due to a lack of saturation seen under the limited solubility range of 8-
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oxoguanine (~140 µM). Substantial activity was also measured for the significantly 
more soluble isocytosine (1) and guanine (2) with both enzymes. No enzymatic activity 
was observed for the deamination of pterin (4). Inspection of the active compounds in 
Scheme 6.2 shows that isocytosine contains all of the minimal requirements for binding 
and catalysis while 8-oxoguanine possibly contains additional enzyme interacting 
groups, making it a more effective substrate.  Selected results from the activity screening 
are summarized in Table 6.1.  
 Pa0142 and SGX-9236e showed some activity against 1 mM ammeline ( 0.9 s-1 
and 6 s-1), as well as 5-azacytosine (0.1 s-1 and  0.2 s-1 ). Due to the greater degree of 
activity seen with the larger compounds, in addition to the genomic context supporting 
purine salvage, not pesticide metabolism, it is highly likely that the isocytosine, guanine, 
ammeline and 5-azacytosine activity observed is merely due to enzyme promiscuity 
resulting from the similarities in substrates. No significant activity (< 0.05 s-1) was 
observed for any of the other compounds in the screening library with SGX-9236e.  
 In light of the guanine deaminase activity measured here, the substrate specificity 
of the guanine deaminase (GDA) from E. coli was investigated for comparison. Of the 
four compounds shown in Scheme 6.2, Pa0134 (probable GDA) and E. coli GDA were 
found to only be active with guanine (2). Sequence evaluations of the genome of E. coli 
identified two genes, SsnA and YahJ, which possess similarities to deaminases such as 
ADE, CDA and GDA. However, no significant activities were found with any of the 
compounds tested.  
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Scheme 6.2 
        
(1) (2) (3) (4) 
    
Table 6.1: Kinetic Parameters for Substrates with 8-Oxoguanine Deaminase and Related Enzymesa. 
enzyme substrate kcat (s-1) Km (mM) kcat/Km (M-1 s-1) 
3HPA (SGX) 1 
2 
3 
4 
62 ± 2 
52 ± 3 
 
< 0.05 
1.6 ± 0.2 
1.0 ± 0.1 
 
 
(3.9 ± 0.5) × 104
(5.2 ± 0.6) × 104 
(2.7 ± 0.1) × 105 
 
Pa0142  1 
2 
3 
4 
3.9 ± 0.1 
3.3 ± 0.6 
 
< 0.005 
1.8 ± 0.1 
2.6 ± 0.6 
 
 
(2.2 ± 0.1) × 103
(1.3 ± 0.4) × 103 
(2.0 ± 0.1) × 104 
 
Pa0134 1 
2 
3 
4 
< 0.005 
21 ± 2 
< 0.005 
< 0.005 
 
0.50 ± 0.09 
 
 
 
(4.2 ± 0.9) × 104 
 
 
GuaD E. coli 1 
2 
3 
4 
< 0.005 
12.5 ± 0.2 
< 0.005 
< 0.005 
 
0.154 ± 0.008 
 
 
 
(8.1 ± 0.4) × 104 
 
 
SsnA E. coli 1 
2 
3 
4 
< 0.005 
< 0.005 
< 0.005 
< 0.005 
 
 
 
 
 
 
 
 
YahJ E. coli 1 
2 
3 
4 
< 0.005 
< 0.005 
< 0.005 
< 0.005 
 
 
 
 
 
 
 
aThe kinetic parameters were determined at pH 8.0, 30 ˚C in 75 mM HEPES, using the glutamate 
dehydrogenase coupled assay for ammonia release. 
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Novel Deamination of 8-Oxoguanine. In the canonical metabolism of guanine, 
GDA deaminates guanine, forming xanthine and ammonia. Xanthine oxidase then 
oxidizes xanthine, forming urate. This discovery of 8-oxoguanine deaminase introduces 
a never before described branch of purine metabolism. In this new path, guanine 
becomes oxidized by a reactive oxidizing species or possibly an unidentified enzyme. 
The resulting 8-oxoguanine is then deaminated by 8-oxoguanine deaminase. This 
pathway essentially bypasses the formation of xanthine as illustrated in Scheme 6.3. The 
verification of the 8-oxoguanine deamination by 8-oxoguanine deaminase has been 
confirmed by: monitoring the release of ammonia through the glutamate dehydrogenase 
coupled assay, comparing the UV spectra of the 8-oxoguanine, the 8-oxoguanine 
deamination product of 9236e, and authentic urate in 50 mM TRIS, pH 8.5 as shown in 
Figures 6.2 and 6.3. The differences in peak heights may be attributed to errors in 
concentration and background interferences from different impurities and buffers. The 
formation of urate from 8-oxoguanine was also verified by (-) ESI analysis showing a 
single, unambiguous peak at m/z = 167, which is consistent with that seen for the urate 
standard. Analysis of unreacted 8-oxoguanine showed a peak at m/z = 166, which is 
consistent with an 8-oxoguanine anion.  
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Figure 6.2: Absorbance spectra of 8-oxoguanine (A) and the urate product (B) formed by 9236e 8-
oxoguanine deaminase in 50 mM TRIS pH 8.5.  
 
 
Figure 6.3: Absorbance spectra of authentic urate (A) and the product of 8-oxoguanine deamination (B) 
formed by 9236e 8-oxoguanine deaminase in 50 mM TRIS pH 8.5.  
A 
B 
A 
B 
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 Crystal Structure of 8-Oxoguanine Deaminase. The NYSGXRC-9236e (8-
oxoguanine deaminase) crystal structure 3HPA was deposited to the PDB on June 03, 
2009 and was released 13 days later. The crystal structure shows a dimer as presented in 
Figure 6.4. One Zn atom is bound in each subunit and each subunit forms three distinct 
domains. The first ~ 80 residues on the N-terminus form a small, mainly beta roll. 
Starting on the beta strand just before the HxH Mα binding motif, the next 264 residues 
form the (β/α)8 TIM-barrel domain. This domain is common to all amidohydrolase 
enzymes and contains all of the metal binding residues and known catalytic residues. A 
ribbon diagram of the functional subunit with displayed active site residues is shown in 
Figure 6.5. At the C-terminus of the protein, the final 134 residues form an alpha-helix 
bundle, which participates in dimerization through coiled coil interactions with the 
adjacent subunit.  
 The Mα binding site is formed through coordinations by: His-93 (2.1 Å), His-95 
(2.1 Å) and His-259 (2.2 Å).  Asp-347 lies 2.7 Å away, which is a very long distance for 
a metal coordinating ligand. The organization of these ligands around the Zn ion forms 
an extremely distorted tetrahedral coordination. The three histidines (93, 95, and 259) 
each share 89-92˚ angles with each other through Zn. The His-259-Zn-Asp-347 bond 
angle is 167˚.  A water molecule is located 3.8 Å from the Zn and the water-Zn-His-93 
bond angle is 167˚. This water is presumably the hydrolytic water molecule and is H-
bonded to His-296 and Asp-347 at distances of 2.8 and 2.9 Å respectively. 
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Figure 6.4: Ribbon diagram of the 3HPA (8-oxoguanine deaminase) dimer.  
His-296 is 3.9 Å from the Zn ion and 171˚ opposite His-95. The arrangement of 
the active site residues with respect to the Zn2+ ion are presented in Figure 6.6.  In the 
crystal structure of cytosine deaminase with a reported Fe3+ (PDB: 1K6W), both the 
Asp-314 and water are closer to the metal ion (2.6 and 1.9 Å), and a less distorted 
tetrahedral coordination is observed (23).  
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Figure 6.5: Ribbon diagram of the 3HPA subunit displaying the active site residues and the bound Zn 
atom. Active site residues are shown with green carbon atoms. The bound Zn atom is shown as a gray 
sphere and the bound water molecule is shown as a small red sphere. 
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Figure 6.6: Active site of 3HPA showing interactions. Distances are presented in Å. 
Sequence Analysis. Evaluation of the existing crystal structure of human GDA 
with bound xanthine (PDB code: 2UZ9) and the sequences of other guanine deaminases 
enabled the identification of two key residues which should provide substrate specificity 
toward guanine. Sequence comparisons of the enzymes 9236e and Pa0142 with several 
guanine deaminases show that these similar enzymes differ at these key locations. The 
presence of these differences should be an indication of a different function.   
Arg-235 and Phe-236 appear to be providing substrate binding interactions and 
control over substrate specificity for guanine deaminase.  An illustration of these 
interactions is shown below in Figure 6.7. Arg-235 is shown to be participating in two 
hydrogen bonds with the xanthine product. Phe-236 appears to be providing 
hydrophobic interactions for C-8 of xanthine. This residue undoubtedly improves 
substrate fidelity through the steric blocking of larger compounds like pterins. Arg-235 
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and Phe-236 are conserved throughout guanine deaminases from organisms as diverse as 
E. coli, H. sapiens and P. aeruginosa. 
 
Figure 6.7: Human GDA-xanthine interactions from crystal structure PDB 2UZ9. Arg-235 is participating 
in multiple hydrogen bonds with the xanthine product. Phe-236 is interacting with C-8 of xanthine through 
hydrophobic interactions. 
Sequence alignments of proteins related to Pa0142 and 9236e as shown in Figure 
6.8 were used to verify that this key conserved Arg-Phe motif is missing in the group of 
enzymes related to Pa0142 and 9236e. Instead a Cys and a Ser have replaced the Arg 
and Phe residues.  This substitution is found in 216 bacterial genes which all share 35 % 
sequence identity or greater to Pa0142. A multiple sequence alignment was constructed 
for the sequences of Pa0142 and SGX-9236e with GDA from P. aeruginosa, H. sapiens 
and E. coli as well as the enzymes of unknown function, SsnA and YahJ. A dendrogram 
of the alignment is shown in Figure 6.9. The TIM barrel β-strands identified from the 
structure of 3HPA are highlighted in gray. Common deaminase active site residues are 
highlighted in red.  Conserved guanine binding residues are highlighted in green and the 
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proposed 8-oxoguanine deaminase specific residues are highlighted in blue. It is 
predicted that these enzymes containing the Cys-Ser motif at the end of β-strand 4 
should demonstrate 8-oxoguanine deaminase activity. The observation of this key active 
site difference provides support that Pa0142 and 9236e function as 8-oxoguanine 
deaminases and not guanine deaminases. 
9236e  - - - - m g a d r r g e r m n l e q h a g a r a p n t s s s r p k t l l v k h a d v l v t m d d t r 46 
Pa0142  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - m s r t w i r n p l a i f t a n 16 
Pa0134  m n d a v p a g n f v p p l i l h s d h g g s a m s s s a h r g r i l h f l g d p a k l g - d k a w 49 
Pa1521  - - - - - - - - - - - - - - - - - - - - - - m t r n a k a y r a a i l h s i a d p a e v g v e r s y 28 
Ec_GDA  - - - - - - - - - - - - - - - - - - m m s g e h t l k a v r g s f i d v t r t i d n p e e i a s a l 32 
Hs_GDA  - - - - - - - - - - - - - - - - - m c a a q m p p l a h i f r g t f v h s t w t c p m e v l r d h l 33 
Ec_SsnA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - m l i l k n v t a v q l h p 14 
Ec_YahJ - - - - - - - - - - - - - - - - - - - - - - - - - m k i t d p h y y l d n v l l e t g f d y e n g v 25 
                                                     
9236e  r e l r d a g l y i e d n r i v a v g - p s a e l p e t a - - d e v l d l r g h l v i p g l v n t h 93 
Pa0142  g l d a a g g l v v e d g r i v e l l g a g q q p a q p c - - a s q f d a s r h v v l p g l v n t h 64 
Pa0134  e y f e d g l l w i e h g h v r a l d h a t y l l p q l p a d l p l e e h p q r l l l p g f v d c h 99 
Pa1521  e y f e d g l l l v e d g k v a r l g d a e t l l g e i g - e v e v f e y r d a l i t p g f i d t h 77 
Ec_GDA  r f i e d g l l l i k q g k v e w f g e w e n g k h q i p d t i r v r d y r g k l i v p g f v d t h 82 
Hs_GDA  l g v s d s g k i v f l e e a s q q e k l a k e w c f k p - c e i r e l s h h e f f m p g l v d t h 82 
Ec_SsnA a k v q e g v d i a i e n d v i v a i g d a l t q r y p d - - a s f k e m h g r i v m p g i v c s h 62 
Ec_YahJ a v q t r t a r q t v e i q d g k i v a l r e n k l h p d a t l p h y d a g g k l m l p t t r d m h 75 
                                                     
9236e  h h m y q s l t r a v p a a q n - - a e l f g w l t n l - y k i w a h l t p e m i e v s t l t a m a 140 
Pa0142  h h f y q t l t r a w a p v v n - - q p l f p w l k t l - y p v w a r l t p e k l e l a t k v a l a 111 
Pa0134  v h y p q - - - l g v i a s y g - - t q l l d w l e t h t f p a e q r f a d a g y a a a q a e l f l 144 
Pa1521  i h f p q - - - t g m i a s y g - - e q l l d w l n t y t f p t e r q f g d q a h a d q v a e i f l 122 
Ec_GDA  i h y p q - - - s e m v g a y g - - e q l l e w l n k h t f p t e r r y e d l e y a r e m s a f f i 127 
Hs_GDA  i h a s q y s - - f a g s s i d - - l p l l e w l t k y t f p a e h r f q n i d f a e e v y t r v v 128 
Ec_SsnA n h f y s g l s r g i m a n i a p c p d f i s t l k n l w w r l d r a l d e e s l y y s g l i c s l 112 
Ec_YahJ i h l d k t f y g g p w r s l n - r p a g t t i q d m i k l e q k m l p e l q p y t q e r a e k l i 124 
I                                                      
9236e  e l l q s g c t t s s d h l y i y p n - - - g s r l d d s i g a a q r i g m r f h a s r g - - a m s 185 
Pa0142  e l l l s g c t t a a d h h y l f p g g - l e q a i d v q a g v v e e l g m r a m l t r g - - s m s 158 
Pa0134  d e l l r h g t t t a l v f g t v h a - - - - v s a e a f f q a a q k r r l r m i a g k v - - - - - 185 
Pa1521  q e l l r n g t t t a l v f g s v h r - - - - q s v e s l f e a a r r l d l r l i a g k v - - - - - 163 
Ec_GDA  k q l l r n g t t t a l v f g t v h p - - - - q s v d a l f e a a s h i n m r m i a g k v - - - - - 168 
Hs_GDA  r r t l k n g t t t a c y f a t i h t - - - - d s s l l l a d i t d k f g q r a f v g k v c - - - - 170 
Ec_SsnA e a i k s g c t s v i d h h a s p a y i g - - g s l s t l r d a f l k v g l r a m t c f e t - - - - 156 
Ec_YahJ d l l q s k g t t i a r s h c n i e p - - - - - - - - - v s g l k n l q n l q a v l a r r - - - - - 160 
                                                      
9236e  v g q r d g g l p p d s v v e r e p d i l r d t q r l i e t y h d e g r y a m l r v v v a p c s p - 234 
Pa0142  l g e k d g g l p p q q t v q e a e t i l a d s e r l i a r y h q r g d g a r v q i a l a p c s p - 207 
Pa0134  - - - l m d r n a p p a l c d t a a s g y a e s r a l i e r w h g n g - - - r l q y a v t p r f a p 229 
Pa1521  - - - m m d r n a p d y l t d t a e s s y r d s k a l i e r w h g q g - - - r l l y a v t p r f a p 207 
Ec_GDA  - - - m m d r n a p d y l l d t a e s s y h q s k e l i e r w h k n g - - - r l l y a i t p r f a p 212 
Hs_GDA  - - - m d l n d t f p e y k e t t e e s i k e t e r f v s e m l q k n - y s r v k p i v t p r f s - 215 
Ec_SsnA - - - t d r n n g i k e l q e g v e e n i r - f a r l i d e a k k a t s e p y l v e a h i g a h a p 202 
Ec_YahJ - - - q a g f e c e i v a f p q h g l l l s k s e p l m r e a m q a g - - - a h y v g g l d p t s v 204 
                                                     
Figure 6.8: Multiple sequence alignment of the 8-oxoguanine deaminases (9236e and Pa0142) with 
guanine deaminases (Pa0134, Pa1521 , Ec_GDA and Hs_GDA) and the proteins of unknown function 
SsnA and YahJ.   
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9236e  f s v s r d l m r d a a v l a r e y g v s l h t h l a e n v n d i a y s r e k f g - - m t p a e y a 282 
Pa0142  f s v t p e i m r a s a e v a a r h d v r l h t h l a e t l d e e d f c l q r f g - - l r t v d y l 255 
Pa0134  t s s p e q l a a a a r l l d e y p g v y l h t h l s e n l k e v a w v g e l f p q a q d y l d v y 279 
Pa1521  t s t a e q l d m a a r l l r e h p g v y l h t h l s e n l k e i e w v k e l f p e r s g y l d v y 257 
Ec_GDA  t s s p e q m a m a q r l k e e y p d t w v h t h l c e n k d e i a w v k s l y p d h d g y l d v y 262 
Hs_GDA  l s c s e t l m g e l g n i a k t r d l h i q s h i s e n r d e v e a v k n l y p s y k n y t s v y 265 
Ec_SsnA f t v p d a g l e m l r e a v k a t g r g l h i h a a e d l y d v s y s h h w y g - - k d l l a r l 250 
Ec_YahJ d g a m e k s l d t m f q i a l d y d k g v d i h l h e t t p a g v a a i n y m v e t v e k t p q l 254 
                                                      
9236e  e d l g w v g h d v w h a h c v q l d d a g i g l f a r t g t g v a h c p c s n m r l a s g i a p v 332 
Pa0142  d s v g w l g p r t w l a h g i h f n a e e i r r l g e a g t g i c h c p s s n m r l a s g i c p t 305 
Pa0134  h r a g l v g e r s v f a h g i h l s e r e c r c l a h k n a a l a h c p s s n l f i g s g l f d l 329 
Pa1521  d h h g l l g p r s v f a h g v h l c d g e c q r l a e t g s a v a f c p t s n l f l g s g l f d l 307 
Ec_GDA  h q y g l t g k n c v f a h c v h l e e k e w d r l s e t k s s i a f c p t s n l y l g s g l f n l 312 
Hs_GDA  d k n n l l t n k t v m a h g c y l s a e e l n v f h e r g a s i a h c p n s n l s l s s g f l n v 315 
Ec_SsnA a q f d l i d s k t l v a h g l y l s k d d i t l l n q r d a f l v h n a r s n m n n h v g y n h h 300 
Ec_YahJ k g k l t i s h a f a l a t - - - l n e q q v d e l a n r m v v q q i s i a s t v p i g t l h m p l 301 
                                                     
9236e  k k m r l a g v p v g l g v d g s a s n d g a q m v a e v r q a l l l q r v g f g p d a - - - m t a 379 
Pa0142  v e l e a a g a p i g l g v d g s a s n d a s n m i l e a r q a l y l q r l r y g a e r - - - i t p 352 
Pa0134  g r a q q y g i r v g i g s d v g g g - - - t s l s l l a n l a d a y k i q q l r g t s - - - l d p 373 
Pa1521  p k l e r y k v k v g l g t d v g a g - - - t s f s q l q s l n e a y k v m q l q g a r - - - l d p 351 
Ec_GDA  k k a w q k k v k v g m g t d i g a g - - - t t f n m l q t l n e a y k v l q l q g y r - - - l s a 356 
Hs_GDA  l e v l k h e v k i g l g t d v a g g y s y s m l d a i r r a v m v s n i l l i n k v n e k s l t l 365 
Ec_SsnA l s d i r n - - - l a l g t d g i g s - - - - d m f e e m k f a f f k h r d a g g p l w p - - - - d 339 
Ec_YahJ k q l h d k g v k v m t g t d s v i d h w s p y g l g d m l e k a n l y a q l y i r p n - - - - - - 345 
                                                      
9236e  r e a l e i a t l g g a k v l n r d d - i g a l k p g m a a d f a a f d l r q p l f a g a l h d p v 428 
Pa0142  e l a l g w a t r g s a r l l g r s d - i g e l a p g k q a d l a l f k l d e l r f s - g s h d p l 400 
Pa0134  f q a l y l a t l g g a r a l d l d g l v g n f l p g r e a d f v a l d l - - - - - - - - a a t p m 415 
Pa1521  f k s l y l a t l g g a r a l e l d d r i g s f a t s n e a d f v v l d y - - - - - - - - h a t p l 393 
Ec_GDA  y e a f y l a t l g g a k s l g l d d l i g n f l p g k e a d f v v m e p - - - - - - - - t a t p l 398 
Hs_GDA  k e v f r l a t l g g s q a l g l d g e i g n f e v g k e f d a i l i n p - - - - - - k a s d s p i 409 
Ec_SsnA s f a k a l t n g n e l m s r n f g a k f g l l e a g y k a d l t i c d y n s p t p l l a d n i a g 389 
Ec_YahJ - - - - - e q n l s r s l f l a t g d v l p l n e k g e r v w p k a q d d - - - - - - - - - - - a s 379 
                                                      
9236e  a a l v f c a p s q t a y t v v n g k v v v - r e g r l a t l d l p p v i e r h n a l a h a l v e a 477 
Pa0142  s a l l l c a a d r a d r v m v g g a w r v - v d g a v e g l d l a a l i a r h r a a a s a l i a g 449 
Pa0134  i a q r m e h a r g l a d t l f v l n t l g - d d r a v a e t w v m g e r r h v k g - - - - - - - - 456 
Pa1521  l s y r l s q a g s l a e r l f a l t i l g - d d r t v k e t f a a g r s v h r r d - - - - - - - - 434 
Ec_GDA  q q l r y d n s v s l v d k l f v m m t l g - d d r s i y r t y v d g r l v y e r n - - - - - - - - 439 
Hs_GDA  d l f y g d f f g d i s e a v i q k f l y l g d d r n i e e v y v g g k q v v p f s s s v - - - - - 454 
Ec_SsnA h i a f g m g s g s v h s v m v n g v m v y e d r q f n f d c d s i y a q a r k a a a s m w r r m d 439 
Ec_YahJ f v l v d a s c s a e a v a r i s p r t a t f h k g q l v w g s v a g - - - - - - - - - - - - - - - 414 
                                                      
9236e  a r -                                                479 
Pa0142  - - -                                                449 
Pa0134  - - -                                                456 
Pa1521  - - -                                                434 
Ec_GDA  - - -                                                439 
Hs_GDA  - - -                                                454 
Ec_SsnA a l a                                                442 
Ec_YahJ - - -                                                414 
  
                                                     
Figure 6.8: Continued. 
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Figure 6.9: Relationship dendrogram obtained from the sequence alignments of 8-oxoguanine 
deaminases, guanine deaminases and the proteins of unknown function, SsnA and YahJ.                              
The active sites of guanine deaminase (PDB: 2UZ9) and 9236e (PDB: 3HPA) 
have been super-imposed by tethering the metal coordinating Nε atoms and Zn atoms 
between the two structures. A view of this alignment is shown in Figure 6.10. The active 
site residues and xanthine molecule corresponding to 2UZ9 are shown with gray carbons 
and the residues corresponding to 3HPA are shown with green carbons. This structural 
approximation indicates that Cys-232 is reasonably positioned for recognition of the 8-
oxo group of the substrate 8-oxoguanine. 
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Figure 6.10: Active site overlay of 3HPA and 2UZ9 with bound xanthine. Gray carbons correspond to the 
guanine deaminase crystal structure. Green carbons correspond to the 8-oxoguanine deaminase crystal 
structure.   
Conclusions. Pa0142 and 9236e were found to be active with isocytosine, 
guanine and 8-oxoguanine. 8-oxoguanine was the best substrate for these two enzymes 
by an order of magnitude. Anything larger, such as pterin, yielded very poor activity. 
The genuine guanine deaminases tested possessed activity only with guanine. To the best 
of our knowledge, this is the first description of any enzyme involved in the deamination 
of 8-oxoguanine. 
 Sequence alignments of proteins related to Pa0142 and 9236e were used to 
identify two key conserved residues (Cys-232 and Ser-234 from 9236e) found in 217 
predominantly proteobacterial genes down to 35% identity, which should possess 8-
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oxoguanine deaminase activity.  The complete list of these enzymes is presented in 
Appendix A. This enzymatic function which is unique to proteobacteria and 
thermotogae, demonstrates the diverse catalytic repertoire utilized by bacteria. The 
closest homolog of 8-oxoguanine deaminase in E. coli is the protein of unknown 
function SsnA.  
It is interesting to note that the gene for 8-oxoguanine deaminase occurs 
predominantly in the microorganisms identified as α, β and γ-proteobacteria. Pathogenic 
microorganisms like many of these carrying an 8-oxoguanine deaminase may be 
especially prone to oxidative stress as a result of the environment inside the host in 
which they may live. It has been shown that all antibodies can efficiently kill bacteria 
through the catalysis of the addition of singlet oxygen to water, forming the transiently 
stable oxidant H2O3 in the process (135). This oxidant has been shown to be an effective 
reactive oxygen species that is capable of forming 8-oxoguanine (136).  It appears that 
these bacteria utilize a novel pathway in the metabolism of 8-oxoguanine, converting it 
into uric acid and ammonia, which can be further metabolized via formation of allantoin 
upon oxidation with uricase.   
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CHAPTER VII 
DISCOVERY OF ISOXANTHOPTERIN DEAMINASE 
Pteridines, such as tetrahydrofolate (THF) and tetrahydrobiopterin, are vital 
cofactors for various cellular functions such as single carbon transfers and activation of 
oxygen. Folates, required in the diet of animals, can be synthesized by bacteria, fungi 
and plants (137). It is known that folates are easily decomposed to pterin-6-carboxylate 
and para-amino-benzoic acid glutamate upon exposure to ultraviolet radiation (138).  
In the shallow sea water of coral reef, significant concentrations of the decomposition 
products of folates and pteridines have been observed. It has also been determined that 
6-biopterin is extremely sensitive to solar radiation, producing pterin-6-carboxylate as 
the main product and further radiation of pterin-6-carboxylate has resulted in the 
observation of pterin (139).  
 In 1949 it was determined that pterin is readily oxidized to isoxanthopterin by a 
xanthine oxidase found in cream (140). The presence of an isoxanthopterin deaminase in 
the proteobacteria Alcaligenes faecalis was first observed by Walter McNutt in 1963. 
Cells of this organism were found to utilize isoxanthopterin as a sole source of carbon 
and nitrogen. McNutt was able to monitor the disappearance of isoxanthopterin and 
concomitant appearance of 7-oxylumazine in the cellular extracts (141). Another 
isoxanthopterin deaminase was observed in extracts of adult and larval silkworms (142). 
Recent estimates suggest that folate in plants can break down at 10% per day and 
evidence is growing for a folate salvage pathway in plants (137). The identification of 
the details of the complex metabolic pathways involving the salvage pathways of 
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pteridines have remained elusive, partly due to the very small amounts that are found in 
natural sources (143).  
This study describes the discovery of function of two bacterial enzymes involved 
in pteridine deamination that are related in sequence to guanine deaminase and the newly 
identified 8-oxoguanine deaminase. The two enzymes of this study are the New York 
SGX Research Center for Structural Genomic protein targets: NYSGXRC-9236b and 
9339a. The X-ray crystal structure of 9339a has been solved and assigned the PDB code: 
2PAJ. These two proteins were isolated from environmental samples of the Sargasso Sea 
under the Global Ocean Sampling Project. The closest homolog of 9339a (88% 
identical) is Bxe_A2016 from Burkholderia xenovorans LB400 and is annotated as an 
ATZ/TRZ-like amidohydrolase. The closest homolog of 9236b (95% identical) is 
Bphyt_7136 from Burkholderia phytofirmans PsJN. This protein is also annotated as an 
ATZ/TRZ-like amidohydrolase. 
The sequence-based chlorohydrolase annotation of these two genes is 
misleading, because the results of a BLAST search of the NCBI protein database 
indicates that these genes show high similarity to various deaminases such as 8-
oxoguanine deaminase, guanine deaminase and SAH deaminase. The presence of 
various transport proteins such as xanthine/uracil permease found in genomic context 
evaluations like that shown in Figure 7.1 can be used to implicate the involvement of 
these unknown genes in some sort of salvage pathway for aromatic heterocycles.  The 
oxidases nearby could also be participating in the catabolism of such compounds. These 
observations led us to the hypothesis that these “chlorohydrolases” were somehow 
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involved in the deamination of aromatic compounds. Subsequent screening of these 
enzymes against select aromatic compounds containing primary amines enabled the 
identification and characterization of the genes responsible for deaminating 
isoxanthopterin and pterin-6-carboxylate. 
 
Figure 7.1: Genomic context tree of NYSGXRC-9339a (orange, COG-SsnA) obtained from 
microbesonline.org. Nearby are decarboxylase-like proteins (gray, COG-UbiD) and (lavender, UbiX), 
possible oxidoreductase/dioxygenases proteins (blue, COG-PcbC), (dark blue,COG-FabG), (indigo,COG-
HhmP, COG-VanB) and (light blue,COG-HcaE), possible hydratases ( red, COG2159), a deaminase like 
protein (orange, COG-SsnA), xanthine/uracil permease (dark red COG-UraA), and the 
nitrate/sulfonate/carbonate transporter subunits (pastel blue, COG-TauA; teal, TauB and sky,TauC).  
MATERIALS AND METHODS 
 Materials. All chemicals and buffers were obtained from Sigma-Aldrich unless 
specified otherwise. 8-Oxoguanine was purchased from Toronto Research Chemicals 
Inc. Kinetic assays were performed in a 96-well plate with a SPECTRAmax 384 Plus 
spectrophotometer from Molecular Devices. 
 Cloning, Expression, Purification and X-ray Crystallography. The environmental 
sample proteins SGX 9339a (gi: 44585104) PDB: 2PAJ; and SGX 9236b (gi: 
44611670), were cloned, expressed and purified by NYSGXRC and assigned the target 
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labels SGX-9339a and SGX-9236b. The crystallization, X-ray diffraction, data 
collection, structure determination and refinement of SGX-9339a were perfomed by a 
group led by Dr. S. Swaminathan of the Biology Department at Brookhaven National 
Laboratory. This structure was assigned the PDB code 2PAJ. 
 Measurement of Enzymatic Activity. Initial screening assays were performed in a 
96-well UV/Vis microplate at 30 °C, using a coupled assay for the detection of ammonia 
release against a library of pteridines, purines and pyrimidines. Most compounds were 
utilized at a concentration of 1.0 mM, but the pteridine compounds and 8-oxoguanine 
were used at a concentration of 0.1 mM. The coupling system was modified from the 
protocol reported previously (79)  and typically contained 7.4 mM α-ketoglutarate, 0.4 
mM NADH, 6 units of glutamate dehydrogenase in 100mM Hepes, pH 8.5. For direct 
assays, average extinction coefficients for the deamination of isoxanthopterin (Δε350 nm = 
7654 M-1 cm-1) and pterin-6-carboxylate (Δε264 nm = 8080 M-1 cm-1) were determined 
from slopes of the difference in absorbance, measured before and after total enzymatic 
deamination, over a range of substrate concentrations from 0.004-0.116 mM. Mass 
spectrometry analysis for reaction verification was performed by the staff at the 
Laboratory for Biological Mass Spectrometry (LBMS) in the Department of Chemistry 
at Texas A&M University. 
 Data Analysis. Sequence alignments were created using the ClustalW program at 
http://align.genome.jp/sit-bin/clustalw. Alignments were formated using the Multiple 
Align Show program at http://www.bioinformatics.org/sms/. Steady-state kinetic data 
were analyzed using the program Softmax Pro version 4.7.1. For the determination of 
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the kinetic parameters: kcat, Km and kcat/Km; saturation curves were fit with equation 2.1 
using the non-linear least squares fitting program SigmaPlot 10.0 where A is the 
substrate concentration, v is the velocity of the reaction, kcat is the turnover number and 
Km is the Michaelis constant.   
ݒ/ܧݐ ൌ  ݇catܣ/ሺܭm  ൅  ܣሻ                                                                                           (2.1) 
RESULTS  
 Crystal Structure. The X-ray structure for 9339a was solved to a resolution of 2.7 
Å and posted to the PDB on March 27, 2007.  The structure of 9339a was solved as a 
monomer and assigned the pdb code 2PAJ. A ribbon diagram of 2PAJ is shown in 
Figure 7.2. The alpha helices are displayed in red and the beta strands are shown in teal 
blue. The bound zinc cation is represented by the gray sphere and the bound water 
molecule is presented as a smaller red sphere. The active site residues are displayed with 
green carbons, blue nitrogens and red oxygen atoms.  
2PAJ possesses 3 distinct domains. At the N-terminus, ~70 residues form a small 
predominantly beta structure that is homologous to the N-terminal domain found in the 
urease subunit c (144). The next ~276 residues form a (β/α)8 TIM-barrel domain 
containing much of the same catalytic residues and metal binding ligands that have been 
shown to be important for cytosine deaminase (23), and adenosine deaminase (17). This 
domain of 2PAJ contains one zinc atom in the active site which is coordinated by His-76 
(2.29 Å), His-78 (2.05 Å), His-248 (2.05 Å) and Asp-336 (2.03 Å), in a distorted 
tetrahedral coordination scheme.  A water molecule is found nearby at 2.66 Å from the 
Zn, as well as His-285 which is 2.85 Å away. The active site interactions and distances 
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are shown in Figure 7.3. Structural data for a section of the protein containing Glu-251 
(a landmark residue for deaminases) to Tyr-263 is missing.  At the C-terminus is a 
mainly alpha helix domain of the up-down architecture that is composed of the final 156 
residues including the terminal (His)6 purification tag.  
 
Figure 7.2: Ribbon diagram of the 2PAJ monomer displaying the active site residues and the bound Zn 
atom. Active site residues are shown with green carbon atoms. The bound Zn atom is shown as a gray 
sphere and the bound water molecule is shown as a small red sphere. 
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Figure7.3: Active site interactions of 2PAJ. Distances are listed in (Å). 
 A structural alignment of the active sites of human guanine deaminase (PDB: 
2UZ9) and 9339a (PDB: 2PAJ), was constructed by tethering the metal atoms and the 
homologous metal-coordinating nitrogen atoms of the three histidines between the two 
structures and superimposing the two molecules, as shown in Figure 7.4. Based on this 
active site alignment, it can be seen that in 2PAJ, the Arg-Phe dyad, implicated in 
substrate binding of guanine deaminases, has been replaced for a novel Thr-Thr motif. 
The water molecule present in 2PAJ is found to occupy a position near the carbonyl 
carbon of the product xanthine. There are noticeable differences in the positioning of the 
histidines from β-strand 6 and the aspartates from strand 8. 
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Figure 7.4: Active site overlay of  2PAJ (green carbons) and  2UZ9 with bound xanthine (gray carbons). 
Residue numbering corresponds to 2PAJ.  
 
Substrate Specificity.  SGX 9339a (gi: 44585104) with the X-ray crystal structure 
(PDB: 2PAJ), and SGX 9236b (gi: 44611670) were tested for ammonia release against  
the library of pteridines, purines and pyrimidines shown in Scheme 7.1.  From those 
initial activity screens with 5 µg/mL (~100 nM) of deaminase in each assay, significant 
ammonia release was detected for both 9339a and 9236b with isoxanthopterin and 
pterin-6-carboxylate as the substrates. The reactions catalyzed by these enzymes are 
shown in Scheme 7.2. Significant rates of ammonia release were not detected for any of 
the other compounds. With the enzyme concentration present in these initial assay 
conditions, activity was determined to be significant if the relative rate of ammonia 
release was greater than 0.1 s-1.  
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Scheme 7.1: Compounds utilized in the initial activity screens. 
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Scheme 7.1: Continued. 
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Scheme 7.2: Reactions catalyzed by 9339a and 9236b. 
  
Absorbance spectra of isoxanthopterin (1) and the product of its deamination by 
9339a, 2,4,7-pteridinetrione (7-oxylumazine) (2), are shown in Figure 7.5.  In 50 mM 
TRIS at pH 8.5, the UV spectrum of isoxanthopterin has two peaks. The major peak has 
a λmax at 333 nm and the smaller peak has a λmax at 281 nm. The spectrum for the 7-
oxylumazine (2) product has two peaks with λmax at 326 nm and 274 nm. Kinetic 
parameters were determined for both enzymes with isoxanthopterin as the substrate 
using the direct assay at 350 nm with an extinction coefficient of 7650 M-1 cm-1. 9339a 
has a kcat of 1.0 s-1, a Km of 8 µM and a kcat/Km of 1.3 × 105 M-1 s-1 with isoxanthopterin 
(1). 9236b has a kcat of 0.58 s-1, a Km of 24 µM and a kcat/Km of 2.4 × 104 M-1 s-1 with 
isoxanthopterin.  The enzymatic deamination of isoxanthopterin by 9339a, producing 7-
oxylumazine was verified by –ESI MS where a peak of m/z = 178 was observed for 
isoxanthopterin. This changed to a strong peak of m/z = 179 after addition of enzyme. 
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For the deamination of pterin-6-carboxylate a peak of m/z = 206 was observed. Upon 
addition of enzyme, a peak of m/z = 207 was observed.  
 
Figure 7.5: Spectra of isoxanthopterin (1) and 2,4,7-trioxopteridine (2) produced by 9339a in 50 mM 
TRIS, pH 8.5. Additional information is provided in the text. 
 
Pterin-6-carboxylate (3) was the second best substrate tested for both 9339a and 
9236b. Absorbance spectra of 3 and the deamination product, 2,4-dioxo-pteridine-6-
carboxylate (4) are shown in Figure 7.6. The spectrum of 3 has two major peaks with 
λmax values of 264 nm and 361 nm. There are two distinct peaks in the spectrum of 4 at 
λmax values of 347 and 287 nm. Direct assays, measured at a wavelength of 264 nm with 
an extinction coefficient of 8080 M-1 cm-1,  yielded a kcat of 1.01 s-1, a Km of 0.14 mM 
and a kcat/Km of 7.2 × 104 M-1 s-1 for 9339a with 3. When tested with 3, 9236b displayed 
a kcat of 0.27 s-1, a Km of 0.09 mM and a kcat/Km of 3.1 × 103 M-1 s-1.  The kinetic 
parameters obtained for 9339a and 9236b with compounds 1 and 3 are summarized in 
Table 7.1.   
 
(1) 
(2) 
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Figure 7.6: Spectra of pterin-6-carboxylate (3) and 2,4-dioxopteridine-6-carboxylate (4), produced by 
9339a in 50 mM TRIS, pH 8.5. Additional information is provided in the text. 
Table 7.1: Kinetic Parameters for Isoxanthopterin and Pterin-6-carboxylate Deamination with 9339a and 
9236b. 
enzyme substrate kcat (s-1) Km mM kcat/Km (M-1 s-1) 
9339a isoxanthopterin 1.05 ± 0.03 0.008 ± 0.001 (1.3 ± 0.2) × 105 
 pterin-6-carboxylate 1.01 ± 0.10 0.14 ± 0.02 (7.2 ± 0.2) × 103 
9236b isoxanthopterin 0.91 ± 0.06 0.05 ± 0.007 (1.8 ± 0.2) × 104 
 pterin-6-carboxylate 0.28 ± 0.05 0.09 ± 0.03 (3.1 ± 0.4) × 103 
 
Sequence Analysis. The amino acid sequences of the two isoxanthopterin 
deaminases NYSGXRC-9339a and 9236b were aligned to the related 8-oxoguanine 
deaminases Pa0142 and NYSGXRC-9236e as well as the characterized guanine 
deaminases from H. sapiens and E. coli. The sequence alignment is shown in Figure 7.7. 
The eight TIM-barrel β-strands were identified from an analysis of the crystal structure 
of 9339a (PDB: 2PAJ) and are highlighted in gray. Conserved metal binding and 
catalytic residues which are currently observed in all AHS deaminases are highlighted in 
red. Conserved substrate binding residues found in guanine deaminases are highlighted 
(4) 
(3) 
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in green.  The residues which have been implicated in the previous chapter of this work 
for the substrate binding of 8-oxoguanine deaminase are highlighted in blue. The 
proposed substrate binding residues specific for the binding of isoxanthopterin and 
pterin-6-carboxylate are highlighted in yellow. 
9339a - - - - - - - - - - - - - - - - - - - - - m t t y d t q p s t l i r n a a a i m t g g r g t a d d p s - 30 
9236b - - - - - - - - - - - - - - - - - - - - - - - - - m q t e a l l i k n p a a v m s g l r g - - - d a a - 23 
9236e - m g a d r r g e r m n l e q h a g a r a p n t s s s r p k t l l v k h a d v l v t m d d t r - r e l - 49 
Pa0142 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - m s r t w i r n p l a i f t a n - g l d - 19 
Ec_GDA - - - - - - - - - - - - - - - - m m s g e h t l k a v r g s f i d v t r t i d n p e e i a s a l r f i - 35 
Hs_GDA - - - - - - - - - - - - - - m c a a q m p p l a h i f r g t f v h s t w t c p m e v l r d h l l g v s - 37 
                                                      
9339a - r v p g p d i r i v g d t i d a i g - a l a p r p g e - - t i v d a t d c v i y p a w v n t h h h l - 77 
9236b - r a g q v d l r i r n g r i e a i a p n l e p r a d e - - r v i d a r s c v v y p g w v n t h h h l - 71 
9236e - r d a g l y i e d n r i v a v g - p s a e l p e t a d - - e v l d l r g h l v i p g l v n t h h h m - 96 
Pa0142 - a a g g l v v e d g r i v e l l g a g q q p a q p c a - - s q f d a s r h v v l p g l v n t h h h f - 67 
Ec_GDA - e d g l l l i k q g k v e w f g e w e n g k h q i p d t i r v r d y r g k l i v p g f v d t h i h y - 85 
Hs_GDA - d s g k i v f l e e a s q q e k l a k e w c f k p c e - - i r e l s h h e f f m p g l v d t h i h a - 85 
                                                      
9339a - f q s l l k g e p a g l d a t l t p w l a a t p y r f r a l f d e r r f r l a a r i g l i e l a r s - 127 
9236b - f q n l l k a v p s g i n a d l q e w l a a v p y p r l a r f t p e l a r v a a r l g m a e l l l s - 121 
9236e - y q s l t r a v p a a q n a e l f g w l t n l - y k i w a h l t p e m i e v s t l t a m a e l l q s - 145 
Pa0142 - y q t l t r a w a p v v n q p l f p w l k t l - y p v w a r l t p e k l e l a t k v a l a e l l l s - 116 
Ec_GDA - p q s e m v g - - - a y g e q l l e w l n k h t f p t e r r y e d l e y a r e m s a f f i k q l l r - 132 
Hs_GDA - s q y s f a g - - s s i d l p l l e w l t k y t f p a e h r f q n i d f a e e v y t r v v r r t l k - 133 
                                                      
9339a - g c a t v a d h n y v y y p g m p f d s s a i l f e e a e k l g l r f v l l r g g a t q t r - q l e - 176 
9236b - g v t t c a d h h y l y h a d g n t e t g d l l f d e a a e f g m r f v l c r g g a l q a a g d h p - 171 
9236e - g c t t s s d h l y i y p n - - - g s r l d d s i g a a q r i g m r f h a s r g - - a m s v g q r d - 190 
Pa0142 - g c t t a a d h h y l f p g g l - e q a i d v q a g v v e e l g m r a m l t r g - - s m s l g e k d - 163 
Ec_GDA - n g t t t a l v f g t v h p - - - - q s v d a l f e a a s h i n m r m i a g k v - - - - - - - - m m - 170 
Hs_GDA - n g t t t a c y f a t i h t - - - - d s s l l l a d i t d k f g q r a f v g k v - - - - - - - c m d - 172 
                                                      
9339a - a d l p t a l r p e t l d a y v a d i e r l a a r y h d a s p r a m r r v v m a p t t v l y s i s p - 226 
9236b - g f s k v a l k p e t l d q m l a d i e r l k s r y h d a g d a s m r r v v v a p t t p t f s l p p - 221 
9236e - g g l p p d s v v e r e p d i l r d t q r l i e t y h d e g r y a m l r v v v a p c s p - f s v s r - 239 
Pa0142 - g g l p p q q t v q e a e t i l a d s e r l i a r y h q r g d g a r v q i a l a p c s p - f s v t p - 212 
Ec_GDA - d r n a p d y l l d t a e s s y h q s k e l i e r w h k n g - - - r l l y a i t p r f a p t s s p e - 217 
Hs_GDA - l n d t f p e y k e t t e e s i k e t e r f v s e m l q k n - y s r v k p i v t p r f s - l s c s e - 220 
                                                      
9339a - r e m r e t a a v a r r l g l r m h s h l s e t v g y q d s a y s m y g k s p - - v a f c g e h d w - 274 
9236b - e l l p e v a r a a r r m g l r l h t h l s e t t r y a d f c k e r f n k l p - - v e f v a d h e w - 269 
9236e - d l m r d a a v l a r e y g v s l h t h l a e n v n d i a y s r e k f g m t p - - a e y a e d l g w - 287 
Pa0142 - e i m r a s a e v a a r h d v r l h t h l a e t l d e e d f c l q r f g l r t - - v d y l d s v g w - 260 
Ec_GDA - q m a m a q r l k e e y p d t w v h t h l c e n k d e i a w v k s l y p d h d g y l d v y h q y g l - 267 
Hs_GDA - t l m g e l g n i a k t r d l h i q s h i s e n r d e v e a v k n l y p s y k n y t s v y d k n n l - 270 
                                                      
9339a - l g s d v w y a h l v k v d a d e i a l l a q t g t g v a h c p q s n g r l g s g i c p v r e m a d - 324 
9236b - l g p d v w f a h l v h l q p s e i a m l a e t g s g c s h c p v s n a r l g s g i a p a p q m a a - 319 
9236e - v g h d v w h a h c v q l d d a g i g l f a r t g t g v a h c p c s n m r l a s g i a p v k k m r l - 337 
Pa0142 - l g p r t w l a h g i h f n a e e i r r l g e a g t g i c h c p s s n m r l a s g i c p t v e l e a - 310 
Ec_GDA - t g k n c v f a h c v h l e e k e w d r l s e t k s s i a f c p t s n l y l g s g l f n l k k a w q - 317 
Hs_GDA - l t n k t v m a h g c y l s a e e l n v f h e r g a s i a h c p n s n l s l s s g f l n v l e v l k - 320 
Figure 7.7: Sequence alignment of two isoxanthopterin deaminases (9339a and 9236b), two 8-oxoguanine 
deaminases (Pa0142 and 9236e) and two guanine deaminases (Ec_GDA and Hs_GDA). Additional details 
are provided in the text. 
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9339a - a g v p v s i g v d g a a s n e a a d m i s e v h m t w l a q r a r l g m l a q p a y r g g s f e g - 374 
9236b - a g v p m s l a v d g v a s n e s g s m t n e a h f a w l v h r a a q - - - - - - - - - - - - - - - - 354 
9236e - a g v p v g l g v d g s a s n d g a q m v a e v r q a l l l q r v g f - - - - - - - - - - - - - - - - 372 
Pa0142 - a g a p i g l g v d g s a s n d a s n m i l e a r q a l y l q r l r y - - - - - - - - - - - - - - - - 345 
Ec_GDA - k k v k v g m g t d i g a g t t f n m l q t l n e a y k v l q l q g y - - - - - - - - - - - - - - - - 352 
Hs_GDA - h e v k i g l g t d v a g g y s y s m l d a i r r a v m v s n i l l i n - - - - - - - - - - - - k v - 358 
                                     
9339a - g a g a a s i a e v i h w g t a g g a r v m g l d e - v g k v a v g y a a d i a v y r l d d p r y f - 423 
9236b - g a s a t t v e e v i h w g s a g g a g v l g l d a - v g t l e v g k a a d f v l y d v s d l r f n - 403 
9236e - g p d a m t a r e a l e i a t l g g a k v l n r d d - i g a l k p g m a a d f a a f d l r q p l f a - 421 
Pa0142 - g a e r i t p e l a l g w a t r g s a r l l g r s d - i g e l a p g k q a d l a l f k l d e l r f s - 394 
Ec_GDA - - - - r l s a y e a f y l a t l g g a k s l g l d d l i g n f l p g k e a d f v v m e p t a t p l q - 399 
Hs_GDA - n e k s l t l k e v f r l a t l g g s q a l g l d g e i g n f e v g k e f d a i l i n p k a s d s p - 408 
                                                      
9339a - g l h d p a i g p v a s g g r p s v m a l f s a g k r v v v d d l i e g v d i k e l g g e a r r v v - 473 
9236b - g f h d v a v a p v t a g e p a r v r y n v v n g r v v v d n g v i p g l d l e r l r h e a a e g v - 453 
9236e - g a l h d p v a a l v f c a p s q t a y t v v n g k v v v r e g r l a t l d l p p v i e r h n a l a - 471 
Pa0142 - - g s h d p l s a l l l c a a d r a d r v m v g g a w r v v d g a v e g l d l a a l i a r h r a a a - 443 
Ec_GDA - q l r y d n s v s l v d - - - k l f v m m t l g d d r s i y r t y v d g r l v y e r n - - - - - - - - 439 
Hs_GDA - i d l f y g d f f g d i s e a v i q k f l y l g d d r n i e e v y v g g k q v v p f s s s v - - - - - 454 
                                                      
9339a - r e l l r e v v v                                          - 482 
9236b - k q l l a d - - -                                          - 459 
9236e - h a l v e a a r -                                          - 479 
Pa0142 - s a l i a g - - -                                          - 449 
Ec_GDA - - - - - - - - - -                                          - 439 
Hs_GDA - - - - - - - - - -                                          - 454 
 
Figure 7.7: Continued. 
DISCUSSION 
Sequence comparisons with guanine deaminases and 8-oxoguanine deaminases 
were used to differentiate a small group of enzymes which might catalyze a new 
reaction. Guanine deaminases utilize an Arg-Phe dyad for the recognition of guanine, as 
observed in the crystal structure of human guanine deaminase with bound xanthine 
(PDB: 2UZ9). It was also noted in the previous chapter of this work that 8-oxoguanine 
deaminases appear to utilize a Cys-Ser motif for recognition of 8-oxoguanine. In this 
small group of very similar enzymes, two threonine residues appear to form a Thr-Thr 
substrate recognition dyad in the same spot, as shown from the active site overlay with 
guanine deaminase and with the sequence alignments shown above.   
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The conservation of the Thr-Thr substrate recognition dyad was used to identify 
other proteins which may be performing a novel deaminase activity. Two of these 
enzymes were then tested for the deamination of a variety of pteridines, purines and 
pyrimidines.  The high levels of activities obtained for the deamination of 
isoxanthopterin (kcat/Km  > 104 M-1 s-1) provide strong support that these enzymes 
function as isoxanthopterin deaminases in vivo. The moderate activity seen for pterin-6-
carboxylate for both enzymes (~ 103 M-1 s-1) may still be reasonably sufficient for 
biological relevance.  
BLAST searches of protein sequences in the NCBI database were then used to 
identify the organisms containing quite similar genes. From this search, it was 
discovered that only a specialized group of 23 sequenced α, β and γ-proteobacterial and 
enterobacterial organisms share this gene as determined by the conservation of the Thr-
Thr motif. The complete list of those genes and organisms are listed in Appendix B. The 
novel isoxanthopterin/pterin-6-carboxylate deaminases all share a sequence identity of 
greater than 41% and are predicted to participate in the deamination of isoxanthopterin 
within these organisms. Included with these 23 genes are 4 outliers which share a 
threonine-serine dyad at this position.  These genes are: Mmwyl1_4101 (GI: 152998097) 
from Marinomonas sp. MWYL1; HMPREF0023_2011 (GI: 226953181) from 
Acinetobacter sp. ATCC 27244; PputW619_2587 (GI: 170721762) from Pseudomonas 
putida W619; and PP_3209 (GI: 26989928) from Pseudomonas putida KT2440. It 
appears that the Thr-Ser dyad could be an evolutionary intermediate between the Cys-
Ser dyad of the 8-oxoguanine deaminases and the Thr-Thr dyad of the isoxanthopterin 
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deaminases. It is not yet clear whether this small difference will have significant 
implications for substrate specificity.  
Both isoxanthopterin, and 2,4,7-trioxopteridine have been isolated from multiple 
biological sources such as: zebrafish embryos (145), the firebug Pyrrhocoris apterus 
(146), royal jelly and caviar (147) and in silkworm where isoxanthopterin activity was 
also measured (142).  6-Carboxypterin is a common product of folate and biopterin 
photo-oxidation, and  2,4-dioxo-pteridine-6-carboxylate production has been observed 
from Pseudomonas fluorescens UK1 when grown on folate (148). Additonally, a 
purified extract of Pseudomonas sp. Fo8 was found to deaminate pterin, 6-
hydroxymethylpterin and pterin-6-carboxylate , while strain Fo1 was found to yield less 
than 1% of that activity. (149).  
Noting the isoxanthopterin deaminase activity observed in extracts of Alcaligenes 
faecalis (141), a search of that genome was performed in pursuit of the specific 
deaminase which may be similar to 9339a and 9236b. Unfortunately, it appears that the 
genome of A. faecalis has not yet been fully sequenced. Of the genes sequenced for A. 
faecalis, there are none similar to the sequence of SGX-9339a or 9236b. Additional 
enzymes implicated in the degradation of isoxanthopterin by A. faecalis, are an unknown 
pterin-6-oxidase and a 2,4,6,7-tetraoxypteridine isomerase. These enzymes were found 
to catalyze the production of xanthine-8-carboxylate from isoxanthopterin (141, 150). 
An inducible xanthine-8-carboxylate decarboxylase of A. faecalis was found to complete  
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the degradation of pterines via entry into purine metabolism through the production of 
xanthine. 
 The proteins of unknown organism, NYSGXRC-9339a and 9236b are found to 
be most similar to the genes; Bxe_A2016 from Burkholderia xenovorans LB400 and 
Bphyt_7136 from Burkholderia phytofirmans PsJN.  They are the first proteins of 
known sequence found to possess significant deaminase activities against the pteridine 
compounds isoxanthopterin and pterin-6-carboxylate. These enzymes utilize a unique 
substrate binding motif that is capable of differentiating isoxanthopterin and pterin 6-
carboxylate from 8-oxoguanine and guanine. While these substrate specificity profiles 
are somewhat different than those seen for the extracts P. fluorescens UK1, 
Pseudomonas sp. Fo8 and Fo1, they are consistent the activity seen for Alcaligenes 
faecalis. Overall, these results demonstrate that the folate degradation pathways in 
bacteria such as Burkholderia and Pseudomonas are extremely diverse and that there are 
many new enzymes to discover in this remarkable pathway.  
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Based on the results of this study, a bacterial folate degradation pathway is 
proposed in Scheme 7.3. Pterin-containing molecules such as folate and biopterin, can 
easily decompose in the presence of solar radiation, forming pterin-6-carboxylate. 
Pterin-6-carboxylate may then become decarboxylated by some unknown decarboxylase 
or solar radiation. Another possible route would be the deamination of pterin-6-
carboxylate by the enzymes homologous to 9339a or 9236b.  The resulting pterin or 2,4-
dioxopteridine is then oxidized at carbon 7 by xanthine oxidase, forming isoxanthopterin 
or 7-oxylumazine. 9339a and 9236b then deaminate isoxanthopterin, forming 7-
oxylumazine. This product ultimately becomes oxidized to 2,4,6,7-tetraoxypteridine, by 
an unknown oxidase such as one of the oxidases seen in the genomic context figure 
shown previously. Tetraoxypteridine then undergoes isomerization to xanthine -8-
carboxylate and is finally decarboxylated to xanthine. A look back at the genomic 
context surrounding 9339a and 9236b shows several probable decarboxylases which 
may be performing this role, or the initial decarboxylation of pterin-6-carboxylate. 
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Scheme 7.3: Bacterial Folate Degradation Pathway 
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CHAPTER VIII 
 
SUMMARY AND CONCLUSIONS 
 
The amidohydrolase superfamily is a remarkable set of evolutionarily and 
mechanistically related enzymes.  Members of this superfamily catalyze a broad array of 
reactions including: hydrations, deaminations, deiminations, dehalogenations, 
decarboxylations, cyclizations and hydrolysis of heterocycles, peptides, amides, lactones 
and phosphtate esters. A result of the different enzymes sharing a common ancestral 
precursor could be the conservation of  similar mechanisms for the catalysis of the 
various reactions. 
Typically, amidohydrolases utilize one or two divalent transition metal cations 
for the activation of a water molecule and or substrate. Metals found in these enzymes 
may be Mn2+, Fe2+, Co2+, Ni2+, and Zn2+. Activities have also been observed with 
enzymes prepared with added Cd2+. Recent crystal structures have identified 
amidohydrolases which contain three or four active-site metals. The metal binding sites 
are named Mα, Mβ, Mγ and Mδ. Variations in the metal content and metal binding ligands 
among structurally characterized AHS members, results in the identification of 16 
distinct types of metal binding active sites. Of these different active sites, five are α/β-
binuclear, 3 are β-mononuclear, four are α-mononuclear, three are α/β/γ trinuclear and 
one is α/β/γ/δ tetranuclear. The most common active site residues found in members of 
the amidohydrolase superfamily are: two histidines from the C-terminal end of β-strand 
1 (HxH), a histidine from strand five, a histidine from strand 6 and an aspartate residue 
from strand 8.  
 205
The mechanistic details of α/β binuclear enzymes are still under debate, in spite 
of a large number of investigations.  Studies have been performed on enzymes of this 
kind such as URE (5, 61, 83, 86, 87, 151-156), PTE (46-51, 78, 80-82), DHO (31-33) 
and IAD (38-40).   Based on the analysis of those studies, a general mechanism for α/β 
binuclear enzymes was described in chapter I. The characterizations of the enzymes 
NagA and CDA presented here were directed toward a greater understanding of the 
mechanisms utilized by β-mononuclear and α-mononuclear amidohydrolase enzymes.  
In NagA, it was uncertain if one or two metals were required for full activity or 
how the active site metal participates in catalysis because the NagA from B. subtilis 
contains two metals bound in the crystal structure 2VHL, while the crystal structure 
1O12 from T. maritima had one metal in the active site. Additionally, in a group of 
NagAs including one from E. coli, it was noticed that the Mα forming HxH motif, was 
replaced by a QxN motif. It also was not known how the active site water becomes 
activated.  
In chapter II of this dissertation, the catalytic mechanism of NagA from E. coli 
was addressed by the characterization of the catalytic properties of different metal-
substituted forms of the enzyme. It was concluded that NagA requires one metal for 
catalysis, and that Mn2+, Fe2+, Ni2+, Co2+, Zn2+ and Cd2+ could all be used for catalysis at 
similar rates. Comparisons of the Zn and Cd forms of the enzyme in conjunction with 
the natural and thio-acetyl substrates demonstrated that the carbonyl oxygen interacts 
with the active site metal for transition state stabilization. pH-rate profiles with Zn and 
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Cd substituted forms of the NagA were used to demonstrate that the active site metal is 
also involved in the activation of the active site water.  
N-acetyl-D-glucosamine-6-phosphate and N-acetyl-D-glucosamine-6-sulfate were 
compared through pH profiles to demonstrate that the doubly negative charge on the 
phosphate is extremely important for binding and catalysis. It was shown that NagA can 
utilize N-acetyl-D-galactosamine-6-phosphate equally as well as the canonical substrate, 
indicating that NagA may perform this function in vivo.N-formyl-D-glucosamine-6-
phosphate and N-trifluoroacetyl-D-glucosamine-6-phosphate both acted as substrates. A 
26-fold rate enhancement was seen for the trifluoroacetyl-substrate.  
Mutants of the E. coli NagA were constructed to ascertain the roles of specific 
residues towards metal binding, substrate binding and catalysis. Substitution of the QxN 
motif for the HxH motif was performed to re-create the active site seen in the binuclear 
B. subtilis NagA. The double mutant was found to contain 50% more metal and a 
decrease in activity by about four orders of magnitude. Mutation of a Glu-131 from 
strand-three resulted in a loss of activity that was comparable to the loss in metal 
content, supporting its role in metal binding not catalysis. Significant losses in activity 
were seen for His-143 and His-251 mutants supporting their respective roles in transition 
state stabilization and substrate binding. There was no detectable activity found for Asp-
273 mutants. It was concluded that this residue is primarily responsible for the activation 
of the hydrolytic water molecule. 
The rates of substrate hydrolysis were compared in H2O and D2O, resulting in 
negligible solvent isotope effects. Solvent viscosity effects were also found to be 
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negligible. N-methylphosphonate-glucosamine-6-phosphate was found to be an excellent 
mimic of the tetrahedral intermediate, as supported by the low nanomolar level 
inhibition constant. These experiments, in conjunction with the large rate enhancement 
seen for the N-trifluoroacetyl-D-glucosamine-6-phosphate substrate, show that the 
chemical step involved in the formation or breakdown of the tetrahedral intermediate is 
rate limiting. 
From these results, a catalytic mechanism was proposed that is similar to that of 
the binuclear enzymes. In this mechanism, catalysis is initiated by interactions of the 
carbonyl oxygen with the metal and His-143, resulting in polarization of the scissile 
bond. Asp-273 activates a metal bound water for hydrolytic attack at the carbonyl carbon 
of the substrate, resulting in the formation of a tetrahedral intermediate. The intermediate 
is stabilized through multiple interactions with Zn, His-143 and Asp-273. Proton transfer 
from Asp-273 to the leaving group amine initiates collapse of the tetrahedral 
intermediate.  
The evolution and structure of NagA was addressed in chapter III. Sequence 
comparisons of N-acetyl-D-galactosamine-6-phosphate deacetylases (AgaA) and NagA 
indicate that all of the same residues required for binding and catalysis are present in 
both enzymes. This is supported by the wild-type level of activity seen in chapter II for 
NagA with the N-acetyl-D-galactosamine-6-phosphate substrate. Even though it contains 
all of the metal binding ligands seen in the α/β-binuclear active site of NagA from B. 
subtilis, metal chelation and reconstitution experiments were used to demonstrate that 
NagA from T. maritima utilizes a single divalent cation for catalysis, like the QxN 
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containing NagA enzymes. Sequence analysis indicated that all of the QxN containing 
enzymes as well as the mononuclear HxH containing T. maritima enzyme possess a 
histidine residue at the same position as His-143 of E. coli NagA. An X-ray crystal 
structure of NagA was obtained with a Zn2+ ion bound in the active site (PDB code: 
2P50), this showed that the metal was bound to Glu-131, His-195 and His-216. Asp-273 
was found to be interacting with a metal bound water. A structure of a D273N mutant 
with Zn2+ and the methylphosphonate inhibitor was also obtained (PDB code: 2P53). 
This structure elucidated the nature of the His-143 interactions with the transition state, 
showing that His-143 is aiding the β-metal in the polarization of the substrate and 
stabilization of the tetrahedral intermediate.  This information provided a great deal of 
support for the establishment of the mechanism reported in chapter II.  
Prior to this work, important mechanistic details of all α-mononuclear enzymes, 
particularly ADA and AMPD, were under debate. For instance, there was no consensus 
on which residues activate the hydrolytic water, or how the leaving group amnonia gets 
protonated. The mechanistic studies of CDA presented in chapter IV set out to shed light 
on the mechanism likely shared by all deaminases of the amidohydrolase superfamily. 
CDA has been described as an Fe2+ dependent enzyme based on the greater level 
of activity seen for iron containing enzyme, compared to Zn2+ containing enzyme at pH 
7.5. Metal chelation and reconstitution experiments showed that CDA was reactivated 
with 1.0 equivalent of Zn2+. An activity assay was utilized with distinct extinction 
coefficients for each pH value measured. pH profiles of Zn2+ and Fe2+ containing 
enzymes were performed to elucidate the nature of the preference of CDA for Fe2+ over 
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Zn2+. It was determined that the Fe2+ enzyme was able to effectively activate the 
hydrolytic water at low pH values, while at pH 7.5, the Zn2+ enzyme was already starting 
to lose activity.  
Mutations performed at Glu-218, His-247 and Asp-314 all resulted in drastic 
losses of activity. This provides support for the vital roles that these enzymes play in 
catalysis. The E218A mutant was found to be able to catalyze the hydrolysis of 3-
oxauracil, a compound which needs no protonation. This helps establish the role of Glu-
218 in the protonation at N-3 of cytosine. Measurable levels of activity for the H247Q 
mutant were used in pH profiles. The resulting profiles dispayed no pH dependence on 
activity between pH 5 and 10. As a result, it was concluded that His-247 and all other 
catalytic residues need to be deprotonated for activity. The extremely low activity seen 
for the Asp-314 mutant supports its role in the final proton abstraction from hydrolytic 
water and its eventual protonation of the leaving group ammonia.   
The sizable inverse isotope effects seen for CDA are indicative of a low-barrier 
H-bond occurring in the steps leading to the formation of the transition state. One such 
H-bond could be the bond formed between Glu-218 and N-3 of cytosine. Both groups 
have pKa values close to four and should result in a compressed H-bond, but upon 
hydrolytic attack, the pKa of the resulting uracil shifts to a much higher value, explaining 
why the H-bond in the structure appears to be of ordinary length. The two inhibitors 
served as excellent probes of the transition-state intermediate. Phosphonocytosine was a 
far better inhibitor than the phosphonouracil, resulting in an inhibition constant that is 
20,000 times lower than the Michaelis constant of cytosine. This shows that transition 
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state stabilization is an essential component of the mechanism of CDA. Given the 
magnitude of the inverse solvent isotope effects, and the observation of the negliglible 
viscosity effects, it appears that the chemical step is rate determining.  
Attempts at identifying a missing deaminase in the riboflavin pathway of archaea 
are described in chapter V of this dissertation. From the research that has been 
performed on the riboflavin biosynthetic genes in archaea, it has been noted that there is 
a deaminase that has yet to be identified. In bacteria and yeast, the deaminase is related 
to bacterial cytidine deaminase, which is not of the amidohydrolase superfamily. A 
cluster of genes containing many riboflavin biosynthetic proteins was identified in 
archaeal organisms such as Methanococcus maripaludis, Methanosarcina mazei, and 
Sulfolobus solfataricus. Within these clusters of proteins, there lies a hypothetical 
protein annotated as COG-SsnA or trzA-like. From the knowledge gained studying 
amidohydrolase enzymes, it was predicted that this enzyme contains all of the conserved 
active site residues found in deaminases. 
For the production of the substrate for the deaminase, GTP cyclohydrolase II 
(RibA) from E. coli was expressed and purified. Mmp1348, a putative pyrimidine 
reductase from Methanococcus maripaludis, was cloned, expressed and purified. The 
substrate for the putative deaminase was prepared enzymatically with the two enzymes 
and verified through derivatization and UV/Vis characterization.  
Three putative deaminases, MmarC7_0625 from M. maripaludis, Mm0823 from 
M. mazei, and Sso0398 from S. solfataricus, were cloned and expressed in BL21 cells, 
Rosetta cells, Rosetta-gami cells, and Rosetta pLysS cells, with and without (His)6 tags, 
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and under a variety of conditions.  Experimental conditions included various 
combinations of the following: low temperature expression at 15 ºC, High temperature 
expression at 45 ºC, variations from 0.1 to 1.0 mM IPTG, LB media with and without 
500 mM NaCl and 1 mM glycine betaine. These conditions all failed to yield soluble or 
active protein.  
The cell lysis pellets appeared to contain very pure protein. The purification of 
these inlusion bodies was attempted through partial denaturation with urea or guanidine 
HCl. Dialysis into less denaturing solutions resulted in immediate precipitation. For the 
thermophilic enzyme from S. solfataricus this dialysis was attempted at temperatures of 
up to 60 ºC, but the protein proved to be insoluble under all conditions. 
Sso0398 was cloned into a pMAL-c4X maltose binding protein fusion vector. 
The resulting fusion protein proved to be soluble and was purified by amylose column. 
The protein fusion failed to yield any activity. The fusion was then cleaved using factor 
Xa protease. The resulting cleavage product precipitated, leaving only the maltose 
binding fusion partner in solution. This was verified by N-terminal sequencing.  
It seems that without some form of subtantially different expression, the function 
of these deaminase-like proteins will remain elusive due to their extremely insoluble 
nature. Other remaining options for achieving soluble and active protein could be 
anaerobic expression, the incorporation of C-terminal fusion tags or the use of cell-free 
protein expression methods. It may also be possible that this protein needs some other 
subunit to be present for solubility and activity. 
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In chapter VI, a group of enzymes related to guanine deaminase were identified 
which appeared to be involved in a pathway with guanine deaminase and adenosine 
deaminase. While very similar in sequence to guanine deaminase, it was observed that 
these enzymes differed at two particular sites which are involved in substrate binding. 
Sequence alignments of these proteins were used to identify a key conserved Cys-Ser 
substrate binding dyad at the end of β-strand 4. One of these genes (9236e) was 
crystallized and assigned the PDB code: 3HPA. The crystal structure 3HPA showed that 
the protein had a Zn2+ bound in the active site and appeared to be very similar to guanine 
deaminase. A structural alignment of 3HPA with the human GDA crystal structure 
2UZ9, showed that the Cys-232 may be participating in substrate recognition which is 
different than that of GDA. Another enzyme was identified within this group of Cys 
containing GDA-like enzymes is Pa0142, which shares a 46% sequence identity to 
9236e. 
Pa0142 and 9236e were tested for deaminase activity against a library of 
pteridines, purines and pyrimidines. These two proteins of unknown function were found 
to be active with isocytosine, guanine and 8-oxoguanine. 8-oxoguanine yielded 10-fold 
more activity for these two enzymes than any other compound, yielding kcat/Km values of 
up to 105 M-1 s-1. The conservation of this cysteine group enabled the identification of 
217 bacterial proteins which should possess 8-oxoguanine deaminase activity.   
The final chapter of this dissertation describes the function discovery of two 
isoxanthopterin deaminases involved in the uncharacterized degradation pathway of folic 
acid. Thorough examination of unknown bacterial sequences related to guanine 
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deaminase produced a small group of 24 sequences which are highly similar to guanine 
deaminase and 8-oxoguanine deaminase, yet they contain another variation at the 
substrate recognition site identified in the previous chapter. This new group of enzymes 
contains a threonine at the very position where guanine deaminases contain a conserved 
arginine and 8-oxoguanine deaminases have a conserved cysteine. This group of genes is 
found among a cluster of genes which appear to be decarboxylases, oxidoreductases, 
dioxygenases, possible hydratases, other unknown deaminases, and xanthine/uracil 
permeases. The relevance of this genomic context became more apparent after the 
function of the deaminase was known.   
Two of these proteins have been previously purified by the New York SGX 
Research Consortium. They are 9339a and 9236b. An X-ray crystal structure was also 
already known for 9339a and was assigned the PDB code: 2PAJ. It contained a single 
zinc atom in the active site and was missing the coordinates for several of the residues 
including the catalytic glutamate conserved among all deaminases. A structural 
alignment of 2PAJ with the human guanine deaminase structure 2UZ9 with bound 
xanthine showed that the threonine residue is positioned in the very spot as the arginine 
of guanine deaminase. It was not known what kind of activity this residue would impart, 
so the proteins 9339a and 9236b were tested for deaminase activity against a host of 
pteridines, purines and pyrimidines. These enzymes yielded maximum activities with 
isoxanthopterin that were 10 × greater than with any other compound. With kcat/Km on 
the order of 1.3 ×105 M-1 s-1 for 9339a and 2.4 × 104  M-1 s-1 for 9236b, it seems likely 
that isoxanthopterin is the natural substrate for these enzymes. The second best substrate 
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was pterin-6-carboxylate. It seems to be an odd substrate for activity, considering that 
the differences in size and charge between the two different pterin modifications. 
Considering the activities seen for these enzymes, it appears that the neighboring 
decarboxylases, dioxygenases, putative hydratases, and deaminases surrounding these 
isoxanthopterin deaminases fit nicely into the proposed pathway for folate degradation 
proposed in chapter VII.  The two different activities make sense as well, because they 
eventually produce the same product. The genes near these enzymes would be of interest 
for further study, because the proteins of this pathway have never been identified.  Genes 
related to 9339a and 9236b containing the threonine at this critical substrate recognition 
site are predicted to be isoxanthopterin deaminases.The conservation of this threonine 
was used to identify 24 genes which are predicted to deaminate isoxanthopterin. These 
genes are listed in Appendix B, and all share greater than 41% sequence identity to 
9339a.  
 In conclusion, this research was successful in establishing detailed reaction 
mechanisms for the β-mononuclear and the α-mononuclear amidohydrolase enzymes 
which are consistent with experimental data. Residues implicated in substrate binding 
and catalysis were evaluated for individual contributions which may be used for future 
function discoveries. Knowledge of enzyme-substrate interactions for human guanine 
deaminase was used in the successful discovery of the related 8-oxoguanine deaminases 
and isoxanthopterin deaminases.  
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APPENDIX A 
List of all genes predicted to possess 8-oxoguanine deaminase activity.  
*8-oxoguanine deaminase activity was confirmed experimentally. 
 
 Locus tag GI Organism 
1* PA0142 879447 Pseudomonas aeruginosa PA01 
2 PaerPA_01000142 107099133 Pseudomonas aeruginosa PACS2 
3 PA2G_04056 6715071 Pseudomonas aeruginosa 2192 
4 PACG_03701 6720155 Pseudomonas aeruginosa C3719 
5 PA14_01750 4383541 Pseudomonas aeruginosa UCBPP-
PA14 
6 PSPA7_0219 5356948 Pseudomonas aeruginosa PA7 
7 Pmen_3705 5105700 Pseudomonas mendocina ymp 
8 PSEEN0675 4088425 Pseudomonas entomophila L48 
9 Pf101_0675 3713960 Pseudomonas fluorescens PfO-1 
10 PFL_0724 3481313 Pseudomonas fluorescens Pf-5 
11 PFLU0669 7819150 Pseudomonas fluorescens SBW25 
12 PSPTOT1_3659 213969358 Pseudomonas syringae pv. tomato 
T1 
13 atzB 1182385  Pseudomonas syringae pv. Tomato 
str. DC3000 
14 Psyr_0669 3366147 Pseudomonas syringae pv. Syringae 
B728a 
15 Psyrpo1_010100001930 237797581 Pseudomonas syringae pv. oryzae 
str. 1_6 
16 PSPPH_4628 3555934 Pseudomonas syringae pv. 
phaseolicola 1448A 
17 atzB 5096040 Pseudomonas stutzeri A1501 
18 Arth_3425 4444155 Arthrobacter sp. FB24 
19 AAur_3399 4639368 Arthrobacter aurescens TC1 
20 Achl_3205 7294686 Arthrobacter chloophenolicus A6 
21 ACIAD0761 2879221 Acinetobacter sp. ADP1  
22 BlinB01003114 62423337 Brevibacterium linens BL2 
23 VSAK1_24940 149188732 Vibrio shilonii AK1 
24 V12B01_19391 84386830 Vibrio splendid 12B01 
25 VSWAT3_19088 148978109 Vibrionales bacterium SWAT-3 
26 P3TCK_01255 90413684 Photobacterium profundum 3TCK 
27 PBPRA2267 3122820 Photobacterium profundum SS9 
28 KT99_04812 163751045 Shewanella benthica KT99 
29 PE36_19015 149908977 Moritella sp. PE36 
30 SI859A1_03023 90420336 Aurantimonas manganoxydans SI85-
 240
9A1 
31 Pcryo_1786 4033973 Psychrobacter cryohalolentis K5 
32 Mnod_1111 7304423 Methylobacterium nodulans ORS 
2060 
33 MELB17_16823 126666105 Marinobacter sp. ELB17 
34 Mext_1697 5832952 Methylobacterium extorquens PA1 
35 Mchl_2016 7118716 Methylobacterium 
chloromethanicum CM4 
36 BRADO1738 5118449 Bradyrhizobium sp. ORS278 
37 Mchl_3248 7117587 Methylobacterium 
chloromethanicum CM4 
38 Mpop_1121 6313798 Methylobacterium populi BJ001 
39 M446_2144 6130066 Methylobacterium sp. 4-46 
40 FP2506_15334 114705851 Fulvimarina pelagi HTCC2506 
41 B116159 1048904 Brandyrhizobium japonicum USDA 
110 
42 MED121_14459 87118237 Marinomonas sp. MED121 
43 MDG893_15717 149375925 Marinobacter algicola DG893 
44 BBta 2050 5153053 Brandyrhizobium sp. BTAi1 
45 Mrad2831_4071 6140129 Methylobacterium radiotolerans 
JCM 2831 
46 HCH_01106 3841406 Hahella chejuensis KCTC 2396 
47 Mext_3024 5835455 Methylobacterium extorquens PA1 
48 CJA_0540 6415371 Cellvibrio japonicus Uedal07 
49 Patl_2224 4172376 Pseudoalteromonas atlantica T6c 
50 StermDRAFT_06890 229881741 Sebaldella termitidis ATCC 33386 
51 Francci3_0845 3904327 Frankia sp. CcI3 
52 Bphy_1293 6242785 Burkholderia phymatum STM815 
53 Bxe_A1936 4003154 Burkholderia xenovorans LB400 
54 Bphyt_2323 6281242 Burkholderia phytofirmans PsJN 
55 BgramDRAFT_5200 170695243 Burkholderia graminis C4D1M 
56 SADFL11_1395 7514273 Labrenzia alexandrii DFL-11 
57 NOR53_2032 7635455 Gamma proteobacterium NOR5-3 
58 Bcep18194_A5267 3750479 Burkholderia sp. 383 
59 BuboB_010100016293 167586903 Burkholderia ubonensis Bu 
60 BTH_I2073 3848116 Burkholderia thailandensis E264 
61* NYSGXRC-9236e 44264246 Env. Samp. of Sargasso sea 
62 BDAG_01340 6703425 Burkholderia dolosa AUO158 
63 BthaT_010100025531 167581531 Burkholderia thailandensis TXDOH 
64 Bpse38_010100010869 167836982 Burkholderia thailandensis 
MSMB43 
65 BH160DRAFT_3765 209518669 Burkholderia sp. H160 
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66 BCPG_02756 6709226 Burkholderia cenocepacia PC184 
67 BCAL2029 6932197 Burkholderia cenocepacia J2315 
68 Bcenmc03 1980 6123644 Burkholderia cenocepacia MC0-3 
69 Bglu_1g13210 7908425 Burkholderia glumae BGR1 
70 KoleDRAFT_1086 213014337 Thermotogales bacterium TBF 
19.5.1 
71 Bcen_6122 4097155 Burkholderia cenocepacia AU 1054 
72 KT71_15846 88703340 Congregibacter litoralis KT71 
73 atzB 3688614 Burkholderia pseudomallei 1710b 
74 Bpse112_010100013174 167911441 Burkholderia pseudomallei 112 
75 GBP346_A2491 7888169 Burkholderia pseudomallei 
MSHR346 
76 Bpse17_030300030822 161374040 Burkholderia pseudomallei 1710a 
78 BPSL2112 3092957 Burkholderia pseudomallei K96243 
79 BURPS1106A_2422  4901051 Burkholderia pseudomallei 1106a 
80 PputW619_3055 6112005 Pseudomonas putida W619 
81 Bpse7_010100013763 167894812 Burkholderia pseudomallei 7894 
82 BpseN_010100013161 167903203 Burkholderia pseudomallei NCTC 
13177 
83 Bamb_1943 4310181 Buckholderia ambifaria AMMD 
84 Bpse110_020300007234 161355267 Burkholderia pseudomallei 1106b 
85 pC2C203U28_p100 7636495 Clostridium botulinum 
86 BamIOP4010DRAFT_5246 170702284 Burkholderia ambifaria IOP40-10 
87  BamMEX5DRAFT_6744 171322619 Burkholderia ambifaria MEX-5 
88 CSBG_01722 7864561 Clostridium sp. 7_2_43FAA 
89 BamMC406_1870 6178204 Burkholderia ambifaria MC40-6 
90 BURMUCGD1_1300 221215518 Burkholderia multivorans CGD1 
91 Bcep1808_1882 4953605 Burkholderia vietnamiensis G4 
92 PputGB1_3262 5871047 Pseudomonas putida GB-1 
93 PP_2584 1045965 Pseudomonas putida KT2440 
94 NT01EI_2443 7959175 Edwardsiella ictaluri 93-146 
95 Pput_3132 5195102 Pseudomonas putida F1 
96 Daci_1591 5747148 Delftia acidovorans SPH-1 
97 PB2503_11584 84704671 Parvularcula bermudensis 
HTCC2503 
98 BURMUCGD2M_1761 221198260 Burkholderia multivorans CGD2M 
99 Noca_1626 4600005 Nocardioides sp. JS614 
100  Bmul_1313 5764920 Burkholderia multivorans ATCC 
17616 
101 mma_0509 5352721 Janthinobacterium Sp. Marseille 
102 Mpop_1247 6313306 Methylobacterium populi BJ001 
103 CLL_A0628 6293100 Clostridium botulinum B str. Eklund 
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17B 
104 Mchl_2080 7115864 Methylobacterium 
chloromethanicum CM4 
105 BoklC_010100010767
  
167570319 Burkholderia oklahomensis C6786 
106 Pden_3916 4582467 Paracoccus denitrificans PD1222 
107 Xaut_2741 5424708 Xanthobactor autotrophicus Py2 
108 CLH_0589 6317741 Clostridium botulinum E3 str. 
Alaska E43 
109 Rxyl_2838 4117689 Rubrobacter xylanophilus DSM 
9941 
110 Franean1_5674 5674001 Frankia sp. EAN1pec 
111 Mrad2831_6206 6142345 Methylobacterium radiotolerans 
JCM2831 
112 BACCAP_04381 154500708 Bacteroides capillosus ATCC 29799 
113 Tmel_1728 5296651 Thermosipho melanesiensis BI429 
114 Cbei_2067 5293279 Clostridium beijerinckii NCIMB 
8052 
115 FRAAL1474 4235777 Frankia alni ACN14a 
116 h16_A1363 4249475 Ralstonia eutropha H16 
117 Pmob_1736 5757974 Petrotoga mobilis SJ95 
118 RALTA_A1283 6453012 Cupriavidus taiwanensis 
119 RCCS2_14544 126735104 Roseobacter sp. CCS2 
120 Mpe_A0782 4784170 Methylibium petroleiphilum PM1 
121 CtesDRAFT_PD0564 221065227 Comamonas testosteroni KF-1 
122 Lcho_1140 6163813 Leptothrix cholodnii SP-6 
123 RB2150_16594 126727973 Rhodobacterales bacterium 
HTCC2150 
124 Cbac1_010100016929 224388129 Clostridiales bacterium 
1_7_47_FAA 
125 R2601_20986 114762995 Roseovarius sp. HTCC2601 
126 THA_25 7070815 Thermosipho africanus TCF52B 
127 S7335_3628 7570418 Synechococcus sp. PCC 7335 
128 HneapDRAFT_0499 225303291 Halothiobacillus neapolitanus c2 
129 VDG1235_1698 7583649 Verrucomicrobiae bacterium 
DG1235 
130 ANACOL_00024 167768708 Anaerotruncus colihominis DSM 
17241 
131 CLOSTASPAR_03878 225390128 Clostridium asparagiforme DSM 
15981 
132 CLOBOL_06600 160941704 Clostridium bolteae ATCC BAA-
613 
133 Reut_A1294 3611928 Ralstonia eutropha JMP134 
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134 Rpic_2259 6289356 Ralstonia pickettii 12J 
135 VspiD_010100021095 171913717 Verrucomicrobi spinosum DSM 
4136 
136 OIHEL45_10143 163745939 Oceanibulbus indolifex HEL-45 
137 MAB_2927c 5965434 Mycobacterium abscessus 
138 Rpic12DDRAFT_0675 153888567 Ralstonia picketti 12D 
139 Jann_1234 3933679 Jannaschia sp.CCS1 
140 GobsDRAFT_06540 227405252 Geodermatophilus obscurus DSM 
43160 
141 atzB 7593298 Roseobacter sp. GAI101 
142 SIAM614_20905 118591899 Stappia aggregata IAM 12614 
143 TM1040_1906 4077403 Silicibacter sp. TM1040 
144 BHWA1_02619 7667707 Brachyspira hyodysenteriae WA1 
145 RB2654_08457 84686221 Rhodobacterales bacterium 
HTCC2654  
146 BmurDRAFT_00390 227999304 Brachyspira murdochii DSM 12563 
147 RR11_659 7624076 Ruegeria sp. R11 
148 MSMEG_1297 4531257 Mycobacterium smegmatis str. MC2 
155 
149 OG2516_00245 89069700  Oceanicola granulosus HTCC2516  
150 RRSL_01271 83748887 Ralstonia solanacearum UW551 
151 RSMK01192 6954169 Ralstonia solanacearum Molk2 
152 RB2083_1302 7579673 Rhodobacterales bacterium 
HTCC2083 
153 SSCG_02005 6838461 Streptomyces clavuligerus  
154 Magn03006515 46203056 Magnetospirillum magnetotacticum 
MS-1 
155 
 
RSK20926_22599 126739238 Roseobacter sp. SK209-2-6 
156 RKLH11_2317 7627427 Rhodobacteraceae bacterium KLH11
157 atzB 4941115 Saccharopolyspora erythraea NRRL 
2338 
158 Dshi_2773 5713672 Dinoroseobacter shibae DFL 12 
159 SnasDRAFT_44920 229865225 Stackebrandtia nassauensis DSM 
44728 
160 Bpse9_010100014316 167816318 Burkholderia pseudomallei 91 
161 Gdia_3513 6976965 Gluconacetobacter diazotrophicus 
PA1 5 
162 guaD 5789984 Gluconacetobacter diazotrophicus 
PA1 5 
163 RGBS107_18053 163737460 Phaeobacter gallaeciensis BS107 
164 OA238_3529 7523411 Octadecabacter antarcticus 238 
165 RG210_13486 163740856 Phaeobacter gallaeciensis 2.10 
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166 RHOER0001_4250 229489548 Rhodococcus erythropolis SK121 
167 EE36_11673 83944527 Sulfitobacter sp. EE-36 
168 OA307_342 7603653 Octadecabacter antarcticus 307 
169 SPO2957 3194390 Silicibacter pomeroyi DSS-3 
170 RER_21130 7714318 Rhodococcus erythropolis PR4 
171 atzB 1220960 Ralstonia solanacearum GMI1000 
172 CaciDRAFT_38210 229248212 Catenulispora acidiphila DSM 44928
173 MED193_21601 86140035 Roseobacter sp. MED193 
174 NAS141_16899 83955348 Sulfitobacter sp. NAS-14.1 
175 SGR_1307 6209440 Streptomyces griseus subsp. Griseus 
NBRC 13350 
176 atzB 4222059 Rhodococcus sp. RHA1 
177 atzB 4196714 Roseobacter denitrificans OCh 114 
178 RLO149_17318 163733433 Roseobacter litoralis Och 149 
179 NamuDRAFT_10270 229222217 Nakamurella multipartita DSM 
44233 
 
180 Rmet_1186 4037987 Ralstonia metallidurans CH34 
181 ROP_44280 7742160 Rhodococcus opacus B4 
182 SSDG_03874 6842290 Streptomyces pristinaespiralis 
ATCC 25486 
183 SCO6213 1101654 Streptomyces coelicolor A3 (2) 
184 SAV_2017 1213459 Streptomyces avermitilis MA-4680 
185 GbroDRAFT_06290 227400018 Gordonia bronchialis DSM 43247 
186 SSEG_02091 6852719 Streptomyces sviceus ATCC 29083 
187 Bpse14_010100013624 167739105 Burkholderia pseudomallei 14 
188 RBY4I_2538 7619385 Rhodobacterales bacterium Y4I 
189 SSBG_04646 6861992 Streptomyces sp. SPB74 
190 OB2597_10014 84500269 Oceanicola batsensis HTCC2597 
191 SrosDRAFT_80950 229857618 Streptosporangium roseum DSM 
43021 
192 Nfa52410 3110729 Nocardia farcinica IFM 10152 
193 SSAG_01926 6859830 Streptomyces sp. Mg1 
194 OM2255_10461 114769985 Rhodobacterales bacterium 
HTCC2255 
195 MCAG_05318 238064352 Micromonospora sp. ATCC 39149 
196 MMAR_2844 6227111 Mycobacterium marinum M 
197 NdasDRAFT_4742 229209177 Nocardiopsis dassonvillei subsp. 
dassonvillei DSM 43111 
198 MUL_2914 4553343 Mycobacterium ulcerans Agy99 
199    
200 Krad_4281 5335917 Kineococcus radiotolerans 
SRA30216 
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201 BpseD_010100013846 167720093 Burkholderia pseudomallei DM98 
202 Noca_0677 4599542 Nocardioides sp. JS614 
203 BoklE_010100011296 167563133 Burkholderia oklahomensis EO147 
204 R2601_07911 114767058 Roseovarius sp. HTCC2601 
205 RHE_PC00089 3895310 Rhizobium etli CFN 42 
206 pRL100336 116254776 Rhizobium leguminosarum bv. 
viciae 3841 
207 HPDFL43_14672 163758676 Hoeflea phototrophica DFL-43 
208 smzB 111183223 Herbaspirillum sp. B601 
209 atzB 55416015 beta proteobacterium CDB21 
210 Rleg2_4464 6977558 Rhizobium leguminosarum bv. 
Trifolii WSM2304 
211 Magn03006970 23012454 Magnetospirillum magnetotacticum 
MS-1 
212 Cbac1_010100004932 224385745 Clostridiales bacterium 
1_7_47_FAA 
213 CLOBOL_05339 160940449 Clostridium bolteae ATCC BAA-
613 
214 trzN 156257442 Arthrobacter sp. AD26 
215 trzN 17432321 Nocardioides sp. C190 
216 AtzB 117583158 Arthrobacter sp. AD25 
227 AAur_pTC10087 119952514 Arthrobacter aurescens TC1 
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APPENDIX B 
 
List of all genes predicted to possess isoxanthopterin deaminase activity. 
*Isoxanthopterin deaminase activity was confirmed experimentally. 
 
 Locus tag GI Organism 
1* NYSGSRC-9339a 145580545 Unknown environmental sample of the 
Sargasso Sea 
2 Bxe_A2016 91783796 Burkholderia xenovorans LB400 
3 BgramDRAFT_0187 170690211 Burkholderia graminis C4D1M 
4 KPK_2302 206579968 Klebsiella pneumoniae 342 
5 KP1_3107 238895075 Klebsiella pneumoniae NTUH-K2044 
6 KPN_02032 152970581 Klebsiella pneumoniae subsp. 
pneumoniae MGH 78578 
7 HMPREF0023_2011 226953181 Acinetobacter sp. ATCC 27244 
8 ACIAD1467 50084641 Acinetobacter sp. ADP1 
9 PputW619_2587 170721762 Pseudomonas putida W619 
10 PP_3209 26989928 Pseudomonas putida KT2440 
11 Bmul_3605 161520154 Burkholderia multivorans ATCC 17616 
12 BURMUCGD1_3770 221209432 Burkholderia multivorans CGD1 
13 H16_A3380 113869328 Ralstonia eutropha H16 
14 Bcep18194_B0632 78061482 Burkholderia sp. 383 
15 Reut_A3081 73542765 Ralstonia eutropha JMP134 
16 BCAM2272 206564108 Burkholderia cenocepacia J2315 
17 BBta_1262 148252823 Bradyrhizobium sp. BTAi1 
18 BURMUCGD2M_4109 221200399 Burkholderia multivorans CGD2M 
19 Pfl01_3434 77459656 Pseudomonas fluorescens Pf0-1 
20 Bphyt_7136 187921762 Burkholderia phytofirmans PsJN 
21 RALTA_A2835 194290915 Cupriavidus taiwanensis 
22 SIAM614_03533 118593746 Stappia aggregata IAM 12614 
23 Mmwyl1_4101 152998097 Marinomonas sp. MWYL1` 
24* NYSGXRC-9236b 44611670 Unknown environmental sample of the 
Sargasso Sea 
 
 
 
 
 
 
 
 247
VITA 
 
Name: Richard Stuart Hall 
Address: Department of Chemistry  
 Texas A&M University 
 P.O. Box 30012 
 College Station, TX 77842 
  
Email Address: hallrich11@yahoo.com 
 
Education: Texas A&M University 
 College Station, Texas 
 Ph.D., Chemistry 
 December 2009 
 
 The University of Arizona 
 Tucson, Arizona 
 B.S., Chemistry 
 May 2003 
 
 
 
 
 
